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Abstract 
Retroviruses possess several biological features that differentiate them from all other 
infectious agents. The obligatory integration step of the retrovirus genome into the host 
genome has allowed these viruses to associate, modulate and alter the biology of the cell 
with a variety of unique mechanisms. Integration of retroviruses into the germ line of 
the host results in the formation of vertically transmitted “endogenous” retroviruses 
(ERVs).  It  is  now  becoming  apparent  that  ERVs  have  often  been  selected  as  they 
provided evolutionary advantages to the host.  Sheep Betaretroviruses provide a unique 
biological system to study the complex interaction between retroviruses and their hosts. 
Jaagsiekte  sheep  retrovirus  (JSRV)  is  the  causative  agent  of  ovine  pulmonary 
adenocarcinoma (OPA), a naturally occurring lung cancer of sheep. The  JSRV Env 
glycoprotein is a dominant oncoprotein and its expression is sufficient to induce cell 
transformation in vitro and in vivo. Thus, OPA is a unique large animal model for the 
study of lung carcinogenesis. The sheep genome harbours at least 27 copies of ERVs 
highly  related  to  JSRV  (enJSRVs).  Studies  on  enJSRVs  have  provided  evidence 
supporting the idea that ERVs, exogenous retroviruses and the host have coevolved 
through  a  dynamic  process  throughout  evolution.  enJSRVs  play  a  critical  role  in 
conceptus development and placental morphogenesis, and can block JSRV replication 
in vitro at both early and late stages of the replication cycle. The work presented here 
focuses on the study of the exogenous and endogenous JSRV Envs and their role in cell 
transformation and trophoblast differentiation respectively. We were able to show that: 
I)  the  JSRV  Env  transforms  epithelial  cells  in  vitro  independently  from  its  cellular 
receptor; II) both the exogenous and endogenous JSRV Envs interact with the receptor 
tyrosine kinase RON and that the cytoplasmic tail of the Env is the major determinant 
modulating  the  biological  effects  of  the  Env-RON  interaction;  III)  the  molecular 
chaperone  Hsp90  regulates  JSRV  Env  induced  cell  transformation,  in  part  by 
downregulating  Akt; and IV) OPA is a useful large animal model for the evaluation of 
new  anti-cancer  therapeutic  agents.  Moreover,  we  characterized  the  transforming 
properties, receptor usage and fusogenic activity of enJSRVs Envs to gain insight into 
their role in placental morphogenesis. The studies described in this thesis contributed to 
the understanding of JSRV induced cell transformation and the biology of enJSRVs. 3 
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Chapter 1 
Introduction 
Historic perspectives  
Retroviruses were originally discovered at the beginning of the 20
th century by Vilhelm 
Ellermann  and  Oluf  Bang  (1908)  and  Peyton  Rous  (1911)  as  “ultrafiltrable”  agents 
associated  with  neoplastic  diseases  of  veterinary  interest  (chicken  leukosis  and 
sarcomas) and much of our current knowledge of cancer development arose from their 
study as well as the study of DNA tumour viruses (Goff 2001). Although the earliest 
descriptions  of  cancer  date  back  to  approximately  1600  B.C.  in  the  Edwin  Smith 
papyrus (Smith 2007), it wasn’t until the discovery of oncogenes and tumour suppressor 
genes, through retroviruses and DNA viruses respectively that key events  in cancer 
causation  began  to  be  elucidated.  However,  it  is  surprising  that  what  the  Egyptian 
writing says about the disease, “there is no treatment”, is still valid for many forms of 
cancer. 
Several milestones in the history of retrovirology have been made using Rous sarcoma 
virus (RSV) one of most informative viruses of this family. RSV was one of the first 
retroviruses  to  be  discovered  (Vogt  1997)  and  studies  on  its  replication  led  to  the 
“provirus”  theory  and  the  anti-dogmatic  hypothesis  that  the  virus  used  RNA  as  a 
template for the synthesis of DNA. In addition, work with the Bryan strain led to the 
hypothesis of the presence of an “endogenous” envelope that allowed the release of 
infectious virus in the absence of a helper virus (Weiss 2006), introducing the concept 
of endogenous retroviruses. Moreover, the use of molecular probes derived from a RSV 
gene  that  was  responsible  for  transformation  (later  known  as  src)  allowed  the 
identification of cellular oncogenes (Stehelin, Guntaka et al. 1976) that dramatically 
changed the understanding of carcinogenesis. 
 Howard Temin was probably one of the investigators that made the most significant 
contributions  to  modern  retrovirology:  I)  in  1958,  together  with  Harry  Rubin,  he 
developed cell culture focus-forming assay for RSV (Temin and Rubin 1958) allowing 
for the first  time measurement of virus infectivity and transformation, and setting up 
the  experimental  platform  for  seminal  studies  on  the  retroviral  cycle  and  viral Mariana Varela, 2007     Chapter 1,18 
oncogenes that began in the 1960s; II) in 1970, simultaneously with David Baltimore, 
he isolated an RNA-dependent DNA polymerase, the reverse transcriptase (RT), that 
not only unravelled the conundrums that had puzzled retrovirologists for decades, but 
also provided an invaluable biotechnological tool. Temin and Baltimore were awarded a 
Nobel Prize in Physiology or Medicine in 1975. 
HIV/AIDS has dominated the last thirty years of retrovirology. The discovery of virus-
induced tumours in higher mammals sparked the search for human retroviruses. Over 
the years, many false “first human retroviruses” were to be discovered and subsequently 
identified  as  cell  culture  contaminants  from  animal  sources.  However,  the 
epidemiological patterns of adult T-cell leukaemias in Japan raised suspicion on the 
presence of a transmissible agent. In 1980, thanks to the development of a long term cell 
culture  system  for  T  lymphocytes, H uman  T-cell  leukaemia  virus  1  (HTLV-1)  was 
identified  as  the  first  human  oncogenic  retrovirus  (Poiesz,  Ruscetti  et  al.  1980). 
Coincidentally, the AIDS epidemic arose around the time HTLV-1 was discovered, and 
the research on this virus provided the foundations for the discovery of HIV and its 
identification as the causative agent of AIDS (Barre-Sinoussi, Chermann et al. 1983; 
Gallo 2005).  Robert Gallo commented in 2006: “…if AIDS had to come, we were 
lucky (scientifically speaking) it came at a very good time” (Gallo 2005). He refers to 
the accumulated knowledge on the retroviral cycle and the modern tools in molecular 
biology that were developed in the seventies. Although the HIV/AIDS epidemics came 
at a “good time” HIV has proven to be unique in its transmission, pathogenesis and 
replication, hampering the way to the discovery of a vaccine and an effective therapy. 
Taxonomy 
Retroviruses comprise a large family of positive stranded RNA enveloped viruses found 
in a variety of vertebrates. Their replication strategy presents two unique events that 
indubitably differentiate them from other virus families: I) upon entry into the target cell 
the RNA genome is reverse-transcribed (by the virion associated reverse transcriptase, 
RT) into DNA that is II) then stably integrated into the host cell genome. This peculiar 
life  cycle  allows  retroviruses  to  establish  persistent  infections  and  possibly  vertical 
transmission  when  they  infect  the  germ  line  of  the  host  giving  rise  to  endogenous 
retroviruses (ERV). Mariana Varela, 2007     Chapter 1,19 
Retroviruses were originally divided into four groups according to the morphology and 
intracellular position of the nucleocapsid core visible by electron microscopy (Vogt 
1997). A-Type viruses were characterized as intracellular structures with a thick shell 
and a hollow, electron-lucent centre representing an immature capsid. This term is now 
used  to  refer  to  the  intracytoplasmic  particles  formed  by  some  retrotransposons 
(intracisternal A-type particles, IAPs). B-type viruses assemble in the cytoplasm and 
possess a round and eccentrically positioned core. C-type viruses on the other hand 
assemble at the plasma membrane and contain a central, spherical inner core (Bouillant 
and Becker 1984). D-type viruses display a bar-shaped core upon budding and they 
assemble in the cytoplasm. Retroviruses are commonly divided into simple or complex 
according to the array of genes encoded by their genomes. Simple viruses encode only 
the Gag, Pro, Pol and Env gene products, while complex viruses encode the same genes 
plus a number of regulatory proteins such as Tat, Rev, Vif etc in HIV-1. The family 
Retroviridae  has  recently  been  re-classified  by  the  International  Committee  on 
Taxonomy of Viruses into two subfamilies (orthoretrovirinae and spumaretrovirinae) 
and seven genera that are summarized in Table 1. 
 
Subfamily 
 
Genera 
 
Genome 
 
Morphology 
 
Examples 
Alpharetrovirus  Simple  C-type 
Avian leukosis 
virus 
Rous sarcoma 
virus 
Betaretrovirus  Simple  B/D-type  Jaagsiekte sheep 
retrovirus 
Gammaretrovirus  Simple  Type-C  Murine leukaemia 
viruses 
Deltaretrovirus  Complex  Type-C  Bovine leukaemia 
virus 
Epsilonretrovirus  Complex  Type-C  Walleye dermal 
sarcoma virus 
Orthoretrovirinae 
Lentivirus  Complex  Type-C 
Human 
immunodeficiency 
virus type 1 
Spumaretrovirinae  Spumavirus  Complex  N/A  Human foamy 
virus 
Table 1. Retrovirus taxonomy. 
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Alpharetroviruses have a simple genomic organization, with a C-type morphology and 
comprise  a  number  of  avian  exogenous  and  endogenous  viruses  including  Avian 
leukosis virus (ALV) and Rous sarcoma virus (RSV). Betaretrovirus have only been 
isolated  from  mammals,  assemble  in  the  cytoplasm  with  either  a  B  or  a  D-type 
morphology and comprise both endogenous and exogenous viruses. This genus includes 
Mouse mammary tumour virus (MMTV), Mason-Pfizer monkey virus (M-PMV) and 
Jaagsiekte sheep retrovirus (JSRV). Gammaretrovirus have so far the largest number of 
members,  infecting  more  than  one  vertebrate  class,  like  murine  leukaemia  viruses 
(MLV), feline leukaemia viruses (FeLV) and avian reticuloendotheliosis viruses among 
others. They are simple viruses (although the recent discovery of  Rev-like protein in 
MMTV  may  challenge  this  notion  (Mertz,  Simper  et  al.  2005))  and  endogenous 
retroviruses are also found in this genus. Deltaretroviruses and lentiviruses share some 
similarities  although  they  are  phylogenetically  different.  Both  are  complex  viruses, 
restricted  to  mammals  and  they  do  not  comprise  oncogene-containing  members. 
Deltaretrovirus include bovine leukaemia virus (BLV) and HTLV.  Lentiviruses include 
both human and animal pathogens such as human immunodeficiency virus type 1 and 2 
(HIV-1 or 2), equine infectious anaemia virus (EIAV) and feline immunodeficiency 
virus (FIV) among others. Epsilonretroviruses include fish and reptile complex viruses 
with  a  C-type  morphology  like  Walleye  dermal  sarcoma  virus  (WDSV).  Finally, 
spumaviruses  include  a  number  of  viruses  with  complex  genomes  widespread  in 
mammals that have not been associated so far with disease (Goff 2001; Gifford and 
Tristem 2003). 
Genomic organization of retroviruses 
The retroviral genome consists of two identical positive stranded RNA molecules held 
together  as  a  homodimer,  through  a  self  complementary  region,  the  dimer  linkage 
structure (DLS) present at the 5’ end. Thus, the virions are operationally diploid. Each 
RNA molecule is between 7 to 13 kb in length and being generated by the cellular 
machinery they possess features of a cellular mRNA molecule including a “cap” at the 
5’end  by  a  methylated  GDP  attached  to  the  first  encoded  nucleotide,  and  a 
polyadenosine tail at the 3’ end (Vogt 1997). 
The retroviral genome is organized into the following regions as illustrated in Figure 1.  Mariana Varela, 2007     Chapter 1,21 
 
Figure 1. Schematic organization of the retroviral genome. 
Adapted from Retroviruses, 1997, Cold Spring Harbour Laboratory press. 
 
 The  repeated  region  (R)  is  a  small  sequence  present  at  both  ends  of  the  genome, 
immediately downstream of the cap at the 5’ end and just upstream of the poly(A) tail. 
It  is  required  for  the  generation  of  the  two  complementary  DNA  molecules  during 
reverse transcription (see below). Downstream of the 5’ R there is the 5’ unique region 
or U5 that contains one of the att sites required for integration. U5 is followed by an 18 
nucleotide  sequence,  the  primer  binding  site  (pbs)  that  accommodates  a  host  tRNA 
required for the initiation of reverse transcription. The packaging (encapsidation) signal 
(Ψ) is found downstream of the pbs and allows packaging of the viral RNA into the 
viral particle. This region usually contains the splice donor sequences necessary for the 
generation of subgenomic mRNA. The genes encoding for the viral proteins occupy the 
sequences downstream of this region and the majority of the genome. All replication 
competent retrovirus carry at least four genes: gag (for group-specific antigen), pro (for 
protease), pol (for polymerase), and env (for envelope). The gene gag encodes for the 
major structural protein of retroviruses. Gag is initially synthesized as a polyprotein that 
is cleaved upon budding by the viral protease (PR) (encoded by pro) during a process 
referred to as maturation. In mature viral particles Gag is proteolytically processed into 
at least three proteins: matrix (MA), capsid (CA) and nucleocapsid (NC). In addition, in 
some retroviruses spacer peptides are present between MA and CA and between CA 
and NC. The gene pol encodes for two enzymes: I) the reverse transcriptase (RT) that 
mediates the conversion of the viral RNA into a double stranded copy of DNA; and II) 
the integrase (IN) that joins this double stranded DNA copy with the DNA of the host 
cell. The env gene encodes for the envelope glycoprotein (Env) that is inserted in the 
lipid bilayer of the cell membrane to form the viral envelope. Env mediates adsorption 
and penetration of the virus into susceptible cells. The envelope protein is cleaved by 
cellular proteases into the surface (SU) domain, responsible for the interaction with the Mariana Varela, 2007     Chapter 1,22 
cellular receptor, and the transmembrane (TM) domain that fixes the SU to the lipid 
bilayer (Vogt 1997; Goff 2001).  
Simple retroviruses contain only the four genes mentioned above. On the other hand, 
complex retroviruses express an array of small regulatory proteins that are translated 
from subgenomic mRNA and regulate viral gene expression and infectivity at different 
levels. HIV for example expresses a small protein called Rev that mediates the nuclear 
export of unspliced RNA.  
Some oncogenic retroviruses display a particular genomic organization as they have 
acquired  (“transduced”)  cellular  genes  (oncogenes)  that  give  them  transforming 
properties. Consequently these viruses are replication defective and require the presence 
of a “helper” virus in order to complete their life cycle. An exception to this rule is 
presented  by  some  strains  of  RSV  where  the  captured  src  oncogene  is  located 
downstream of env and consequentially these viruses retain their ability to replicate 
(Vogt 1997; Goff 2001).  
The polypurine tract (ppt) is located at the 3’ end of the region encoding the viral genes 
and it is used as a primer for the start of the synthesis of the plus strand of DNA since it 
survives  the  RNase  H  activity  of  the  RT  during  reverse  transcription. The  last  two 
regions of the genomic RNA comprise the unique region 3 (U3) and the 3’ copy of R. 
U3 contains numerous cis-acting elements that are required for viral gene expression as 
well as the other att site needed for integration. R is followed by the poly(A) tail. 
Virion structure and proteins 
When retroviral virions are released from the infected cells they display an “immature” 
morphology given by the unprocessed nature of the Gag and Gag-Pol precursors. These 
immature virions are spherical  and characterized by an electron-lucent centre. After 
proteolytic  cleavage,  mediated  by  PR,  the  CA  protein  “collapses”  inducing  the 
condensation  of  the  core.  The  mature  viral  particles  are  approximately  100  nm  in 
diameter, although the size varies within a viral preparation (Goff 2001).  
Gag is formed in all retroviruses by at least three domains placed invariably in the same 
order: MA (matrix), CA (major capsid protein) and NC (nucleocapid). The core of the 
viral particle is formed by the CA protein that surrounds the viral RNA which is kept in Mariana Varela, 2007     Chapter 1,23 
a  highly  condensed  state  through  interactions  with  the  NC  protein.  A  peculiar 
characteristic  of  retroviruses  is  that  members  of  different  genera  display  a  different 
shape of the core, from spherical to cylindrical or conical. The MA protein forms a shell 
around the core, and the whole structure is enclosed by a lipid bilayer, derived from the 
host cell, modified by the insertion of the Env glycoprotein. Virions not only contain the 
structural proteins that give shape to the viral particle but also viral enzymes and some 
of the regulatory proteins, like Vpr in the case of HIV-1. It is interesting to note that 
cellular  proteins  are  also  packaged  into  the  virions.  One  of  the  cellular  proteins 
packaged by HIV-1 is APOBEC3G, a cytidine deaminase that catalyzes the conversion 
of  cytosine  to  uracil.  APOBEC3G  acts  as  a  restriction  factor  at  early  stages  of  the 
retroviral cycle (Goff 2004) and it is a paradox that a virus carries factors impeding the 
next round of replication! Figure 2 shows a schematic representation of a retroviral 
particle. 
MA  harbours  the  so-called  membrane  domain  (M  domain),  composed  in  most 
retroviruses by a myristyl group and a patch of basic amino acids that target Gag to the 
cell membrane. MA is also able to interact with Env in a non-specific manner, allowing 
the incorporation of heterologous Envs, a phenomenon known as pseudotyping (Vogt 
1997; Goff 2001).  
 
Figure 2. Retroviral particle. 
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The CA protein is relatively conserved among different genera and contains a highly 
conserved  motif  among  retroviruses  the  major  homology  region  (MHR) 
(spumaretroviruses do not have a recognisable  MHR). The function of MHR is not 
completely understood, however its mutation impairs assembly of some viruses, (e.g. 
M-PMV) (Strambio-de-Castillia and Hunter 1992). 
NC is a small basic protein, cleaved from the carboxy terminus of Gag, which is found 
in association with the viral RNA to form the core of the virion. The affinity of NC for 
RNA can be attributed to the presence of basic residues and one or two Cys-His motifs 
with the sequence CX2CX4HX4C. NC recognizes the packaging signal (Ψ) in the viral 
RNA  thus differentiating them from the cellular mRNAs (Berkowitz, Ohagen et al. 
1995). This intrinsic affinity for the viral RNA also promotes the dimerization of the 
two copies of the viral genome as well as the formation of the duplex between the tRNA 
and the sequences of the primer binding site. NC also bears the interaction domain (I) 
that is involved in Gag-Gag associations. Mutations on this domain reduce or block 
assembly and reduce the incorporation of Gag precursors into the viral particle (Goff 
2001).  
As previously mentioned, in most retroviruses Gag has also spacer peptides between 
MA and CA or between CA and NC. Their function is not clear, however it is worth 
mentioning that the L (late) assembly domains often lie on these peptides. L domains 
are involved in the late stages of the retroviral cycle since L-domain mutants induce the 
accumulation of viral particles under the cell membrane. Some viruses contain more 
than one L domain. They can be located at different positions in Gag and in some cases 
they are interchangeable (Goff 2001). 
The Env glycoprotein is originally translated as a precursor from a sub-genomic singly-
spliced mRNA. The Env precursor is subsequently cleaved into SU and TM proteins by 
cellular proteases while crossing the Golgi complex. The SU protein is the external, 
hydrophilic portion of the Env complex and it is attached to the TM protein through 
non-covalent interactions and in some viruses also by disulfide bonds. TM anchors the 
Env to the host cell membrane that decorates the viral lipid bilayer. The Env protein 
mediates receptor recognition and viral entry, determining cell tropism (Vogt 1997).  
The JSRV Env exhibits unique features among retroviruses as it is oncogenic both in 
vitro (Maeda, Palmarini et al. 2001; Allen, Sherrill et al. 2002) and in vivo (Wootton, Mariana Varela, 2007     Chapter 1,25 
Halbert  et  al.  2005;  Caporale,  Cousens  et  al.  2006)  while  the  Env  of  endogenous 
retroviruses highly related to JSRV (enJSRVs) are involved in conceptus development 
and placenta morphogenesis (Dunlap, Palmarini et al. 2006). 
Retroviral replication cycle 
As  illustrated  in  Figure  3,  retroviruses  replicate  through  a  complicated  cycle  that 
involves the following steps: 
I) Receptor recognition 
II) Entry 
III) Uncoating 
IV) Reverse transcription 
V) Nuclear entry and integration 
VI) Transcription and splicing of viral RNA 
VII) Nuclear export of spliced and unspliced viral RNA 
VIII) Translation of viral proteins 
IX) Assembly of virions 
X) Budding of the newly formed virions 
XI) Virion particle maturation 
 
The first five steps, starting from the attachment of the viral particle to the cell surface 
to the integration of the viral cDNA, are generally referred to as the early phases of the 
replication  cycle.  The  late  phase  begins  with  the  expression  of  the  viral  genes  and 
culminates with the release and maturation of the newly formed viral particles.  
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Figure 3. Schematic representation of the retroviral cycle. 
1) Recognition of the cellular receptor. 2) Viral entry. 3) Uncoating. 4) Reverse transcription. 5) 
Integration. 6) Transcription and splicing of viral RNAs. 7) Nuclear export of spliced RNAs. 7’) 
Nuclear export of unspliced RNAs. 8) Translation of viral RNAs. 9) Assembly. 10) Budding. 11) 
Maturation. 
 
Viral entry 
The first event to take place during the retroviral replication cycle is the adsorption of 
the viral particles to the cell membrane of the target cell. This process is believed to be 
independent from the cellular receptor but dependent on surface molecules, like heparin 
sulphate proteoglycan in the case of HIV (Nisole and Saib 2004). HIV-1, HIV-2 and 
Simian immunodeficiency virus (SIV) also bind to the surface of dendritic cells via the 
C-type mannose lectins DC-SIGN and DC-SIGNR, which are believed to allow the 
transport of the virions from the site of infection to the peripheral lymph nodes where 
they can encounter cells expressing the appropriate receptors (Pohlmann, Soilleux et al. 
2001). 
Once  the  virions  are  attached  to  the  cell  membrane,  the  interaction  of  the  Env 
glycoproteins with specific receptors allows the penetration of the virus into the cell. 
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A  particular  feature  of  retroviruses  is  the diverse  set  of  molecules  that  they  use  as 
receptors as shown in Table 2. 
Avian  leukosis/sarcoma  viruses,  for  example,  are  divided  into  ten  different  viral 
subgroups (A-J) based in part on their receptor usage. From the genus gamaretrovirus, 
MLVs are divided into four groups according to the distribution of their receptor in 
different species and to the viral interference patterns: I) ecotropic viruses can only 
infect mouse or rat cells through the use of a cationic, basic amino acid transporter 
(mCAT-1); II) xenotropic viruses are endogenous viruses that only infect non-murine 
cells; III) amphotropic viruses can infect cells derived from a variety of species using a 
sodium-dependent  phosphate  symporter  (PiT-2);  and  IV)  polytropic  viruses  are  also 
endogenous viruses with a wide host range including murine cells. Lentiviruses such as 
HIV-1,  HIV-2  and  SIV  require  not  only  the  presence  of  CD4,  which  was  the  first 
retroviral receptor to be identified, but also the presence of a second molecule, the co-
receptor (often CCR5 or CXCR4) for efficient infection (Maddon, Dalgleish et al. 1986; 
Hoxie, Haggarty et al. 1988; Sattentau, Clapham et al. 1988; Alkhatib, Combadiere et 
al. 1996; Dragic, Litwin et al. 1996; Feng, Broder et al. 1996; Hunter 1997; Goff 2001). 
The series of events that ultimately allow the entry of the viral particles into the cell are 
very complex and have been extensively studied in the HIV system. In HIV, the SU and 
TM proteins (gp120 and gp41 respectively) are arranged as trimers which recognise the 
cellular receptor (CD4). This interaction leads to a conformational change in both gp120 
(SU) and CD4 allowing the recruitment of the co-receptor (CXCR4 or CCR5). A new 
conformational  change  takes  place  inducing  the  insertion  of  the  hydrophobic  signal 
peptide present in gp41(TM) into the target cell membrane. This is followed by the 
dissociation of gp120 from gp41 and the formation of a six-helix bundle that ultimately 
promotes complete fusion and the release of the viral core into the cytoplasm. It appears 
that the efficiency of this process depends on the amount of Env, CD4 and co-receptor 
molecules that interact in one particular event (Gallo, Finnegan et al. 2003). 
 
 
 Mariana Varela, 2007     Chapter 1,28 
 
Virus 
 
Receptor 
 
Function 
MLV ecotropic  CAT-1  Basic amino acid transporter 
MLV amphotropic  Ram-1/GLVR2/PiT-2  Phosphate transporter 
MLV 10A1; FeLV; GaLV  GLVR1/PiT-1  Phosphate transporter 
MLV xenotropic, polytropic  Rmc1/XPR1  G-coupled receptor 
M813 ecotropic  SMIT-1  Na/inositol transporter 
FeLV-C  Flvcr  Organic anion transporter 
MMTV  TfR1  Transferrin receptor 
ASLV-A  tv-a  LDLR-like 
ALV-B,D,E  tv-b, -e  Fas receptor like 
ALV-C  tv-c  Butyrophilin-like 
Perv-A  HuPAR-1, -2  G-coupled receptor 
RD114, BaEV, MPMV, HER-W  RDR, RDR2/ASCT1,2 
Neutral amino acid 
transporter 
BLV  Blvr  AP-3 delta subunit-like 
JSRV  HYAL2  Hyaluronidase receptor 
HTLV-1  GLUT-1  Glucose transporter 
HIV-1, HIV-2, SIV  CD4 and CCR5, CXR4  T-cell differentiation marker 
Table 2. Retrovirus receptors
1. 
 
Reverse transcription 
Soon after fusion, uncoating of the viral core and reverse transcription take place. The 
mechanism and signals leading to the disassembly of the viral core and initiation of 
reverse  transcription  are  poorly  understood,  however  these  two  events  seem  to  be 
coupled.  It  is  believed  that  exposure  of  the  core  to  the  high  deoxyribonucleotide 
concentration of the cytoplasm and the presence of viral and cellular proteins in the 
viral particle trigger uncoating and reverse transcription. In HIV-1 the lack of the viral 
proteins Nef and Vif and the cellular protein Cyclophilin A is associated with reduced 
                                                 
1 Adapted from Fields of Virology, 2001, Fifth edition. 
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infectivity,  attributed  to  defects  in  the  early  phases  of  the  retroviral  cycle  (von 
Schwedler, Song et al. 1993; Aiken and Trono 1995; Braaten, Franke et al. 1996). 
The  hallmark  of  the  retroviral  life  cycle  is  the process  of  reverse  transcription  that 
generates a DNA duplex containing duplicated ends, known as long terminal repeats 
(LTR),  which  are  not  present  in  the  viral  RNA  template  (Figure  4).  This  complex 
reaction is mediated by the RT, thanks to its dual enzymatic activity: DNA polymerase 
and RNase H. The DNA polymerase activity lies at the amino terminal domain of pol 
and allows the incorporation of nucleotides to a growing 3’OH end. RT requires the 
presence of a DNA or RNA primer as well as a DNA or RNA template which can be 
used  with  the  same  efficiency.  The  enzyme  has  low  fidelity  and  generally  no 
proofreading activity, allowing the virus a high mutagenic rate and the chance to evade 
the  immune  system  and  develop  drug  resistance.  The  endonuclease  activity  of  the 
RNase H of the RT is present in the carboxyterminal domain and permits the release of 
3’OH and 5’PO4 only when the RNA is in a duplex form, mainly RNA:DNA. This 
activity allows the generation of primers that are used in the initiation of the DNA 
synthesis (Goff 2001).  
 
 
 
Figure  4.  Comparison  of  viral  RNA  and  DNA  after  reverse  transcription  and  the 
duplication of the U5 and U 3 regions. 
Adapted from Retroviruses, 1997, Cold Spring Harbour Laboratory press. 
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Reverse transcription starts with the synthesis of the minus-strand strong-stop DNA (-
sssDNA) which is initiated near the 5’ end of the viral RNA using as a primer a tRNA 
annealed in the PBS (Figure 5). The -sssDNA is relatively short and contains U5 and R 
sequences.  The  RNA  that  forms  part  of  the  newly  formed  RNA:DNA  hybrid  is 
degraded by the RNase H activity of the RT and the first “jump” occurs where the –
sssDNA anneals in the R region of the 3’ end of the RNA molecule, a process that 
seems to be facilitated by NC. Once in the 3’ end, the synthesis of the minus strand 
continues until the PBS, while the RNA template is degraded by an incomplete RNase 
H digestion that leaves behind the PPT which serves as a primer for the synthesis of the 
plus strand DNA, using the minus strand DNA as a template. Polymerization extends 
until it reaches the tRNA generating the plus-strand strong-stop DNA (+sssDNA). At 
this  point  the  tRNA  is  removed  by  the  RNase  H  activity  of  the  RT  exposing 
complementary sequences in the 3’ end of +sssDNA and allowing the second “jump” 
where these sequences anneal in the PBS present in the 3’ end of the minus strand 
DNA. This process creates a circular intermediate that permits the complete elongation 
of both the minus and the plus strands (Telesnitsky and Goff 1997; Goff 2001).  
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Figure 5. Reverse transcription 
The black line represents the viral RNA; the red light line the minus-strand DNA and the bold 
red line, the plus-strand DNA. From Retroviruses (Cold Spring Harbour Laboratory Press, with 
permission). 
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Integration 
The newly synthesized retroviral DNA genome has to gain access to the nucleus where 
it will become permanently integrated into the host genome. This is a crucial step that 
allows retroviruses to persist in the infected cell and be transmitted to daughter cells in a 
classical Mendelian fashion and perpetuating indefinitely viral production. The process 
of integration also gives retroviruses the chance to enter the germ cells and become a 
permanent element in the host genome (see endogenous retroviruses below). Although 
integration into the host genome provides retroviruses with certain advantages, the road 
to chromatin is complex and hazardous, that is why the retroviral DNA does not travel 
alone but as part of a big complex: the preintegration complex (PIC). The components 
of the PIC are not completely known, however in simple retroviruses it seems to contain 
CA, RT, IN and possibly other viral proteins while the PIC of complex retroviruses 
contains MA, NC, Vpr, RT and IN. These variations of the PIC composition within 
different retroviruses might reflect differences in the mechanisms used to gain access to 
the nucleus. Most retroviruses can infect only dividing cells during mitosis. In contrast, 
lentiviruses can infect non-dividing cells thanks to their ability to cross the nuclear 
envelope, through the nuclear pores. Although the mechanisms facilitating infection of 
non dividing cells are not yet well characterized there is evidence supporting the role of 
HIV-1  CA  and  some  tRNAs  species    (Goff  2001;  Zaitseva,  Myers  et  al.  2006; 
Yamashita, Perez et al. 2007). 
Once in the nucleus, the PIC has to find a suitable site to integrate into the host DNA 
and, although it usually occurs in a non sequence-specific manner, it is believed that the 
structure of the surrounding chromatin and interactions with host proteins influences the 
choice of the target site. The integration reaction is mediated by the viral IN into two 
steps (Figure 6). Firstly, the two terminal nucleotides at both 3’ends of the viral DNA 
are  removed  just  downstream  of  a  highly  conserved  CA  sequence,  leaving  two 
protruding 5’ ends. Secondly, the 3’OH ends of the viral DNA attack the phosphodiester 
bonds of the target host DNA and produce a new bond between the extremes of the viral 
and host DNA. This reaction results in the formation of short gaps in the host DNA and 
unpaired  bases  in  the  viral  DNA  that  are  repaired  (filled  in)  presumably  by  host 
enzymes, leading to the duplication of the target sequence that now flanks the integrated 
provirus (Goff 2001). Mariana Varela, 2007     Chapter 1,33 
 
Figure 6. Integration 
Adapted from Fields of Virology, (Goff 2001). 
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Expression of viral RNA 
The post-integration phase of the retroviral replication cycle begins with the expression 
of the viral RNA. This and other late phases of the viral cycle utilise mostly cellular 
proteins that are part of the normal transcription and translation machinery, as opposed 
to the early phase, where the most relevant reactions are mediated by viral proteins. The 
objective of the virus is to produce all the elements required for the formation of newly 
infectious  viral  particles,  including  proteins  and  viral  genomes.  The  proviral  LTRs 
contain the promoter that is recognized by the cellular RNA polymerase II complexes to 
initiate transcription in the U3-R border. The promoter in the 5’ LTR is much more 
efficiently used than the one in the 3’ LTR. The U3 contains enhancer binding motifs 
that  regulate  viral  expression  and  is  one  of  the  main  determinants  of  viral  tropism. 
Ultimately the cell type, its  physiological state and the integration site determine the 
levels of activity of the retroviral promoter (Rabson and Graves 1997; Goff 2001). 
The retroviral primary transcript displays features of a cellular mRNA, capped in the 5’ 
end and polyadenylated in the 3’ end, and follows one of two pathways: I) it is spliced 
to yield subgenomic mRNA for the synthesis of Env, in simple retroviruses, or Env and 
accessory  proteins  in  the  case  of  complex  retroviruses;  or  II)  it  is  exported  to  the 
cytoplasm,  unspliced,  where  it  is  used  for  the  translation  of  Gag  or  Gag-Pol 
polyproteins or as genomic RNA for encapsidation. Some retroviruses like MLV use 
two distinct populations of genomic RNAs for protein translation and for encapsidation 
while complex retroviruses use only one, interchangeably (Balvay, Lopez Lastra et al. 
2007). Simple and complex retroviruses use different mechanisms to export unspliced 
RNA into the cytoplasm. While the RNAs of simple retroviruses are exported via the 
action  of  cis-acting  elements,  the  constitutive  transport  element  (CTE);  complex 
retroviruses  export  their  RNAs  through  interactions  between  accessory  proteins, 
responsive elements and cellular factors (Bray, Prasad et al. 1994; Ernst, Bray et al. 
1997; Goff 2001). 
Gag,  Pro  and  Pol  are  expressed  as  polyproteins  from  the  unspliced  RNA  in  a 
complicated fashion that varies between different viruses but that ultimately ensures the 
presence of the correct amount of each protein in the viral particle. Gag is the first 
protein to be synthesized by the ribosomes until they reach a stop codon. From here 
each  virus  will  use  a  different  strategy  to  synthesize  Gag-Pro-Pol  polyproteins 
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a stop codon or sometimes they are present as a separate ORF. In gammaretroviruses 
and epsilonretroviruses, Gag and Pro-Pol ORF are all in the same reading frame but 
separated  by  a  stop  codon  and  they  are  translated  by  a  mechanism  referred  to  as 
translational readthrough. When ribosomes reach the stop codon they do not terminate 
translation but introduce a normal amino acid (usually glutamine) in its position and 
translation continues through the reading frame  of pro-pol (Yoshinaka, Katoh et al. 
1985).  Another mechanism known as translational frameshifting is used when the ORF 
of pro-pol or pol are in different reading frames. In this case when ribosomes encounter 
the stop codon they slip back one nucleotide and proceed with translation with the new 
ORF. This last mechanism is dependent on the presence of a heptanucleotide slippery 
sequence  upstream  of  an  RNA  pseudoknot  (Balvay,  Lopez  Lastra  et  al.  2007).  In 
betaretroviruses and deltaretroviruses two frameshifting events take place since both 
pro  and  pol  are  in  different  reading  frames.  Spumaviruses  are  unique  in  that  they 
synthesize Pro-Pol through a subgenomic mRNA (Goff 2001). 
The env gene is expressed through a spliced mRNA where the majority of gag, pro and 
pol are removed. Translation starts in the cytoplasm and soon after is relocated to the 
rough endoplasmic reticulum (ER) through signals provided by the first hydrophobic 
amino acids of the nascent Env, the signal peptide. In the ER the signal peptide is 
removed and the protein is glycosylated. The cotranslational insertion of the Env inside 
the ER reaches a stop by signals provided by a hydrophobic segment near the end of the 
protein which anchors it to the membrane. Before accessing to the Golgi apparatus, Env 
is folded and oligomerized. In the Golgi the sugar resides get further modified and the 
Env is cleaved by furin proteases into the SU and TM subunits. From here it travels to 
the cell membrane likely by using cellular vesicular transport systems (Goff 2001). 
Viral assembly and budding 
Once all the components required for the formation of the viral particle are synthesized 
they have to recognise each other at particular cellular locations, assemble and bud from 
the  cell  membrane.  These  processes  are  mainly  orchestrated  by  uncleaved  Gag 
precursors. For retroviruses with a type C morphology assembly takes place at the cell 
membrane, where Gag precursors are targeted via the M domains and aggregate by side 
to side contacts through the I domains (Jouvenet, Neil et al. 2006). As the aggregate 
grows bigger, the cell membrane bends until the structure takes the form of a sphere 
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cell membrane is sealed. As previously mentioned the L domains play a critical role in 
the late phases of assembly and it is believed that they mediate virus-cell separation, 
since mutant Gag proteins form spherical structures that remain tethered to the cell 
surface by a membrane stalk (Freed 2002). For some betaretroviruses, assembly occurs 
in  the  cytoplasm.  In  particular  for  M-PMV  assembly  is  believed  to  occur  in  the 
pericentriolar region, and the immature capsids then travel to the cell membrane by 
uncertain mechanisms, probably assisted by the Env protein (Sfakianos, LaCasse et al. 
2003). Interestingly, one amino acid change in M-PMV Gag (MA) changes its site of 
assembly from the cytoplasm to the cell membrane, indicating that the two mechanisms 
are not extremely different (Rhee and Hunter 1990; Goff 2001). 
Maturation 
The final step of the retroviral cycle is the processing (cleavage) of the viral proteins by 
the PR. The viral protease is an aspartyl protease that functions only as a dimer. Viral 
maturation is a controlled process that takes place during and after budding but only 
when  the  protein  precursors  are  assembled.  The  structural  changes  that  lead  to  the 
change in morphology associated with maturation are due to the cleavage of Gag and 
are required for infectivity. In murine leukaemia viruses a short peptide (the R peptide) 
is  removed  from  the  carboxyterminal  of  TM  upon  maturation,  which  is required  to 
activate the fusogenic activity of the Env (Goff 2001; Bukrinskaya 2004). 
Retroviral oncogenesis 
As previously mentioned, much of the current knowledge on the molecular mechanisms 
leading  to  cancer  development  arose  from  studies  of  oncogenic  retroviruses.  The 
discovery  that  retroviruses  carry  genes  with  transforming  properties  (v-oncogenes) 
derived from cellular genes (c-oncogenes or proto-oncogenes) lead to the conclusion 
that  cancer  was  due  to  genetic  alterations.  This  concept  was  supported  by  the 
observation that ALV induced tumours in a high percentage of chickens although it 
lacked an oncogene. It was then found that these tumours were caused by the integration 
of the virus adjacent to the c-myc gene inducing its over expression (Hayward, Neel et 
al. 1981). From here on the study of oncogenes and their role in cancer development 
exploded and it became apparent that cancer is a genetic disease resulting from the 
successive accumulation of genomic alterations. Thus cancer development is a multistep 
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cancer is the result of somatic mutations  selected during tumour evolution and that 
susceptibility to cancer is the result of design limitations and flaws of our evolutionary 
legacies,  that  persist  as  long  as  they  are  not  detrimental  for  reproductive  fitness 
(Greaves 2007). 
Hallmarks of cancer 
We cannot approach the subject of retroviral oncogenesis without understanding first 
the basic mechanisms leading to cell transformation. It is now accepted that cancer is 
the  manifestation  of  six  fundamental  alterations  in  cell  physiology  that  lead  to 
malignant transformation (Hanahan and Weinberg 2000).  
Growth independence 
Insensitivity to anti-growth signals 
Evasion of apoptosis 
Immortalization 
Sustained angiogenesis 
Tissue invasion and metastasis 
Genome instability provides the enabling context for these alterations to develop. 
Growth independence 
To  proliferate,  normal  cells  require  mitogenic  growth  signals  provided  by  the 
surrounding microenvironment. This dependence on other cells and the extracellular 
matrix creates a homeostatic balance where the behaviour of each cell type within a 
tissue is highly controlled (Lodish, Berk et al. 2003). Tumour cells have a reduced 
dependence on the surrounding environment thanks to three different strategies. Many 
cancer cells create positive feedback loops by autocrine stimulation. In other words, 
cancer cells produce their own growth factors and activate themselves. Another strategy 
is to modify cell surface receptors that transduce signals from growth factors to the 
interior of the cell by switching the type of extracellular matrix receptor displayed or by 
receptor  overexpression.  Massive  receptor  overexpression  can  lead  to  ligand 
independent  activation,  which  can  also  be  achieved  by  expression  of  a  modified 
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pathways that transduce the signals provided by growth factors (Hanahan and Weinberg 
2000). 
Insensitivity to anti-growth signals 
Cell proliferation is ultimately the result of the balance between mitogenic and anti-
growth signals, thus cancer cells not only have to take advantage of signals that promote 
growth but also escape antiproliferative mechanisms.  Antigrowth signals can function 
in two ways: I) they can promote the entry of cells into a reversible quiescent state (Go); 
or II) they can induce cells to enter into a postmitotic state, frequently associated with 
terminal differentiation, with the loss of their replication capability. In the majority of 
cases, inhibitory signals are conducted by the retinoblastoma protein and its relatives, 
p107 and p130. If hypophosphorylated retinoblastoma protein sequesters transcription 
factors controlling the expression of genes which promote the transit from G1 to S 
phase of the cell cycle if the conditions dictate so. In cancer cells this circuit can be 
disturbed in several different ways (Hanahan and Weinberg 2000). 
Evasion of apoptosis 
Programmed cell death or apoptosis and cell proliferation are the major mechanisms 
used by tissues to regulate the number of cells of which they are composed. In cancer 
cells the balance is shifted towards proliferation, and resistance to apoptosis is a major 
contributor of this imbalance. The apoptotic machinery is triggered by the action of 
“sensors”, that detect abnormalities in the extracellular and intracellular environment, 
and “effectors” that ultimately commit the cell to death. The release of cytochrome C by 
the  mitochondria  activates  a  group  of  intracellular  proteases,  the  caspases,  which 
destroy organelles, cellular structures and the genome. The pro-apoptotic members of 
the  Bcl-2  family  of  proteins  (Bax,  Bak,  Bid,  Bim)  can  activate  the  release  of 
cytochrome C and many cancer cells evade apoptosis by the loss of the p53 tumour 
suppressor gene, which upregulates the expression of Bax under circumstances of DNA 
damage (Hanahan and Weinberg 2000). 
Immortalization 
Cancer cells not only have to overcome the barriers mentioned above but also the fact 
that normal cells have an intrinsic program that restricts their multiplication. Cells in 
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senescence. It is now known that this process is controlled by the size of the ends of the 
chromosomes,  the  telomeres.  The  inability  of  the  DNA  polymerase  to  completely 
replicate  the  3’  ends  of  the  chromosomes  after  each  replication  cycle  generates  a 
shortening of the telomeres. When this erosion can no longer protect the ends of the 
chromosomes, the ends fuse causing genomic abnormalities that lead to cell death. So 
far  there  are  two  known  mechanisms  evolved  by  cancer  cells  to  escape  death  by 
telomere  shortening:  I)  overexpression  of  the  telomerase  enzyme,  that  adds 
hexanucleotides repeats to the telomeric DNA; or II) regeneration of telomeres through 
recombination-based interchromosomal exchange of sequence information, a process 
also known as “alternative lengthening of telomeres” (Hanahan and Weinberg 2000). 
Sustained angiogenesis 
The ability of a tissue to develop depends on the oxygen and nutrients provided by the 
vasculature.  Therefore  for  a  tumour  to  grow,  angiogenesis  has  to  be  turned  on 
(Carmeliet 2003). The formation of new blood vessels, as any other cellular mechanism, 
is regulated by the action of positive and negative signals. It seems that tumour cells 
induce angiogenesis in mid-stage lesions, via an “angiogenic switch”, before the onset 
of macroscopic lesions. The vascular endothelial growth factor (VEGF) plays a critical 
role  in  the  angiogenic  switch  and  it  has  been  shown  to  be  overexpressed  in  many 
tumours. Other tumours choose to downregulate the expression of inhibitors, but it is 
now evident that different types of tumour cells choose different mechanisms to turn on 
the angiogenic switch (Hanahan and Weinberg 2000). 
Tissue invasion and metastasis 
Ninety percent of human cancer deaths are due to metastasis, which is the process by 
which tumour cells invade the surrounding tissues, access the body’s circulation system 
and establish secondary areas of growth (Lodish, Berk et al. 2003). Apart from the 
previously  mentioned  changes  required  for  uncontrolled  cell  growth,  additional 
modifications are necessary for the acquisition of an invasive and metastatic phenotype. 
These modifications include changes in: I) molecules that mediate cell-cell adhesion, 
like members of the immunoglobulin and calcium dependent cadherin families which 
are required for the transmission of antigrowth signals; II) molecules that connect cells 
to the extracellular matrix, like integrins, to be able to face the changes of the new 
microenvironments; III) as well as changes in extracellular matrix degrading proteases 
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Transforming retroviruses 
Oncogenic retroviruses have been classically divided in two groups according to the 
rapidity  with  which  they  induce  disease:  acute  and  slow  transforming  viruses 
(Rosenberg and Jolicoeur 1997). Acute transforming retroviruses induce tumours very 
rapidly  after  infection  and  in  a  high  percentage  of  the  infected  animals  and  can 
transform cells in vitro. They are also referred to as “transducing” retroviruses since 
they mediate transformation through the expression of viral oncogenes which derive 
from cellular genes. This group of viruses is replication defective since they lack part of 
their  coding  sequences  in  exchange  for  the  cellular  oncogene.  However,  since  they 
retain all their cis-acting elements, they can replicate with the assistance of a replication 
competent (helper) virus. An exception is RSV that encodes the v-src oncogene but 
retains the fully coding regions for Gag, Pol and Env and thus is replication competent 
(Muriaux  and  Rein  2003).  Some  examples  of  acute  transforming  retroviruses  are: 
Abelson murine leukaemia virus, encoding the non-receptor tyrosine kinase abl as a 
gag-Abl fusion protein; the MC29, CMII, OK10 and MH2 avian retroviruses encoding 
myc and the murine sarcoma virus 3611 which encodes the raf gene (Fung, Fadly et al. 
1981; Rapp, Reynolds et al. 1983; Rosenberg and Jolicoeur 1997).  
Transducing  retroviruses  are  produced  by  a  complex  mechanism  that  involves 
recombination events at the DNA and RNA levels, thus their occurrence is a very rare 
event even in animals with high levels of viremia. Although the genomes of transducing 
retroviruses are very distinct they retain the cis-acting elements required for replication: 
LTRs, PBS, ppt and packaging signals. Many of the regions encoding for the structural 
genes are lost and are occupied by the host sequence to be transduced, that can be 
expressed as a separate unit or fused to Gag, Pol or Env. These rearrangements can lead 
to drastic changes in the expression patterns of the viral oncogene compared to the 
cellular counterpart. In addition, often the fusion protein between a retroviral gene and 
an  oncogene  can  acquire  subsequent  mutations  and  display  different  localization, 
stability  and  activity  that  render  it  a  fully  transforming  protein  (Goff  2001).  The 
currently accepted model to explain the formation of a transducing virus comprises the 
following steps (Muriaux and Rein 2003): 
1)  Firstly, a replication competent virus integrates upstream of a cellular gene to be 
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2)  Transcription of the viral RNA is initiated from the 5’LTR and generates a long 
transcript containing the viral sequences fused to the downstream cellular gene 
by “readthrough” transcription ignoring the normal termination signals in the 
3’LTR. This process is favoured by lesions or deletions in the 3’LTR. 
3)  The chimeric RNA is then spliced and packaged into a viral particle along with a 
full molecule of genomic RNA. 
4)  The  newly  formed  viral  particles  infect  other  cells  and  during  reverse 
transcription non homologous recombination takes place between the chimeric 
RNA and the RNA of the helper virus through a template switch performed by 
the RT. This process generates a provirus containing host sequences flanked by 
viral termini. 
This whole mechanism is supported by the ability of retroviruses to package chimeric 
and long RNAs as well as cellular mRNAs and allows recombination events between 
them.  At  the  moment  the  possibility  that  transducing  retroviruses  arise  through 
recombination at the DNA level, albeit at a lower rate cannot be excluded (Muriaux and 
Rein 2003). 
Slow transforming retroviruses are replication competent, since they harbour the fully 
coding sequences required for replication; they produce tumours with longer incubation 
periods and do not cause cell transformation in vitro. They mediate transformation by 
proviral insertional mutagenesis that leads to the activation of proto-oncogenes (Nervis 
2001).  Examples  of  slow  transforming  retroviruses  are  the  Rous-associated  viruses 
types  1  and  2,  that  integrate  within  the  myc  gene  and  MMTV  whose  integration 
promotes the rearrangement of the Notch family of proteins and the p48 component of 
the eukaryotic translation initiation factor-3 (Callahan and Smith 2000). 
Each retroviral integration event could be considered a somatic mutation, most of the 
time being harmless, not causing a significant disruption of gene expression or affecting 
only  one  allele  creating  a  recessive  mutation.  However,  occasionally  a  dominant 
mutation arises that leads to a disruption of the normal mechanisms controlling cell 
proliferation and induces the clonal expansion of the cell that ultimately will form a 
tumour. Several mechanisms have been identified that induce proto-oncogene activation 
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1)  Promoter insertion: in this case the provirus integrates upstream or within the 
gene  in  the  same  transcriptional  orientation  and  the  promoter  and  enhancer 
elements in one of the LTRs can induce an increased level of gene expression. 
Transcription can be initiated in either LTR but it is usually favoured for the 
3’LTR that reads into the gene. This results in the creation of a transcript with 
R-U5 sequences in the 5’ end that can be of the same size, longer or truncated 
with regard to the normal mRNA and expressed at abnormal levels. This is the 
mechanism  by  which  c-myc  is  activated  in  80  %  of  ALV-induced  tumours 
(Fung, Fadly et al. 1981; Uren, Kool et al. 2005). 
2)  Enhancer insertion: the provirus inserts upstream of the cellular gene in the 
opposite transcriptional orientation or downstream of it in the same or opposite 
orientation.  This  allows  the  positioning  of  the  enhancers  present  in  U3  in  a 
suitable location to activate the promoters of cellular genes leading to the altered 
expression of normal transcripts. c-myc is also activated by this mechanism in 
MLV-induced tumours (Rosenberg and Jolicoeur 1997) (Uren, Kool et al. 2005). 
3)  Read-through transcription: gene expression can be driven by the 5’ or 3’ 
LTR  of  a  provirus  if  it  is  integrated  within  a  gene  in  the  sense  orientation. 
Provirus transcription initiates in the 5’ LTR and continues into the gene usually 
due to defects in the 3’ LTR allowing read through transcription resulting in the 
formation of a chimeric transcript that is then spliced in a complex fashion. In 
ALV-induced  erythroblastosis  a  provirus  is  integrated  within  the  erbB  gene 
leading to the expression of a truncated form of the gene (Nilsen, Maroney et al. 
1985). 
4)  Posttranscriptional stimulation of expression: proviral insertions downstream 
of the coding regions can remove regulatory or destabilizing signals or provide a 
polyadenylation signal that increases the formation of stable transcripts. This 
mechanism is used by MLV to remove a portion of the 3’ untranslated region 
(UTR) of the Pim-1 gene that reduces mRNA stability (Selten, Cuypers et al. 
1985; Uren, Kool et al. 2005). 
Insertional  mutagenesis  can  also  lead  to  gene  inactivation  by  inducing  premature 
transcript termination or aberrant splicing events which can result in the production of a 
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allele is still able to produce a functional protein. A loss of function arises when the 
second  allele  is  mutated  leading  to  loss  of  tumour  suppressor  gene  activity  and 
consequent tumour induction (Goff 2001). 
Although the classification of acute and slow transforming retroviruses is widely used it 
is  incomplete  since  some  oncogenic  retroviruses  do  not  fit  in  either  of  these  two 
categories. Deltaretroviruses, such as Human T-cell leukaemia virus type 1 (HTLV-1), 
Simian T-cell leukaemia virus type 1 (STLV-1) and Bovine leukaemia virus (BLV), do 
not harbour cellular derived oncogenes, instead transformation is initiated by the viral 
accessory  protein,  Tax,  which  functions  as  a  transcriptional  activator.  HTLV-1  Tax 
protein induces transformation by the activation of cyclin-dependent kinases, NfκB and 
the Akt pathways, silencing of p53 and spindle assembly checkpoints as well as the 
creation of chromosomal instability, centrosome amplification and abrogation of DNA 
repair systems. Tax is not required to maintain transformation, which seems to depend 
on the function of HBZ (HTLV-1 basic leucine zipper factor) encoded by the minus 
strand of the provirus (Matsuoka and Jeang 2007). The interplay between Tax, HBZ, 
cellular proteins and possibly other viral proteins that ultimately leads to leukaemia 
development is poorly understood at the moment. 
JSRV is a replication competent retrovirus lacking cellular derived oncogenes (Fan, 
Palmarini  et  al.  2003).  In  natural  conditions  JSRV  induces  disease  with  a  long 
incubation  period,  usually  appearing  in  animals  aged  1  to  4  years  (De  las  Heras, 
Gonzalez  et  al.  2003).  These  are  characteristics  of  a  slow  transforming  retrovirus, 
however  when  newborn  lambs  are  experimentally  inoculated  with  lung  fluid  from 
infected  animals  clinical  signs  appear  within  weeks  (De  las  Heras,  Gonzalez  et  al. 
2003),  consistent    with  an  acute  transforming  virus.  It  is  now  known  that  JSRV 
mediates transformation through its Env glycoprotein (Fan, Palmarini et al. 2003), a 
unique feature among retroviruses, which will be described in detail in the following 
sections. 
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Figure 7. Mechanisms of proto-oncogene activation by proviral insertion. 
Top panel shows a hypothetical proto-oncogene formed by four exons. Green boxes exons and 
protein products after splicing. Black lines introns. Yellow boxes untranslated regions. Blue box 
sequences in the protein encoded by the virus. Linear arrows indicate transcriptional orientation 
of the provirus. 1) Promoter insertion. 2) Activation by enhancer sequences. 3) Read-through 
transcription. 4) Posttranscriptional stimulation of expression. Adapted from Retroviruses, 1997, 
Cold Spring Harbour Laboratory press. 
 
Endogenous retroviruses 
During the retroviral cycle the viral genetic information (provirus) is integrated into the 
chromosomal DNA of the infected cell, which is then passed on to the descendants of 
that cell after division as any other cellular gene. Occasionally, some retroviruses infect 
the germ cells of the host, resulting in the transmission of the provirus to the somatic 
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provirus  (in  this  case  known  as  “endogenous”  retrovirus,  ERV)  does  not  exert  any 
pathogenic effect it is then transmitted from generation to generation and becomes fixed 
in the host species (Coffin 2004). Since changes in the genomic DNA of a species take 
place  very  slowly,  the  presence  of  ERVs  gives  us  insights  into  the  ecology  and 
evolution of ancient viruses (Coffin 2004). ERVs have heavily colonized the genome of 
all animal species and account for approximately 8% of the human genome (Lander, 
Linton et al. 2001). 
The frequency of an ERV in a population may increase over time as a result of genetic 
drift (the statistical effect that chance has on the survival of alleles), hitchhiking (the 
process by which an evolutionary neutral allele or mutation is spread through the gene 
pool by means of being linked to a beneficial mutation) or positive selection if the 
provirus was to provide a beneficial effect to the host (Arnaud, Caporale et al. 2007). 
Retrotransposition  or  reinfection  of  the  germ  line  can  generate  further  insertions 
augmenting the number of a particular lineage in the genome (Gifford and Tristem 
2003).    ERVs  are  destined  to  extinction  if  their  expression  brings  deleterious 
consequences for the host. Their persistence in the host genome is the result of a fine 
balance reached throughout evolution which usually renders them replication defective 
due  to  the  accumulation  of  mutations,  deletions,  rearrangements  and  methylation 
(Boeke  and  Stoye  1997).  However,  replication  defective  ERVs  can  be  rescued  if 
complemented in trans or recombined with another ERV within the same cell or with an 
exogenous retrovirus, should those retain the essential regulatory sequences, as is the 
case for the endogenous gammaretrovirus BaEV (baboon endogenous retrovirus) that 
bears a betaretrovirus env gene (Gifford and Tristem 2003). 
ERVs fall into the category of transposable elements (TE). TE are stretches of DNA that 
cut  themselves  out  of  the  genome  and  splice  themselves  into  another  region, 
contributing to genetic diversity in a variety of organisms (Biemont and Vieira 2006). 
Forty five percent of the human genome is composed of transposable elements (TE) 
(Lander, Linton et al. 2001).  As shown in Figure 8 they can be divided into DNA 
transposons (Class II) which act via a DNA intermediate and retrotransposons (Class I) 
that use a RNA intermediate. DNA transposons comprise 2.8% of the TEs of the human 
genome,  while  the  remaining  42.2%  are  retrotransposons.  Retrotransposons  can  be 
further  divided  into  non  LTR  elements  (33.9%),  comprising  the  long  and  short 
interspersed  elements  (LINEs  and  SINEs  respectively),  and  LTR  elements  (8.3%), 
comprising ERV. Mariana Varela, 2007     Chapter 1,46 
 
Figure 8. Classification of transposable elements. 
 
ERVs are restricted to vertebrates, indeed they have been found in every vertebrate 
class analyzed with the exception of the most basal vertebrates (Herniou, Martin et al. 
1998). LTR retrotransposons are also found in plants, fungi and insects. ERVs belong to 
most of the retroviral genera, although there is no consensus on how they should be 
incorporated into the current retroviral classification. Some ERVs are highly related to 
exogenous retroviruses like JSRV, MMTV, FeLV, ALV, and thus can be included in a 
specific genera, albeit they constitute a minority of the cases (Boeke and Stoye 1997). 
They can also be classified into recent and ancient. Recent ERVs integrated into the 
host genome after speciation and in some cases are closely related to exogenous viruses 
that are still infectious. Some recent ERVs are still able to produce infectious virus. 
These  ERVs  haven’t  accumulated  inactivating  mutations  and  are  often  insertionally 
polymorphic  since  they  are  not  completely  fixed  in  the  population  and  are  still 
undergoing endogenization. This is the case for Koalas and sheep which are presently 
being  invaded  by  the  Koala  retrovirus  (KoRV)  (Tarlinton,  Meers  et  al.  2006)  and 
enJSRVs  (Arnaud,  Caporale  et  al.  2007)  respectively.  Ancient  ERVs  invaded  the 
genomes before speciation and thus are present in all vertebrates and in every individual 
at the same genomic location. They are replication defective due to the accumulation of 
mutations and genetic damage (Coffin 2004). 
ERVs in general can be used as genetic markers to perform phylogenetic analysis of the 
host  species.  The  presence  of  specific  ERV  in  the  same  genomic  location  in  two 
different species indicate that invasion took place in a common ancestor since provirus 
integration is a random event and it is highly unlikely that the same provirus integrated 
exactly in the same genomic location in two different hosts (Coffin 2004). 
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Several studies have indicated that ERVs are able to modulate the outcome of infection 
of exogenous retroviruses both in a beneficial or a detrimental manner to the host. The 
expression of some ERVs can confer resistance to superinfection by receptor blockage, 
where  the  expression  of  endogenous  env  genes  impedes  interaction  of  exogenous 
viruses with their receptors. An example of this interference mechanism is provided by 
mice expressing the Fv4 locus which encodes a mutated Env protein whose receptor 
binding domain resembles the one of ecotropic MLV and blocks infection by exogenous 
MLVs  (Boeke  and  Stoye  1997).  Another  mechanism  by  which  ERVs  modulate 
exogenous  retroviral  infections  is  provided  by  the  expression  of  the  Fv1  locus  in 
particular strains of mice. Fv1 determines susceptibility to MLVs infection, by as yet 
not completely characterized mechanisms. Fv1 is homologous to the Gag protein of 
human endogenous retrovirus L (HERV-L) and presumably interference takes place by 
interactions with CA altering the binding of the latter to the PIC (Nethe, Berkhout et al. 
2005). 
Some  ERVs  can  shape  the  immune  response  towards  retroviral  infections  or  other 
microorganisms, like bacteria (Bhadra, Lozano et al. 2006). MMTV is transmitted to 
newborn pups through the milk of infected females. The virus enters the small intestine 
and infects B lymphocytes and dendritic cells of the underlying lymphoid tissue which 
then express a viral encoded protein referred to as superantigen or Sag. Expression of 
sag induces a T cell response that results in the proliferation of cells susceptible to 
MMTV. These cells act as a reservoir of infection and transmit the virus to the dividing 
mammary gland during puberty. Laboratory mice harbour between 2 to 8 replication 
defective endogenous MMTVs which express sag genes early in life leading to a clonal 
deletion  of  responsive  T  cells  and  thus  preventing  infection  by  exogenous  MMTV.  
However, it has recently been shown that laboratory mice lacking endogenous MMTVs 
are  not  only  resistant  to  mammary  tumours  but  also  to  Vibrio  cholerae  and  this 
phenomenon is reverted by the restoration of  any of the endogenous MMTVs present in 
that particular mice strain (Bhadra, Lozano et al. 2006). Another example is provided by 
ALVs-related ERVs which reduce immunoresponses to exogenous ALVs augmenting 
the risk of infection, although their expression prevents the development of wasting 
syndrome (Gifford and Tristem 2003).  
ERVs RNAs can be copackaged with the genomes of exogenous viruses which can 
result in recombination and the appearance of novel pathogenic variants, as is the case 
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phenomenon also generates concern in the preparation of vectors for gene therapy since 
ERVs genomes present in packaging cell lines can contaminate therapeutic vectors.  
Physiological functions 
The biological role of ERVs has been debated for the last twenty years. Initially ERVs 
were mostly deemed as “junk DNA”. However, recent studies have shown that in some 
cases ERVs have been selected as they conferred beneficial effects to the host besides 
protecting it against exogenous virus infections. One example is given by ERV-induced 
expression of the α-amylase gene in humans. The α-amylase gene family in humans 
comprise five active genes clustered in chromosome 1, including two pancreatic and 
three salivary genes, which are all associated with insertions of two TEs : a γ-actin 
pseudogene and an endogenous retrovirus. Using transgenic mice it was shown that the 
endogenous provirus contains specific enhancer sequences which promote expression in 
the  salivary  gland,  although  other  mechanisms  regulating  gene  expression  might  be 
present  since  Old  World  monkeys  show  high  levels  of  salivary  amylase  and  lack 
proviral insertion (Ting, Rosenberg et al. 1992; Samuelson, Phillips et al. 1996). 
Another example for the selection of ERVs with a physiological function is provided by 
the expression of the env gene of enJSRVs in trophoblast cells of the sheep placenta. 
enJSRV Env expression has been found to be critical for conceptus development and 
placenta morphogenesis of sheep as will be described later (Dunlap, Palmarini et al. 
2006). A similar role has been attributed to the env gene of HERV-W, which is highly 
expressed  in  the  human  placenta  although  for  obvious  reasons  this  has  not  been 
confirmed by in vivo experimentation (Mi, Lee et al. 2000). 
Endogenous retroviruses and disease 
It is implicit that ERVs cannot have deleterious effects otherwise they would be counter 
selected during evolution. However, ERVs may persist if the deleterious effects they 
induce are intermittent or if they are counterbalanced by beneficial consequences. Most 
of the associations between disease and the expression of ERVs remain speculative, in 
particular the association with autoimmune diseases. The strongest evidence supporting 
a role for ERVs in pathogenic processes is provided by some strains of mice selected for 
high incidence of tumours. AKR mice develop spontaneous lymphoma in the absence of 
exogenous  virus,  probably  from  retroviral  insertional  activation  of  oncogenes.  The Mariana Varela, 2007     Chapter 1,49 
oncogenic agents are a group of viruses referred to as mink cell focus forming viruses 
(MCF) which arise by recombination events from three different endogenous viruses 
(Stoye, Moroni et al. 1991). 
Another  example  is  provided  by  the  proviral  loci  Mtv1  and  Mtv2  which  induce 
mammary tumours in mice not exposed to MMTV. Expression of these loci releases 
infectious virus in the lactating mammary gland, with reinfection of the same tissues 
followed by transformation (Boeke and Stoye 1997). 
Jaagsiekte sheep retrovirus 
Historical introduction 
Jaagsiekte  sheep  retrovirus  (JSRV)  is  the  causative  agent  of  ovine  pulmonary 
adenocarcinoma (OPA) a naturally occurring lung cancer of sheep (Palmarini, Sharp et 
al.  1999),  occasionally  diagnosed  also  in  goats  and  wild  moufflons,  although  more 
rarely (De las Heras, Gonzalez et al. 2003). “Jaagsiekte” was the name given to the 
disease in South Africa which derives from the Afrikaner word Jaag, for chase, and 
siekte, for sickness, as sheep affected by the disease showed signs of respiratory distress 
and  consequently  looked  as  if  they  had  been  chased  (Tustin  1969).  The  earliest 
documentations  and  descriptions  of  the  disease  date  from  the  nineteenth  century  in 
South Africa, although it was later recognised throughout the world (York and Querat 
2003). In 1891 a description performed by a South African veterinarian suggested that 
the  disease  was  contagious  (Hutcheon  1891),  but  it  wasn’t  until  1929  that 
transmissibility of the disease was shown by de Kock (De Kock 1929). In 1974 viral 
particles  were  observed  in  lung  lesions  of  affected  animals (Perk,  Michalides  et  al. 
1974), and soon after the disease was reproduced experimentally in lambs using viral 
particles containing reverse transcriptase (RT) activity that were derived from tumours 
and lung fluids of OPA-affected sheep (Martin, Scott et al. 1976; Verwoerd, Williamson 
et  al.  1980).  Soon  after  Verwoerd  et  al.  also  showed  that  the  incubation  period  of 
experimentally reproduced OPA in lambs was inversely proportional to the amount of 
RT  present  in  the  inoculum  (Verwoered  and  Williamson  1981).  Experimental 
transmission  of  OPA  in  goats  was  demonstrated  a  few  years  later  although  in  this 
animal species tumours were not induced as readily as in sheep (Sharp, Angus et al. 
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Molecular studies on OPA were hampered initially by the difficulty of isolating a virus 
associated with the disease. The difficulty in associating JSRV to OPA was due to the 
combination of several factors including: I) the impossibility to grow the virus in cell 
culture; II) the presence of contaminants in the “purified” samples obtained from lung 
secretions; III) the simultaneous infection with Maedi-Visna virus (MVV) and IV) the 
presence of endogenous retrovirus related to JSRV. It was by the use of antisera against 
M-PMV and MVV that JSRV and MVV could be distinguished (Sharp and Herring 
1983).  In  1991  York  and  colleagues  deduced  the  nucleotide  sequence  of  JSRV  by 
constructing a cDNA library from viral particles purified from lung fluids of OPA-
affected  sheep  (York,  Vigne  et  al.  1991)  and  provided  evidence  of  the  presence  of 
endogenous retroviruses highly related to JSRV in sheep and goats (York, Vigne et al. 
1992).  
The  development  of  reagents  and  techniques  to  differentiate  enJSRVs  from  the 
exogenous JSRV (Bai, Zhu et al. 1996; Palmarini, Cousens et al. 1996) and the finding 
that JSRV was detected only in tumour tissues (Palmarini, Holland et al. 1996), ruled 
out the possibility that oncogenesis was the result of reactivation of enJSRVs. Finally, 
the construction of a molecular clone, referred to as JSRV21, by Palmarini et al. allowed 
the  production  of  virus  in  vitro  and  firmly  established  that  JSRV  was  sufficient  to 
induce OPA (Palmarini, Sharp et al. 1999). JSRV21 proved to be an invaluable tool for 
several molecular studies that followed its isolation including the identification of the 
env gene as the major determinant of cell transformation (Maeda, Palmarini et al. 2001), 
a unique feature among oncogenic retroviruses. In addition, the isolation of enJSRV 
molecular clones led to the discovery of a novel mechanism of retroviral interference 
acting at late stages of the replication cycle (Mura, Murcia et al. 2004). 
OPA 
OPA has been recognized in Europe, Africa, Asia and America (Sharp and DeMartini 
2003). It was eradicated in Iceland after its introduction in 1933 from Russian Karakul 
rams  imported  from  Germany,  which  introduced  not  only  OPA  but  also  MVV  and 
Paratuberculosis and resulted in the death of more than 60 percent of the stocks of the 
island (York and Querat 2003). It does not affect the bulk sheep population of Australia 
and  New  Zealand  and  it  is  endemic  in  Peru,  Europe  and  South  Africa.  A  recent 
longitudinal study estimated that the prevalence of infection in a commercial flock can 
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their commercial life span (Caporale, Centorame et al. 2005). More studies are required 
to reveal the true prevalence of OPA in natural settings in different regions now that 
JSRV can be detected by high sensitive PCR techniques from peripheral blood samples. 
Under natural conditions, most OPA cases appear in animals aged 1-4 years, although 
all  ages  are  susceptible  under  experimental  settings.  The  incubation  period  ranges 
between 6 to 8 months in natural occurring cases and 5 to 12 months in experimentally 
infected adult sheep and lambs of several months of age. Very rapid onset of clinical 
signs  occurs  (raging  from  4  to  6  days  to  3-6  weeks)  when  newborn  lambs  are 
experimentally infected. It appears that the natural mode of transmission for JSRV is the 
respiratory route, albeit maternal-foetal intra-uterine or perinatal transmission through 
colostrum and milk cannot be excluded (De las Heras, Gonzalez et al. 2003) (Caporale, 
Centorame et al. 2005).    
Clinical manifestations appear once the lesions are big enough to interfere with lung 
function. Firstly, sheep appear less active, they tend to be left behind by the rest of the 
flock when walking and look exhausted. They are afebrile and loose weight. This is 
followed by tachypnoea, intense movements of the abdominal wall and moist rales due 
to  the  accumulation  of  fluids  in  the  respiratory  airways.  This  sero-mucous  fluid  is 
discharged through the nostrils and can cause spasmodic coughing. The animals will 
ultimately die after variable lengths of time depending on the presence of secondary 
pulmonary infections (De las Heras, Gonzalez et al. 2003). 
OPA can occur in two pathological forms: classical and atypical. In classical OPA the 
tumours appear mainly in the cranioventral parts of all lung lobes as diffused or nodular 
lesions with a moist surface. They are usually multiple and tend to coalesce giving a 
diffuse  glandular  appearance.  Metastases  are  rare  but  occasionally  can  occur  in  the 
regional lymph nodes and extrathoracic organs. In the atypical form they tend to be 
more nodular and mainly in the diaphragmatic lobe. They are very hard in consistency 
and well demarcated from the surrounding tissue with a dry surface. Both forms may be 
present in a flock and in individual sheep with no differences in JSRV at the molecular 
level (De las Heras, Gonzalez et al. 2003). 
The  tumour  cells  derive  from  type  II  pneumocytes  or  Clara  cells,  given  their 
ultrastructure  and  the  expression  of  markers  such  as  surfactant  protein  A  (SP-A),  
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10)  for  Clara  cells  (Sharp  and  DeMartini  2003).  Both  cell  types  have  secretory 
properties and this is the reason for the large amount of secretions that accumulate in the 
lungs  of  most  affected  sheep.  Histologically,  the  lesions  are  characterized  by  the 
neoplastic proliferation of epithelial cells of the alveolar and bronchiolar walls, forming 
foci  that  compress  the  surrounding  tissues.  The  structure  of  the  alveolar  wall  is 
preserved although the flat type I pneumocytes are replaced by columnar cells. The 
stroma  supporting  the  lesions  is  composed  of  variable  amounts  of  lymphoid  cells, 
depending on the presence of secondary infection, and connective tissue fibres, which 
tend to be more abundant in advanced lesions leading to the fibrosis of the centre. The 
neoplastic focus is surrounded by macrophages which delineate the lesion. The terminal 
bronchioles are occupied by polypoid ingrowths composed of prismatic epithelial cells 
that can occlude their lumen. Myxomatous tissue composed of fusiform cells contained 
in a homogeneous matrix can be found mainly in association with alveolar neoplastic 
proliferations, although it not clear whether these are transformed cells as well. Atypical 
OPA lesions are mainly characterized by the same features, however their arrangement 
is more acinar than papillary and they display a higher inflammatory infiltrate of cells 
and connective fibres. An example of a classical and an atypical lesion are shown in 
Figure 9. 
 
Figure 9. Histological sections of classical and atypical OPA. 
Histological section stained with hematoxilin and eosin of a classical (1) and an atypical (2) OPA 
lesion. Bars represent 100 µm. Images kindly provided by Dr. Marcelo de las Heras. 
 
Genetic organization of JSRV 
JSRV  is  a  Betaretrovirus  phylogenetically  related  to  M-PMV  and  MMTV.  It  is 
considered a type-B/D retrovirus since the gag, pro and pol  genes are more closely Mariana Varela, 2007     Chapter 1,53 
related to M-PMV while the env  gene is more related to MMTV (York and Querat 
2003). There are three completely sequenced JSRV strains: the South African JSRV 
strain  (JSRV-SA)  (York,  Vigne  et  al.  1991;  York,  Vigne  et  al.  1992)  and  the  UK 
JSRV21 (Palmarini, Sharp et al. 1999) and JSRVJS7 (DeMartini, Bishop et al. 2001) 
strains. All the strains share a high degree of  similarity, although JSRV21 is the most 
thoroughly studied (Palmarini and Fan 2003). The genome of JSRV is approximately 
7.5 Kb in length and has the typical retroviral genes gag, pro, pol and env (Figure 10). It 
also  contains  an  additional  ORF  referred  to  as  orf-x  overlapping  pol  of  unknown 
function (Palmarini and Fan 2003).  
 
Figure 10. JSRV genetic organization. 
 
The U3 region of JSRV21 is 266 base pairs (bp) long and contains enhancer binding 
motifs, a TATA box and a polyA signal. The R region is 13 bp and U5 115 bp. The 
JSRV LTR, along with the JSRV Env, determine tissue tropism. In vivo, high levels of 
JSRV proteins are found only in the tumour cells of OPA-affected sheep although DNA 
and  RNA  are  found  in  lymphoid  tissues  (Palmarini,  Dewar  et  al.  1995;  Palmarini, 
Holland et al. 1996; Palmarini, Sharp et al. 1999). This restricted tissue expression is 
not due to the confinement of the JSRV receptor to these cells but to the preferential 
activity of the JSRV LTR in type II pneumocytes and Clara cells of the lung. The JSRV 
LTR contains multiple putative factor binding sites, however it seems that its activity is 
driven by the presence of HNF-3, a transcription factor of the hepatocyte nuclear factor 
-3/forkhead  homology  protein  family  (McGee-Estrada  and  Fan  2006).  HNF-3  is 
expressed in liver and lungs, in particular in type II pneumocytes and Clara cells, where 
it influences the expression of SP-B and CC-10. The activity of the JSRV LTR also 
seems to be under the influence of the CCAAT-Box/enhancer binding protein (C/EBP), 
since  mutations  or  deletions  of  its  putative  site considerably  reduce  transcription  in 
MLE-15  and  mtCC1-2  cells  (McGee-Estrada  and  Fan  2006).  C/EBP  has  been 
implicated in the regulation of expression of SP-A and D as well as CC-10 (Cassel and 
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JSRV proteins 
The JSRV Gag polyprotein is cleaved into at least five products: MA-p15-CA-NC-p4 in 
this order (Murcia, Arnaud et al. 2007). MA contains in its N-terminus a consensus 
myristilation signal which forms part of a M domain that abrogates viral particle release 
in  vitro  when  mutated  (Mura,  Murcia  et  al.  2004).    P15  harbours  two  putative  L 
domains (Murcia, Arnaud et al. 2007). Pro and Pol are encoded in different ORFs, as in 
all betaretroviruses, probably encoding for a deoxyuridine triphosphastase (dUTPase) 
and protease in the case of pro, and a reverse transcriptase and integrase in the case of  
pol  (Palmarini  and  Fan  2003).  The  Env  glycoprotein  is  synthesized  from  a  single 
spliced transcript of 2.4 Kb in length (Palmarini, Murgia et al. 2002). The SU domain 
contains a hydrophobic signal peptide that is cleaved at residue 81 (Murcia, Arnaud et 
al. 2007). The cleavage between the SU and TM probably takes place between residues 
385  and  386  (RPKR-GLS)  (Palmarini  and  Fan  2003).  The  TM  contains  a  short 
cytoplasmic tail of approximately 44 amino acids. 
The JSRV receptor 
The  JSRV  receptor  was  identified  by  the  phenotypic  screening  of  human/hamster 
radiation hybrid cell lines (Rai, Duh et al. 2001) as the glycosylphosphatidylinositol 
(GPI)-anchor protein, hyaluronidase 2 (Hyal-2). Hyal-2 is located in the p21.3 region of 
chromosome 3 (Rai, DeMartini et al. 2000), that is commonly deleted in human cancers 
(Lerman and Minna 2000; Petursdottir, Thorsteinsdottir et al. 2004), thus genes present 
in this zone are suspected to be tumour suppressors. However, as it will be described 
later, the role of Hyal-2 in JSRV induced cell transformation is controversial (Chow, 
Alberti et al. 2003; Danilkovitch-Miagkova, Duh et al. 2003). 
Hyal-2  belongs  to  the  hyaluronidase  gene  family  (Csoka,  Frost  et  al.  2001)  which 
degrade hyaluronan,  a component of the extracellular matrix. The biological role of 
normal Hyal-2 is not known at the moment. Its hyaluronidase activity is low compared 
to other members of the family (Vigdorovich, Miller et al. 2007) and is not required for 
its ability to function as the JSRV receptor.  Mariana Varela, 2007     Chapter 1,55 
Endogenous JSRVs 
After the viral genome of JSRV was sequenced it was clear that the sheep and goat 
genomes harboured proviral sequences related to JSRV (York, Vigne et al. 1992). By 
the use of CA and SU probes, these proviruses were later found to be widely distributed 
in the Ovis and Capra genera (Hecht, Stedman et al. 1996). A recent study (see attached 
paper) which screened a sheep genomic BAC library revealed that sheep possess at least 
27  individual  enJSRV  proviruses,  including  the  previously  cloned  enJS5F16  and 
enJS56A1 and predicts the existence of another 10 proviruses (Arnaud, Caporale et al. 
2007). 
The genomic organization of the known enJSRV proviruses is shown in Figure 11. Five 
of  the  27  enJSRV  proviruses,  named  enJSRV-7-15-16-18  and -26  contain  an  intact 
genomic  organization  with  uninterrupted  ORF  for  all  the  retroviral  genes.  These 
proviruses are presumed to be recent integrations since four of them have identical 
5’and 3’ LTRs and enJSRV-16 and -18 are identical to each other at the nucleotide 
level. In addition, these enJSRV loci are insertionally polymorphic and present only in a 
portion  of  the  sheep  populations.  enJS56A1  maintains  intact  ORFs  for  all  the  viral 
genes except for orf-x due to the presence of a premature stop codon. It also contains a -
2 bp deletion at the end of pol which causes a frameshift that would render a protein 14 
residues shorter and with 33 amino acids different at the carboxy terminus. There is a 
85-89% identity at the nucleotide level between the various enJSRVs and the JSRV21 
molecular clone. The major differences lie in U3 and in three regions along Gag and 
Env referred to as variable regions 1, 2 and 3 (VR1-2-3) (Palmarini, Hallwirth et al. 
2000). VR1 and VR2 are 50 residues apart and reside in MA while VR3 comprises the 
last 67 amino acids of TM. Mariana Varela, 2007     Chapter 1,56 
 
Figure 11. Genomic organization of enJSRV proviruses. 
Note that five enJSRV loci maintain an intact genomic organization. The “W” in the gag reading 
frame  indicates  the  R21W  substitution  present  in  enJS56A1  and  enJSRV-20.  enJSRV-20 
contains a portion of an env gene before the proximal LTR which is indicated by the orange box 
and a question mark. Stop codons are indicated by vertical lines and an asterisk (*).  Hatched 
boxes indicate large deletions in the proviruses. The letter M in enJSRV-6 indicates the position 
of the first methionine (M) in env after the usual start codon present in the other enJSRV loci 
and the exogenous JSRV. EnJSRV-6 contains a recombined structure with internal sequences 
present in the opposite direction compared to the 5’/3’ LTRs and the env gene (indicated by 
horizontal arrows). EnJSRV-1 presents a LINE element within the pol reading frame. The 3’ 
flanking region of enJS56A1 and enJSRV-20 are identical. Adapted from Arnaud et al. (Arnaud, 
Caporale et al. 2007). 
 
The characterization of the evolutionary history of these proviruses together with the 
current knowledge of ruminant evolution suggest that the integration of enJSRVs began 
before the split between the genus Ovis and the genus Capra, approximately 5 to 7 
million years ago, and continued after sheep domestication (9000 years ago). Some 
proviruses are found in none or a few sheep tested indicating their recent integration. 
enJSRV-26 in particular was found only in the Texel ram whose DNA was used to 
construct the BAC library used by Arnaud et al. (Arnaud, Caporale et al. 2007).  None 
of  the  330  sheep  DNA  samples  (including  150  obtained  from  Texel  sheep)  tested 
harboured enJSRV-26. Given the history of the selection of the Texel breed it appears Mariana Varela, 2007     Chapter 1,57 
that enJSRV-26 integrated within the last 200 years and may be a unique integration 
event in a single animal (Arnaud, Caporale et al. 2007). 
enJSRV-induced restriction 
enJSRVs have been found to interfere with JSRV replication at early and late stages of 
the retroviral cycle. Expression of enJSRVs blocks viral entry probably by receptor 
interference  since  JSRV  is  not  able  to  enter  a  cell  line  derived  from  the  ovine 
endometrial luminal epithelium (oLE) which expresses high levels of enJSRVs. JSRV 
entry is not affected when the assay is performed using a cell line derived from the 
uterine stroma (oST) which does not express enJSRVs (Spencer, Mura et al. 2003). The 
notion that enJSRVs block JSRV entry by receptor blockage is supported by the fact 
that  enJSRVs  and  JSRV  use  the  same  cellular  receptor  for  entry.  This  has  been 
measured by the ability of MLV-based retroviral vectors pseudotyped with the Env 
proteins of enJSRVs and JSRV to transduce cell lines expressing the JSRV receptor 
(Spencer, Mura et al. 2003) (see chapter 5 and attached paper). 
enJSRVs  can  also  block  JSRV  replication  at  the  late  stages  of  the  retroviral  cycle. 
enJS56A1 displays a novel mechanism of retroviral interference known as JSRV late 
restriction (JLR). Cells transfected with an expression plasmid for enJS56A1 do not 
release viral particles in the supernatant despite the fact that Gag can be detected in the 
cell lysates (Palmarini, Hallwirth et al. 2000). This defect is transdominant over JSRV 
and has been mapped to residue 21 of enJS56A1 Gag (Mura, Murcia et al. 2004). JSRV 
displays an arginine (R) in position 21 which is highly conserved among members of 
the genus betaretrovirus, while enJS56A1 harbours a tryptophan (W). A single JSRV 
mutant where R21 is replaced with a trytophan residue recapitulates the phenotype of 
enJS56A1  (Mura,  Murcia  et  al.  2004).  The  molecular  mechanisms  of  JLR  are  not 
completely understood. It has been recently shown that JSRV Gag is targeted to the 
microtuble  organization  centre  (MTOC)  and  then  colocalizes  with  pericentriolar 
recycling  endosomes  which  are  assumed  to  facilitate  Gag  trafficking  to  the  cell 
membrane. JLR occurs before Gag reaches the MTOC. In particular, enJS56A1 induces 
the accumulation of Gag in microaggregates that develop into aggresomes when the 
proteasome machinery is inhibited (Arnaud, Murcia et al. 2007; Murcia, Arnaud et al. 
2007).  These  studies  suggest  that  mutations  in  MA  can  induce  conformational 
alterations resulting in the production of defective particles that are unable to interact 
with the cellular trafficking machinery and accumulate in the cytoplasm where they are Mariana Varela, 2007     Chapter 1,58 
degraded  by  the  proteasome  (Arnaud,  Murcia  et  al.  2007).  Interestingly,  another 
provirus  (enJSRV-20)  bearing  a  W  in  position  21  has  been  recently  identified  and 
displays a defective transdominant phenotype like enJS56A1 (Arnaud, Caporale et al. 
2007). Interestingly, the same study shows that enJS56A1 and enJSRV-20 originally 
possessed  the  R21  residue  in  Gag  when  first  entered  the  host  genome.  W21  was 
acquired later during evolution and was positively selected for its ability to interfere 
with replication competent retroviruses. Interestingly, enJSRV-26 is able to produce 
viral particles in vitro and escapes the JLR. These results highlight the idea that some 
enJSRVs  act  as  restriction  factors  and  were  selected  around  sheep  domestication 
supporting the hypothesis that ERVs could help the host to fight retroviral infections 
(Arnaud, Caporale et al. 2007). 
enJSRVs and sheep reproductive biology 
enJSRVs play a critical role in conceptus development and placental morphogenesis of 
sheep.  The  earliest  hints  that  enJSRVs  could  participate  in  some  aspect  of  sheep 
reproductive biology came from the observation that high levels of enJSRV expression 
were limited to the reproductive tract by in situ hybridization, although enJSRV RNA 
could be detected by PCR-based assays in a variety of organs including lungs, kidneys, 
thymus, bone marrow, spleen, mediastinal lymph nodes and leukocytes. Highest levels 
of  enJSRVs  expression  are  observed  in  the  endometrial  luminal  and  glandular 
epithelium of the uterus and the epithelium of the oviducts and cervix (Spencer, Stagg et 
al. 1999; Palmarini, Hallwirth et al. 2000; Palmarini, Gray et al. 2001). Lower levels of 
enJSRVs RNA are also detected in the posterior and anterior regions of the vagina. The 
lamina propia of the gut also shows strong signal by in situ hybridization (Palmarini, 
Gray  et  al.  2001).  enJSRVs  expression  is  also  observed  in  the  mononuclear 
trophoectoderm cells of the developing placenta, indeed the highest levels of expression 
are  observed  in  the  trophoblast  giant  binucleate  cells  (BNCs)  and  multinucleated 
syncytial plaques of the placentomes (Dunlap, Palmarini et al. 2005). Expression of 
enJSRVs Env in trophoblast cells starts at day 12 after mating which is coincident with 
conceptus elongation. As it will be described in detail later, inhibition of enJSRV Env 
expression  by  morpholino  antisense  oligonucleotides  in  utero  retarded  blastocyst 
elongation  and  inhibited  BNC  differentiation,  with  consequent  loss  of  pregnancy 
(Dunlap, Palmarini et al. 2006). The results of this study demonstrate how some ERVs 
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Moreover, the level of enJSRV expression in the endometrium is influenced by the 
oestrous cycle. There is an increase in the levels of enJSRV RNA between days 1 to 13, 
followed by a decrease by day 15 which correlates with an increase in the levels of 
progesterone and progesterone receptor. Constant exposure to progesterone decreases 
the levels of progesterone receptor in the uterine epithelium and this may be linked to 
the reduction in enJSRV expression that follows (Spencer and Bazer 1995; Palmarini, 
Gray et al. 2001). Moreover, the LTR of enJS59A1 can be activated by progesterone in 
transient transfection assays (Palmarini, Gray et al. 2001).  
enJSRV expression has also been investigated in sheep foetuses by in situ hybridization 
with an enJSRV env probe (Spencer, Mura et al. 2003). These experiments revealed 
positive  signal  in  the  lymphoid  cells  of  the  lamina  propia  of  the  gut,  in  bronchial 
epithelial cells of the lungs and in the cortico-medullary junction of the thymus where it 
is thought that the final selection of T lymphocytes takes place. Expression of enJSRVs 
in these regions might tolerize sheep towards related exogenous betaretroviruses and 
this could explain the lack of circulating antibodies against JSRV in affected sheep. 
All the studies conducted so far highlight that the relationship between JSRV, enJSRVs 
and the host is a dynamic process and that the invasion of the sheep genome is still 
taking place. It is speculated that the expression of enJSRV in the genital tract protected 
sheep/goats from related exogenous betaretroviruses present at that time. This generated 
a  selective  pressure  for  viruses  with  a  different  tropism  from  the  genital  tract  (i.e. 
respiratory tropism). The different tropism might have given JSRV/ENTV the chance to 
replicate in a host with high levels of expression of enJSRVs and establish successful 
infection. The fixation of enJSRVs in the sheep genome then contributed to conceptus 
implantation  and  the  development  of  the  ruminant  placenta  (Palmarini,  Mura  et  al. 
2004). 
JSRV induced cell transformation 
The study of the molecular mechanisms leading to cell transformation by JSRV started 
with the development of the molecular clone JSRV21 (Palmarini, Sharp et al. 1999). 
Originally,  JSRV  was  thought  to  be  an  acute  transforming  retrovirus  bearing  an 
oncogene  since  it  could  induce  multi-focal  tumours  very  rapidly  in  experimentally 
inoculated lambs. However, the JSRV sequence did not reveal the presence of apparent 
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indicated that JSRV contains a gene capable of transforming cells in vitro and probably 
being an acute transforming retrovirus.  (Maeda, Palmarini et al. 2001). Using deletion 
mutants it was possible to identify env as the gene with the oncogenic potential (Maeda, 
Palmarini et al. 2001). Since then, a number of studies have shown that the JSRV Env is 
able  to  transform  a  variety  of  cell  lines  in  vitro  including:  mouse,  rat  and  chicken 
fibroblasts as well as human bronchial, canine and rat epithelial cells (Figure 12) (Rai, 
Duh et al. 2001; Allen, Sherrill et al. 2002; Danilkovitch-Miagkova, Duh et al. 2003; 
Zavala, Pretto et al. 2003; Liu and Miller 2005; Varela, Chow et al. 2006). Moreover, 
the  sole  expression  of  the  JSRV  Env  is  able  to  induce  lung  tumours  in 
immunocompromised  mice  with  similar  characteristics  to  OPA  when  expressed  by 
replication-incompetent adeno-associated virus vectors (Wootton, Halbert et al. 2005). 
More  importantly,  the  JSRV  Env  is  able  to  induce  lung  adenocarcinomas  in 
immunocompetent sheep when expressed by a JSRV based vector under the control of 
the JSRV LTR (Caporale, Cousens et al. 2006). This study not only demonstrates that 
JSRV Env is a dominant oncoprotein but also that JSRV can induce OPA without viral 
spread, a unique feature among oncogenic retroviruses. 
 
Figure 12. Focus of transformed cells induced by the JSRV Env in 208F cells. 
208F cells transfected with 1) an expression plasmid of the JSRV Env and 2) empty vector, 
photographed two weeks after transfection. 
The cytoplasmic tail of  the TM domain of the JSRV Env glycoprotein bears a YXXM 
motif (Y for tyrosine, X for any amino acid and M for methionine), which has been 
deemed critical for transformation (Palmarini, Maeda et al. 2001). This is a distinctive 
feature from other retroviruses which normally harbour YXXΦ motifs (Φ for any amino 
acid with a bulky hydrophobic chain) which are implicated in trafficking, endocytosis 
and pathogenesis (Ye, Bu et al. 2004). Mutations in the YXXM motif of the JSRV Env 
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depends on the experimental conditions and the cell type used to perform the assays 
(Palmarini, Maeda et al. 2001; Allen, Sherrill et al. 2002; Liu, Lerman et al. 2003; Liu 
and Miller 2005). Y590 forms part of a potential binding site for p85, the regulatory 
subunit  of  phosphatidyl  inositol-3  kinase  (PI3K).  In  addition,  JSRV-derived 
transformed cell lines show activation of Akt which is an important PI3K downstream 
effector (Palmarini, Maeda et al. 2001; Liu, Lerman et al. 2003; Zavala, Pretto et al. 
2003;  Varela,  Chow  et  al.  2006). Transformation  by  the  JSRV Env  is  considerably 
reduced when assays are performed under the presence of a PI3K inhibitor (LY294002) 
(Alberti, Murgia et al. 2002; Liu, Lerman et al. 2003). However, the effects of PI3K 
inhibitors vary according to the cell type used to perform the assays (Maeda, Inoshima 
et al. 2003) and indeed transformation of chicken fibroblasts is not critically dependent 
on Y590 (Allen, Sherrill et al. 2002; Zavala, Pretto et al. 2003). Furthermore, a crucial 
step in the activation of the PI3K-Akt pathway is the interaction between p85 and the 
phosphorylated tyrosine present in the YXXM motif. No interaction between p85 and 
the JSRV Env in GST pull-down assays and co-immunoprecipitation (CoIP) assays and 
no Y590 phosphorylation were ever observed (Liu, Lerman et al. 2003). It is now clear 
that  the  mechanisms  of  cell  transformation  induced  by  the  JSRV  Env  are  more 
complicated than originally thought and depend on the cell type used to study them. 
However  it  is  agreed  that  the  tyrosine  present  in  the  YXXM  motif  is  crucial  for 
transformation since  Y590 mutant viruses are unable to induce OPA in vivo (Cousens, 
Maeda  et  al.  2007)  and  that  the  activation  of  Akt  is  both  PI3K  dependent  and 
independent. The role of Akt in JSRV Env transformation in vivo remains elusive since 
no phosphorylation is detected by immunohistochemistry (IHC) of OPA lung sections 
(Zavala, Pretto et al. 2003), although its activation has been shown in 10 out of 27 
samples of OPA lung tumours analysed by western blotting (Suau, Cottin et al. 2006). 
The role played by the SU domain in JSRV Env transformation has been controversial 
and forms part of the work presented in this thesis. In rodent fibroblasts, replacement of 
the receptor binding domain (RBD) and proline rich region of the SU of the JSRV Env 
with that of Moloney murine leukaemia virus (MoMLV) does not considerably affect 
transformation (Chow, Alberti et al. 2003). This chimeric Env does not use Hyal-2 as a 
receptor to mediate entry when pseudotyped with MoMLV vectors. Other studies have 
also  shown  that  overexpression  of  mouse  Hyal-2  does  not  modify  the  outcome  of 
transformation assays (Liu, Duh et al. 2003). Taken together these results indicate that 
the SU domain of the JSRV Env is not important in the induction of cell transformation 
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However, others have shown that large deletions or small insertions in SU abolished 
transformation of rodent fibroblasts and that transformation may require both SU and 
TM (Hofacre and Fan 2004).  
In contrast to the scenario in rodent fibroblasts, the SU domain and Hyal-2 seem to be 
important  in  Env  transformation  of  BEAS-2B  human  bronchial  epithelial  cells.  In 
normal BEAS-2B cells Hyal-2 is apparently bound to the receptor tyrosine kinase RON, 
inhibiting its activation. It is proposed that the JSRV Env triggers transformation by 
interacting with HYAL-2 and inducing its degradation thus liberating RON which is 
able to dimerize, autophosphorylate and initiate signals that ultimately will lead to cell 
transformation (Danilkovitch-Miagkova, Duh et al. 2003). Since the RBD is responsible 
for the interaction with Hyal-2, it is assumed that the SU is required to transform these 
cells. 
Beside the PI3K/Akt pathways, the Raf-MEK-MAPK signalling cascade has also been 
implicated in JSRV induced cell transformation. The mitogen-activated protein kinases 
(MAPKs)  are  expressed  generally  in  all  cell  types  although  they  regulate  different 
responses according to the cell type (Dhanasekaran and Johnson 2007). The key to their 
specific biological functions lies in their spatial and temporal regulation within cells. As 
shown in Figure 13, MAPKs, which include ERK1/2, are phosphorylated and activated 
by  MAPK  kinases  (MAPKKs).  MAPKK  kinases  (MAPKKKs)  phosphorylate  and 
activate  MAPKKs.  MAPKKKs  possess  different  regulatory  domains  that  selectively 
govern the localization and activation status of the associated MAPKKs and MAPKs 
(Dhanasekaran and Johnson 2007). The ERK pathway is deregulated in one third of all 
human cancers and is the best studied of the MAPKs pathways (Dhillon, Hagan et al. 
2007).  ERK1/2  are  phosphorylated  and  thus  activated  by  MEK1/2,  which  are 
themselves activated by phosphorylation by Raf (A-Raf, B-Raf and C-Raf) (Figure 13). 
The activation of the ERK pathways can be triggered by several extracellular signals. 
Usually ligand activation of receptor tyrosine kinases (RTK) causes the loading of Ras 
with guanosine triphosphate (GTP), which then recruits Raf to the cell membrane for 
activation (Dhillon, Hagan et al. 2007). Once activated, ERKs are able to phosphorylate 
a variety of cytoplasmic and nuclear factors that in turn will lead to diverse cellular 
responses  like  proliferation,  differentiation,  survival,  migration,  angiogenesis  and 
chromatin remodelling. It is now clear that the signals from RTK to ERKs are highly 
dynamic  and  form  part  of  the  complex  regulated  processes.    The  role  of  MAPKs 
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and  Erk1/2  have  been  found  by  IHC  in  lung  sections  of  naturally  occurring  and  
experimentally induced OPA (Caporale, Cousens et al. 2006; De Las Heras, Ortin et al. 
2006). Additionally, transformation assays performed under the presence of the MEK1 
and Ras inhibitors reduce transformation in a dose dependent manner (Maeda, Fu et al. 
2005).  However,  no  Erk1/2  phosphorylation  is  detected  in  JSRV  Env  transformed 
rodent fibroblasts. This could be explained by the fact that Erk activation is transient or 
unstable or it takes place in specific cell compartments and is “lost” when analyzed in 
whole cell extracts. The picture is complicated even more by the fact that inhibition of 
p38 (a MAPK protein) increases transformation by the JSRV Env and enhances the 
phosphorylation  status  of  Mek1/2  and  Erk1/2  in  JSRV-derived  transformed  cells, 
indicating cross-talk between p38 and Erk pathways (Maeda, Fu et al. 2005). These 
results show that a fine tuning regulates the signal pathways involved in JSRV induced 
cell transformation. 
 
Figure 13. Overview of MAPK pathway. 
Adapted from Dhillon et al., 2007. 
 
In conclusion, all the evidence collected so far supports the fact that JSRV Env induces 
transformation at least in part by the activation of Akt and the Raf-Mek-Erk pathways. Mariana Varela, 2007     Chapter 1,64 
The relevance of each pathway might vary depending on the cell type analyzed and it is 
likely that transformation is ultimately the result of the combinatory effects of these two 
pathways among others not yet identified. This notion is supported by the fact that in 
natural  settings  the  development  of  OPA  takes  months  to  years,  emphasizing  the 
multistep essence of JSRV-induced cancer progression and the probable requirement of 
several  genetic  alterations  for  its  full  expression.  The  early  steps  in  this  process, 
including the mechanism used by the JSRV Env to engage the cell signalling network, 
remain the least understood area in the study of JSRV oncogenesis. 
Enzootic nasal tumour virus  
Enzootic nasal adenocarcinoma (ENA) is a contagious tumour of the gland cells of the 
nasal mucosa of sheep and goats. Enzootic nasal tumour virus-1 (ENTV-1) and ENTV-
2  have  been  associated  with  the  disease  in  sheep  and  goats  respectively  (Cousens, 
Minguijon et al. 1999; Ortin, Cousens et al. 2003). ENTV-1 and -2 are highly related to 
JSRV; however they have enough differences to be considered distinct betaretroviruses.  
Affected animals are usually 2 to 4 years of age and clinical signs are characterized by 
the presence of variable amounts of seromucous fluid coming from the nostrils. The 
tumour affects the nasal chambers and expands in all directions penetrating the frontal 
and nasal sinuses (De las Heras, Ortin et al. 2003). The neoplasm is characterized by the 
presence  of  epithelial  cells  that  proliferate  in  an  acinar,  tubular,  papillary  or  cystic 
pattern. As for JSRV, the affected animals do not mount an immune response towards 
the virus. 
ENTV uses Hyal2 as a cellular receptor, thus the differences in tissue specificity may lie 
in the transcription factors required for LTR activation (Dirks, Duh et al. 2002). This is 
supported  by  sequence  analysis  of  the  ENTRV  LTR  which  reveals  differences  in 
transcriptional regulators (Cousens, Minguijon et al. 1999).  The major determinant of 
transformation is the env gene as is demonstrated by its ability to transform cells in vitro 
(Dirks, Duh et al. 2002) and both the PI3K/Akt and the Raf-Mek-Erk pathways have 
been implicated in the mechanism leading to cell transformation (Zavala, Pretto et al. 
2003; De Las Heras, Ortin et al. 2006). Mariana Varela, 2007     Chapter 1,65 
Conclusions 
Betaretrovirus of sheep have proven to be a fascinating system to study several aspects 
of the biology of retroviruses. JSRV is unique among oncogenic retroviruses since one 
of its structural proteins behaves as a dominant oncogene both in vitro and in vivo, 
allowing the study of basic mechanisms leading to cell transformation. In addition, OPA 
serves as an animal model for the study of lung carcinogenesis where novel diagnostic 
and  therapeutic  interventions  can  be  investigated.  enJSRVs  are  able  to  block  JSRV 
replication  at  early  and  late  stages  of  the  retroviral  cycle.  This  together  with  the 
characterization of the evolutionary history and molecular virology of these enJSRVs 
have provided evidence suggesting that selection of ERVs acting as restriction factors 
could be a mechanism used by the host to fight retroviral infections. Moreover, the Envs 
of enJSRVs are essential for conceptus development and placental morphogenesis and 
their  study  has  provided  the  first  in  vivo  evidence  of  a  role  for  retroviral  Envs  in 
reproductive  biology.  The  profound  role  that  the  Envs  of  both  exogenous  and 
endogenous JSRV play in OPA pathogenesis and sheep reproductive biology merits 
further  investigation.  The  aim  of  the  study  presented  here  is  to  provide  a  better 
understanding of the biology of JSRV and enJSRVs Envs. 
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Materials and Methods 
Plasmids  
pCMV3JS21ΔGP, the expression plasmid for the JSRV21 envelope, has been previously 
described (Maeda, Palmarini et al. 2001). pJSE-V5 expresses wild type JSRV Env fused 
with  the  V5  epitope  in  the  carboxyterminal  of the  TM  domain.  pMoMLVprr-JSE  , 
which contains the MoMLV receptor binding domain (RBD) and proline rich region of  
Moloney murine leukaemia virus (MoMLV) and the remaining portion of the envelope 
from  the  JSRV  Env,  has  been  previously  described  (Chow,  Alberti  et  al.  2003). 
MoMLVprr-JSE-F, derives from MoMLVprr-JSE and contains a FLAG epitope in the 
carboxyterminal  of  the  TM  domain  (Chow,  Alberti  et  al.  2003).  pEnvEn2,  the 
expression plasmid for the Env of enJS5F16, has been described before (Palmarini, 
Maeda et al. 2001). JSEY590D-F and JSE-En2-Flag express respectively the JSRV Env 
with a Y590D mutation (Palmarini, Maeda et al. 2001) in the CT and the enJS5F16 Env 
(Palmarini, Hallwirth et al. 2000). In these two plasmids both Envs are fused in their 
carboxyterminal with the FLAG epitope. See Figure 14 for a schematic representation 
of the various env expression plasmids. pCEE-F , expressing the MMuLV Env with a 
C-terminal FLAG epitope was derived from pCEE+ (MacKrell, Soong et al. 1996) and 
was kindly provided by Paula Cannon.  
pCMV3JS21ΔGP-neo,  pMoMLVprr-JSE-neo,  pCMV3JS21ΔGPY590D-neo, 
pCMV3JS21ΔGPY590F-neo and pEnvEn2-neo express the respective envelopes and 
the  neomycin  resistance  gene.  They  were  constructed  by  PCR  amplification  of  the 
neomycin resistance cassette from pcDNA3.1+ (Invitrogen) and introduction into the 
env expression plasmids between HindIII and KpnI restriction sites.  
pCMV1-F-hHyal2 is an expression plasmid for the human HYAL-2 gene containing a 
preprotrypsin leader sequence and the FLAG epitope at the N-terminal of the human 
HYAL-2 gene and was constructed by introducing the human HYAL-2 cDNA sequence 
(Gene Bank accession number: BC000692.2; cDNA clone: MGC-1922) into pFLAG-
CMV-1 (Sigma). pC1-neo-hRON, an expression plasmid for the human RON tyrosine 
kinase, was kindly provided by Pam Correll. pRK5-HERc, the expression plasmid for Mariana Varela, 2007     Chapter 2,67 
Epidermal growth factor receptor was provided by Silvia Gartner. pCDNA 3.1-STK-
HA, pCDNA 3.1-Ron-Ha and MSV-Neo-MYC-SFSTK expressing the mouse (Stk) and 
human Ron proteins and a short form of Stk  that lacks most of the extracellular domain 
but retains the transmembrane and tyrosine kinase sequences (Persons, Paulson et al. 
1999) respectively were kindly provided by Pam Correll.  
The envelopes of enJSRV1, 4, 6, 7, 9, 11, 13, 15, 16/18, 19, 20 and 26 were PCR 
amplified from the original BAC clones and cloned into pCMV3JS21ΔGP by replacing 
the  exogenous  JSRV  Env. The  same  envelopes  were  also  cloned  into  the  retroviral 
vector pLNCX2JS21ΔGP, which expresses the JSRV Env. F-JSE expresses the JSRV 
Env  and  was  kindly  provided  by  Claudio  Murgia.  F-enJSRV6,13  and  26  are 
homologous  to  F-JSE  expressing  the  respective  enJSRV  Envs.  F-JSEY590F  was 
obtained by site directed mutagenesis (SDM) from F-JSE. 
pLNCX2ovHyal2 was cloned by removing by restriction enzyme digestion the ovine 
Hyal2  gene  present  in  pCR3.1ovineHyal2  (using  HindIII  and  NotI  sites)  and 
introducing  it  into  the  same  sites  into  the  retroviral  vector  pLNCX2  (Clontech). 
pLNCX2goatHyal2 was constructed by introducing the cDNA of the goat Hyal2 gene 
derived  from  RNA  extracted  from  TIGEF  cells  into  pLNCX2  using  XhoI  and  SalI 
restriction sites. pLNCX2BovHyal2 was constructed by PCR amplification of the Bos 
taurus Hyal2 from cDNA (Clone BC102042) obtained from Geneservice (I.M.A.G.E. 
number: 7928340) and introduced into pLNCX2 between XhoI and SalI . 
For  cloning  purposes,  PCR  were  performed  using  the  Pfu  polymerase  (Stratagene).  
Ligation reactions were done using the Rapid Ligation Kit (Roche). Plasmid DNA was 
produced in DH5α and Top 10 strains of E. coli (Invitrogen), using the DNA Maxiprep 
kit  from  Invitrogen.  SDM  was  performed  using  the  Quickchange  site  directed 
mutagenesis kit from Stratagene following the manufacturers’ instructions. Primers for 
site-directed  mutagenesis  were  designed  with  PrimerX,  a  web-based  software  that 
automatically designs mutagenic PCR primers (http://bioinformatics.org/primerx/). Mariana Varela, 2007     Chapter 2,68 
 
Figure 14. Schematic representation of env expression plasmids used in this study. 
 
Cell culture 
All the cells used in this study were cultured at 37ºC in a 5% CO2 atmosphere and 95% 
humidity. 208F, human 293, 293T, COS, TIGEF (Da Silva Teixeira, Lambert et al. 
1997) and HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) Mariana Varela, 2007     Chapter 2,69 
with high glucose (4.5 g/l) supplemented with 10% foetal bovine serum (FBS) and 1% 
penicillin-streptomycin. NIH 3T3 cells were grown in the presence of new born calf 
serum instead of FBS. Rat epithelial IEC-18 cells (ATCC CRL-1589) were grown in 
DMEM supplemented with 5% foetal bovine serum, 0.1 U/ml of bovine insulin. JS8, a 
cell line derived from an OPA tumour, and oST (Johnson, Burghardt et al. 1999) cells 
were grown in DMEM nutrient mixture F-12 Ham (Sigma) media. oTr cells were grown 
in  DMEM/F-12  Ham  media  supplemented  with    10%  FBS,  1%  of  penicillin-
streptomycin, 1%  non essential amino acids, 1% sodium piruvate, 1%  glutamine and 8 
µg/ml of  human recombinant insulin (Invitrogen). 
 
Cell line 
 
Origen 
293  Immortalized human Embryonic 
kidney cells 
HeLa  Immortalized human cervical 
cancer cells 
208F  Immortalized rat fibroblasts 
NIH 3T3   Immortalized mouse fibroblasts 
IEC-18  Immortalized normal ileum 
epithelium 
COS  Immortalized African green 
monkey kidney cells 
TIGEF  Immortalized goat embryo 
fibroblasts 
oTr  Primary ovine trophoblast cells 
oLE  Primary ovine luminal epithelium 
cells 
JS8  Immortalized ovine lung 
transformed cells 
Table 3. Cell lines used in this study. 
Transfections 
Cells were transfected using either the Calphos Mammalian transfection kit (Clontech) 
or lipofectamine (Invitrogen) following manufacture’s instructions. In some cases cells 
were transfected using Polyethylenimine (PEI) 25kD linear form (Polysciences via Park 
Scientific Labs). When PEI was used, cells were plated in a 10 cm dish and allowed to 
reach between 80 and 90% confluence. Ten µg of plasmid DNA were then diluted in 
500 µl of DMEM and 400 µl of PEI (1 mg/ml in distilled water, pH 7) and incubated for 
10  minutes  at  RT.  The  transfection  mix  was  added  drop  by  drop  to  the  cells  and Mariana Varela, 2007     Chapter 2,70 
incubated for 2 hours in a 37ºC in a 5% CO2 atmosphere and 95% humidity incubator. 
Before the addition of the transfection mix, 5 ml of fresh media were added to the cells. 
Dishes were then washed twice with PBS and cells were grown in normal culture media 
until transgene expression was analysed (Boussif, Lezoualc'h et al. 1995). 
Stable cell lines 
NIH-3T3 expressing sheep (sheep-Hyal2), goat (goat-Hyal2), or bovine (bovine-Hyal2) 
Hyal-2  and  208F  cells  expressing  various  enJSRV  Envs  were  produced  as  follows. 
Ecophoenix cells (kindly provided by Linda Hanlon) were transfected with retroviral 
vectors expressing the genes in question and supernatants were collected 24 and 48 
hours after transfection. Supernatants were clarified by centrifugation at 900 rpm for 5 
minutes and polybrene was then added to a final concentration of 8 µg/ml. Supernatants 
were then used to infect NIH 3T3 or 208F cells twice with a 24 hour interval. Eight 
hours after the last infection cells were split at different ratios and stable clones were 
selected by the addition of a G418 (500 µg/ml) to the culture media.  
Transformation assays 
2.5 x 10
5 IEC-18 rat epithelial cells were seeded in a 6 cm diameter plate. Each plasmid 
(10.4 µg) was transfected in 4 X 6 cm plate using the Calphos Mammalian transfection 
(Clontech).  Approximately  16  hours  after  the  transfection,  cells  were  washed  three 
times with phosphate-buffered saline (PBS) and split into 4 X 10 cm plates.  Media was 
replaced every other day for four weeks when foci of transformed cells were counted. 
The same procedure was used when transformation assays were performed with the Env 
constructs expressing the neomycin resistance gene, except that cells were cultured in 
the presence of G418 (500 µg/ml). 
Transformation  assays  performed  to  test  the  effects  of  inhibitors  of  various  signal 
transduction pathways on JSRV Env transformation were performed by transfecting 5 x 
10
5  208F  cells  (per  10  cm  diameter  plate)  with    pCMV3JS21ΔGP  (an  expression 
plasmid of the JSRV Env) (Palmarini, Sharp et al. 1999; Rai, Duh et al. 2001; Maeda, 
Inoshima  et  al.  2003)  or  an  empty  vector  as  a  negative  control  using  Calphos 
mammalian  transfection  kit  (Clontech).  Cells  were  washed  12-16  hours  after 
transfection with PBS and split into 4 x 6 cm plates.  Cell culture medium was replaced 
every other day for one week with the addition of 1 µM of dexamethasone. Thereafter, Mariana Varela, 2007     Chapter 2,71 
two cell culture dishes were treated with inhibitor and the remaining two with DMSO as 
negative control. Foci of transformed cells were counted 14 days post transfection. 208F 
cells were co-transfected with 1 µg of pCMV3JS21ΔGP and increasing amounts of a 
dominant  negative  form  of  Src  (SrcMF)  (kindly  provided  by  Valerie  Brunton) 
(Timpson, Jones et al. 2001) in order to test the ability of the latter to block JSRV Env 
transformation.  Foci  of  transformed  cells  were  counted  14  days  post  transfection. 
Analogous experiments were performed using the enJSRVs Env as possible inhibitors 
of JSRV Env-induced cell transformation.  
Entry assays 
The ability of the enJSRV Env proteins to mediate cell entry was assessed by standard 
entry  assays  using  murine  leukaemia  virus  (MLV)-based  vectors.    293-GP-AP  is  a 
packaging cell line that expresses MLV Gag and Pol and a MLV-based retroviral vector 
expressing the alkaline phosphatase gene (Chow, Alberti et al. 2003). 293-GP-AP cells 
were  transfected  with  the  expression  plasmids  for  the  various  enJSRV  Env  or  with 
plasmids expressing the exogenous JSRV Env as a control. Supernatants were collected 
48 and 72 hours after transfection and stored at –70°C.  Subsequently, naïve NIH-3T3, 
NIH-3T3 expressing either ovine (sheep-Hyal2), goat (goat-Hyal2), or bovine Hyal2 
(bovine-Hyal2)  or  oST  cells  were  exposed  to  10-fold  serial  dilutions  of  vector 
supernatants  supplemented  with  8µg/ml  of  polybrene.  Two  days  post-infection  cells 
were fixed with 0.5 % of glutaraldehyde for 5 minutes, washed twice with PBS and 
incubated at 55°C for an hour to inactivate endogenous alkaline phosphatase activity. 
Cells were then washed once with staining solution (1X NBT, 1X XPHOS in buffer 3; 
Buffer 3: 100 mM Tris pH 8.5, 100 mM NaCl, 50 mM MgCl;  100X NBT: 50 mg/ml of 
nitro blue tetrazolium in 70% dimethylformamide and 30% water; 100X XPHOS 10 
mg/ml of 5bromo-4chloro-3indolyl phosphate in water). Alkaline phosphatase-positive 
foci were revealed after staining ON. Viral titer is expressed as alkaline phosphatase 
foci per ml (APF/ml). Experiments were performed at least twice with two replicates 
tested for each dilution.  
Cell proliferation assays 
The effect of Hsp90 inhibitors on the proliferation of JS8 cells was measured using the 
WST assay from Roche following manufacture’s instructions. 10
3 cells were plated in a 
96 well plates and cultured in normal growth media with the addition of 17-DMAG or Mariana Varela, 2007     Chapter 2,72 
radicicol at concentrations ranging from 0.025 to 0.1 µM. Cell media was replaced 
every  day  for  3  days.  Experiments  were  repeated  three  times  with  at  least  three 
replicates each time. 
The effect of enJSRV Env expression on the growth of 208F cells was measured using 
the WST assay from Roche. Briefly naïve 208F and 208F stabling expressing various 
enJSRVs Envs were plated in 96 well plates (10
3 cells/ well) and cell proliferation was 
measured every day for 5 days. Two independent cells lines were prepared for each Env 
construct and each cell line was analysed twice with at least three replicates each time. 
The effect of enJSRV Env expression on the growth of oTr cells was measured using 
the WST assay (Roche) as above. oTr cells were transfected with the respective enJSRV 
Env expression plasmids using PEI as described above. Two hours after transfection 
cells were seeded at a ratio of 10
3 per well into a 96 well plate and cell proliferation was 
measured after 72 hours of culture in normal growth media without the addition of 
insulin. 
Inverted cell invasion assay 
A 100 µl of a 1:1 dilution of complete matrigel (BD Biosciences) in PBS was pipetted 
into a 6.5 mm diameter polyester transwell chambers with a pore size of 8 µm (Corning) 
and was left to sit for al least 30 minutes at 37°C. 1.45 x 10
4 cells were pipetted into the 
underside  of  the  membrane  (by  inverting  the  chambers)  and  then  covered  with  the 
bottom part of a 24 well plate so that the base of the plate contacted the droplet of cell 
suspension. The plates were incubated between 2 to 4 hours to allow cell attachment. 
Thereafter the plates were turned upside down and each well was sequentially dipped 
three times into 1 ml of serum free media as a washing step. The transwells were left 
into the third washing media and 100 µl of serum free media was pipetted on top of the 
transwell. The plates were then incubated for 4 days at 37ºC in a 5% CO2 atmosphere 
and 95% humidity incubator. Cells were then stained with a 4µM solution of calcein 
AM  (Molecular  Probes)  in  serum  free  media  for  1  hour  at  37ºC  in  a  5%  CO2 
atmosphere and 95% humidity incubator. Cells invading the matrigel were then imaged 
using a Leica GMIR2 confocal microscope as follow. At least three optical sections (Z-
sections) per transwell were scanned using a 20X objective at 15 µm intervals (Z-steps), 
moving up form the underside of the membrane, into the matrigel producing a series of 
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pixel a value from 0 to 255 (Abramoff, Magelhaes et al. 2004). The background pixel 
value is operator-defined as the pixel value on the 0 to 255 scale at which only cells 
from that individual section are visible with no bleed-through from bordering sections 
(for this experiments it was set to 75). Only pixels with an intensity value greater than 
background were then quantified. Each image was quantified and the sum of the values 
for  each  optical  section  was  used.  Since  three  optical  sections  were  analyzed  per 
transwell and each experiment was done in duplicate, the average of six sections was 
used to create the charts shown as results. 
Cell migration assay 
Migration  assays  were  performed  in  6.5  mm  diameter  polyester  transwell  chambers 
with a pore size of 8 µm (Corning). A morpholino antisense oligonucleotide (MAO) 
was designed to specifically inhibit the expression of enJSRV env mRNAs (MAO-env) 
while a five-mismatch (MAO-5mis) was designed as a negative control. oTr (10
4) cells 
were plated inside the chamber in their normal growth media with the exception of FBS 
and insulin. The bottom chamber contained complete growth media and Endo-Porter, 
the delivery reagent (8 µl/ml), MAO-5mis (80 µM) or MAO-env (80 µM) as required 
for each experiment. After three days in culture cells were stained with calcein AM as 
described above. Cells on the inside of the chamber were carefully removed with a 
cotton soap and cells that migrated to the other side of the membrane were imaged using 
a Leica GMIR2 confocal microscope with a 20X objective and quantified basically as 
described above using the Image J software. 
Antibodies 
RON C-20 polyclonal antibody against the β chain of RON, CD4 MT310 and Hsp90 
α/β (H-114) antibodies were purchased from Santa Cruz Biotechnology. Monoclonal 
Anti Flag M2 and Anti Flag polyclonal antibodies were purchased from Sigma. Anti-
HA monoclonal and polyclonal antibodies were purchased from Covance and Abcam 
respectively.  Monoclonal  anti  phosphotyrosine  antibody  clone  G410  and  Anti-EGF 
Receptor clone LA22 were purchased from Upstate Biotechnology. Anti MYC,  Akt 
and  phosphorylated  AKT  antibodies  were  purchased  from  Cell  Signaling.  Anti-V5 
antibody was purchased from Invitrogen. Secondary anti-rabbit IgG peroxidase linked 
F(ab’) fragment from donkey was purchased from Amersham Biosciences. Peroxidase 
conjugated goat anti mouse antibody was purchased from Jackson Research. Goat anti-Mariana Varela, 2007     Chapter 2,74 
rabbit IgG labeled with Alexa-488 and donkey anti-mouse IgG labeled with Alexa-594 
were purchased from Molecular Probes. 
Cell lysates and immunoprecipitations 
For the evaluation of AKT phosphorylation, transformed and parental IEC-18 cells were 
grown up to approximately 80% confluency, serum starved overnight and lysed with 
Triton lysis buffer (Cell Signaling) with the addition of a protease inhibitors cocktail 
(Complete- Roche) and 1 mM PMSF. To test RON phosphorylation, human 293 cells 
were transfected with the appropriate plasmids (see Results section) using the Calphos 
Mammalian transfection kit (Clontech); 48 hours after transfection cells were serum-
starved for 12-16 hours and lysed as described above.  
Co-immunoprecipitation assays shown in Chapter 3 and 4 were performed in 293T cells 
transfected with the appropriate plasmids using the Calphos Mammalian transfection 
kit.  48  hours  after  transfection  cells  were  lysed  with  SDS-NP40  lysis  buffer  [0.5% 
Sodium  Deoxycholate,  0.1%  sodium  dodecyl  sulphate  (SDS),  0.5%  NP-40,  50  mM 
TRIS, 150 mM NaCl] with the addition of a protease inhibitors cocktail (Complete- 
Roche) and 1 mM PMSF. Lysates were sonicated and then centrifuged for 20 minutes at 
10,000 rpm to remove insoluble material. Protein concentration was determined using 
the  Lowry  method  provided  by  Biorad.  For  the  evaluation  of  protein-protein 
interactions 200 µg of whole cell extracts were rocked with 20 µl of protein A agarose 
beads (Santa Cruz Biotechnology) and  primary antibody at 4ºC for 3 hours. After three 
washes with lysis buffer, beads were resuspended in SDS loading buffer, boiled for 5 
minutes,  subjected  to  SDS-PAGE  and  western  blotting  using  standard  protocols 
(Ausbel, Brent et al. 2000). Detection was achieved by using the appropriate secondary 
antibodies  labelled  with  horseradish  peroxidase  followed  by  enhanced 
chemiluminscence  (ECL)  detection  using  SuperSignal  West  Pico  chemiluminescent 
reagent  (Pierce).  When  necessary  membranes  were  stripped  with  restoring  buffer 
(Pierce) and used again with another antibody. Each experiment has been repeated at 
least twice independently.  
Co-immunoprecipitation  assays  shown  in  Chapter  5  were  performed  in  293T  cells 
transfected with the appropriate plasmids using the Calphos Mammalian transfection 
kit. 48 hours after transfection cells were lysed with a lysis buffer containing 25 mM 
Hepes pH 7.5, 150 mM NaCl, 1% NP-40, 10% glycerol, 25 mM of NaF, 1 mM of 
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PMSF. Lysates were rocked for 30 minutes at 4°C and then centrifuged for 20 minutes 
at 10,000 rpm to remove insoluble material. 500 µg of cell lysates were pre-cleared with 
10 µl of protein A agarose beads (Santa Cruz Biotechnology) for 30 minutes at 4°C. 
Lysates were then centrifuged for 5 minutes at 12,000 rpm to remove beads and were 
immunoprecipitated for 12-16 hours using 20 µl of protein A agarose beads and 1 µl of 
Flag  M2  antibody  (Sigma).  Immunoprecipitates  were  then  washed  and  analyzed  as 
described above. 
Western blot analysis  
50 µg of protein extracts obtained from cell lysates (or whole pellets resulting from 
immunoprecipitations)  were  subjected  to  SDS-PAGE  and  then  transferred  to 
nitrocellulose membranes (Hybond, Amersham), and blocked for 1 hour at RT with 
blocking buffer (5% skimmed milk in TBS/T [0.1% of Tween 20]). After blocking, 
membranes were rinsed with TBS/T three times for five minutes and further incubated 
with the selected primary antibody. This step was performed either for 1 hour at RT or 
overnight at 4
oC. Primary antibodies were diluted as follows: 
Anti-FLAG: 1:5000 in 5% BSA in TBS/T. 
Anti-HA: 1:10000 in 5% BSA in TBS/T. 
Anti-phosphotyrosine: 1:1000 in 5% BSA in TBS/T. 
Anti-RON: 1:5000 in 5% BSA in TBS/T. 
Anti-Akt and phospho-Akt: 1:1000 in 5% BSA in TBS/T. 
Anti-EGFR: 1:1000 in 5% BSA in TBS/T. 
Anti-CD4: 1:2000 in 5% BSA in TBS/T. 
Anti-MYC: 1:1000 in 5% BSA in TBS/T. 
Anti-HSP90: 1:1000 in 5% BSA in TBS/T. 
Anti-γ tubulin: 1:000 in 5% BSA in TBS/T. 
Anti-JSRV Env: 1:500 in blocking buffer 
After incubation with primary antibody, membranes were rinsed three times in TBS/T 
for  five  minutes  and  further  incubated  with  the  appropriate  peroxidase-conjugated 
secondary antibodies for 1 hour at RT. Secondary antibodies used were donkey anti-
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in blocking buffer; and goat anti-mouse (IgG [H+L])  from Jackson Research, diluted 
1:10000  also  in  blocking  buffer.  Chemiluminescence  was  developed  using  ECL 
(Amersham, GE). If membranes were to be reblotted with a different primary antibody, 
they were first stripped with Restore (Pierce) for an hour at 37
oC, and washed three 
times with TBS/T for 5 minutes.  
Confocal microscopy 
HeLa or COS  (6.5 x 10
4 cells/well) cells were plated onto two well-chambered glass 
slides (Lab-Tek, Nalge Nunc International) and cultured as described above. Cells were 
transfected  with  Lipofectamine  (Invitrogen)  supplemented  with  Plus  reagent 
(Invitrogen)  according  to  the  manufacturer’s  instructions.  Cells  were  kept  with  the 
transfection mixture (without serum or antibiotics) between 3 and 5 hours. After this 
time the transfection mixture was replaced by complete medium. Forty-eight hours after 
transfection cells were fixed with 3% paraformaldehyde (PFA) for 15 minutes at RT or 
with methanol for 5 minutes at -20°C. After fixation cells were quenched with 10 mM 
ammonium  chloride  (not  when  cells  were  fixed  with  methanol)  and  further 
permeabilized  with  PBS  containing  0.1%  Triton  X-100  (10  minutes  at  RT).  After 
permeabilization,  slides  were  blocked  twice  for  five  minutes,  firstly  with  PBS 
containing  0.4%  fish  skin  gelatine  and  0.2%  Tween  20,  and  secondly  with  PBS 
containing 2.5% normal goat serum and 0.2% Tween 20. The primary antibody was 
diluted in PBS containing 2.5% normal goat serum and 0.2% Tween 20 and incubated 
for 45 minutes at 37
oC. Slides were further washed with PBS containing 0.2% Tween 
20  and  blocked  a  second  time  as  described  above.  Fluorescently-labelled  secondary 
antibodies (Alexa 488 and 594 [Molecular Probes, Invitrogen]) were diluted in PBS 
containing 2.5% normal goat serum and 0.2% Tween 20 and incubated for 30 minutes 
at 37
oC. Slides were washed with PBS containing 0.2% Tween 20 and mounted with 
Vectashield (Vector Labs) mounting medium with DAPI. Slides were analyzed with a 
Leica TCS SP2 confocal microscope.  
To detect HA and FLAG epitopes, mouse monoclonal anti-HA (Covance) and anti-
FLAG polyclonal (Sigma) were diluted 1:500 and 1:200, respectively. V5 epitopes were 
detected  using  anti-V5  antibodies  (Invitrogen)  at  1:200  dilution.  To  detect 
JSRV/enJSRV Envs an antibody raised against the JSRV TM domain was used at a 
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The  Image  J  parameters  used  to  analysed  colocalization  were  for  minimum  ratio 
between  channels:  0.5;  red  channel  lower  threshold:  100;  green  channel  lower 
threshold: 100  (Abramoff, Magelhaes et al. 2004). 
RT PCR 
Total  RNA  from  cultured  cells  was  extracted  using  the  Qiagen  RNeasy  mini  kit 
following manufacture’s instructions.  Contaminating genomic DNA was removed by 
DNase treatment as follows. 10 µg of RNA were diluted in 25 to 100 µl volume using 
DEPC water and 2U/µl of DNase (DNase I RNase-free, Ambion) were added after the 
addition  of  10X  reaction  buffer.  Treatment  was  performed  for  one  hour  at  37°C. 
Thereafter, EDTA was added at a final concentration of 5 mM and the DNase activity 
was stopped by heat inactivation at 75°C for 5 minutes. cDNA was prepared using 
Omniscript  reverse  transcriptase  from  Qiagen.  RNase  inhibitors  and  oligod(T)  used  
were obtained from Ambion and used at respectively 10U/µl and 10 µM. 
 The RT reaction was prepared as follows and performed for 1 hour at 37°C: 
RNA                             2 µg 
10X buffer                    2 µl 
dNTPs (5mM)              2 µl 
oligod(T) (10 µM)       2 µl 
RNase inh. (10U/ µl)   1 µl 
RT (4U/ µl)                  1 µl 
Water                            up to 20 µl 
5 µl of the cDNA was later used in the PCR reaction with specific primers. 
Cell staining 
Cells were stained with basic fuchsin/methylene blue for the visualization of cell-cell 
fusion. Cells were first washed three times with PBS and then covered for 20 min with a 
1% methylene blue and 0.25% basic fuchsin in methanol solution. Thereafter the dishes 
were washed with water and examined.  Mariana Varela, 2007     Chapter 2,78 
oTr cells were stained with May-Grunwald and Giemsa to examine the appearance of 
BNCs. Briefly cells were washed three times with PBS and fixed with methanol for 15 
minutes at RT. Cells were then stained with a 50% solution of May-Grunwald dye in 
buffered water (pH 6.8) for 5 minutes. After 3 washes with buffered water cells were 
stained with an 8% solution of Giemsa in buffered water for 8 minutes. The stain was 
removed after another three washes with buffered water. 
Hydrophobic profile 
The hydrophobic profile of enJSRV Envs and wild type JSRV Env was calculated by 
the  Kyte  and  Doolittle  method  implemented  by  the  Proscale  program  provided  by 
Expasy. 79 
Chapter 3 
Summary 
This chapter will describe studies aimed to understand: I) the role of the SU domain of 
the JSRV Env glycoprotein in the process of transformation of epithelial cells in vitro, 
and II) the interplay between the receptor tyrosine kinase RON and the Env protein of 
both exogenous and endogenous JSRVs. 
Introduction 
JSRV is a replication competent oncogenic retrovirus that induces transformation using 
different mechanisms from other oncoretroviruses. Its Env glycoprotein is a dominant 
oncoprotein  that  alone  is  able  to  transform  a  variety  of  cell  lines  in  vitro  (Maeda, 
Palmarini et al. 2001; Rai, Duh et al. 2001; Allen, Sherrill et al. 2002; Danilkovitch-
Miagkova, Duh et al. 2003; Zavala, Pretto et al. 2003; Liu and Miller 2005). Moreover, 
the sole expression of the JSRV Env is capable of inducing lung adenocarcinomas in 
immunocompromised  mice  when  expressed  by  adeno-associated  virus  vectors 
(Wootton, Halbert et al. 2005). More importantly, when the JSRV Env is expressed in 
immunocompetent sheep by a JSRV based vector it causes OPA in a high percentage of 
animals (Caporale, Cousens et al. 2006). Thus the JSRV Env can function as a powerful 
oncoprotein both in vitro and in vivo. 
The  mechanisms  used  by  the  JSRV  Env  to  induce  cell  transformation  are  not 
completely understood and both receptor dependent and independent mechanisms have 
been proposed. In the receptor independent mechanisms the cytoplasmic tail (CT) of the 
TM of the JSRV Env is the main determinant of transformation (Palmarini, Maeda et al. 
2001). In particular, a tyrosine in position 590, that is part of a SH-2 binding domain, 
has been shown to be critical for transformation although its influence in JSRV Env-
induced cell transformation varies and depends on the amino acid substitution, the cell 
line used to perform the assays and experimental conditions (Liu, Wang et al. 2001; 
Palmarini, Maeda et al. 2001; Allen, Sherrill et al. 2002; Zavala, Pretto et al. 2003; 
Hofacre and Fan 2004; Liu and Miller 2005; Cousens, Maeda et al. 2007). The Ras-
MEK-MAPK and the PI3K/Akt pathways have been implicated in JSRV-induced cell 
transformation but how JSRV Env engages the cell signalling network is not clear at the Mariana Varela, 2007     Chapter 3,80 
moment (Maeda, Palmarini et al. 2001; Palmarini, Maeda et al. 2001; Liu and Miller 
2005; Maeda, Fu et al. 2005; Caporale, Cousens et al. 2006; De Las Heras, Ortin et al. 
2006). Akt activation has been found in several cell lines transformed by the JSRV Env 
and  it  seems  to  be  dependent  on  Y590.  Both  PI3K  dependent  and  independent 
mechanisms have been implicated in Akt activation (Liu, Lerman et al. 2003; Maeda, 
Inoshima et al. 2003), however its role in vivo has proven harder to demonstrate (De Las 
Heras, Ortin et al. 2006; Suau, Cottin et al. 2006).  
JSRV Env receptor-dependent mechanisms have been proposed in the transformation of 
human  BEAS-2B  cells  (Danilkovitch-Miagkova,  Duh  et  al.  2003).  HYAL-2  is  a 
glycosylphosphatidylinositol (GPI)-anchor protein that functions as a cellular receptor 
for  exogenous  and  endogenous  JSRVs (Rai,  Duh  et  al.  2001;  Spencer,  Mura  et  al. 
2003).  In  humans,  HYAL-2  is  located  in  the  p21.3  region  of  chromosome  3  (Rai, 
DeMartini et al. 2000) which is commonly deleted in lung and other types of human 
cancers (Lerman and Minna 2000; Petursdottir, Thorsteinsdottir et al. 2004), indicating 
the possible presence of tumour suppressor genes in this location. BEAS-2B cells are 
human bronchial epithelial cells immortalized with an adenovirus-12 SV40 hybrid virus 
(Reddel,  Ke  et  al.  1988). It  was  shown  in  this  cell  line  that  HYAL-2  binds  to  the 
receptor tyrosine kinase RON leading to an inactive complex. However, when the JSRV 
Env is overexpressed, HYAL-2 binds to it, inducing their degradation and allowing the 
release  of  RON  which  then  is  able  to  dimerize,  autophosphorylate  and  activate 
downstream  signal  pathways,  including  PI3K/Akt  and  MEK/MAPK  pathways,  that 
ultimately induce cell transformation (Danilkovitch-Miagkova, Duh et al. 2003). The 
fact that a dominant negative kinase inactive form of RON blocked transformation by 
the JSRV Env in these cells demonstrated that RON was required for transformation.  
The proposed model is illustrated in Figure 14. This model was also proposed as the 
mechanism for transformation of epithelial cells in general however, subsequent studies 
performed by the same group in Madin-Darby canine kidney cells (MDCK) did not find 
RON or canine Hyal-2 involved in the mechanism of transformation by the JSRV Env 
(Liu  and  Miller  2005).  In  addition,  HYAL-2  was  unable  to  modulate  the  basal  or 
macrophage stimulating factor (MSP)-induced RON activity in 208F cells (Miller, Van 
Hoeven et al. 2004) arguing against a direct regulation of RON by HYAL-2. In addition 
both our group and other groups have been unable to transform BEAS-2B cells with the 
JSRV Env (Palmarini, M., personal communication). Mariana Varela, 2007     Chapter 3,81 
 
Figure 15. Model of JSRV Env mediated transformation of BEAS-2B cells. 
RON is expressed at the cell membrane as a dimer and maintained in an inactive state thanks 
to its association with HYAL-2. Expression of the JSRV Env sequesters HYAL-2 and induces its 
degradation  in  a  proteasomal-dependent  manner.  This  allows  the  liberation  of  RON  which 
undergoes conformational changes that trigger its catalytic activity and the activation of the Akt 
and MAPK pathways that lead to cell transformation. Adapted from Danilkovitch et al. 2003. 
 
The recepteur d’origine nantais, RON, is a receptor tyrosine kinase that structurally 
belongs to the MET proto-oncogene family, which contains only two members, MET 
and RON (Manning, Whyte et al. 2002). The RON protein is synthesized as a single 
chain precursor that matures at the cell membrane leading to a 180 kDA heterodimeric 
protein composed of a 40 kDA α-chain and a 150 kDA transmembrane β-chain with 
intrinsic kinase activity (Gaudino, Follenzi et al. 1994; Wang, Ronsin et al. 1994). It is 
mainly expressed in cells of epithelial origin and proteins highly homologous to it have 
been identified in mouse, chicken, xenopus and puffer fish (Wang, Yao et al. 2006). The 
only known ligand identified so far of RON is a serum-derived protein referred to as 
MSP (Gaudino, Follenzi et al. 1994; Wang, Ronsin et al. 1994). RON is required for 
normal embryogenesis since RON gene knockouts lead to the death of mouse embryos 
at early stages (Muraoka, Sun et al. 1999). RON overexpression has been identified in 
breast, colon, lung, bladder and ovarian human cancers and is usually correlated with 
increased activation and the presence of splice variants (Wang, Yao et al. 2006). At the 
moment there are six known spliced variants of RON and two have shown tumour-
producing activity (Chen, Zhou et al. 2000; Wang, Kurtz et al. 2000; Zhou, He et al. 
2003).  The  tumourogenic  potential  of  RON  has  been  demonstrated  by  mutational 
analysis of the kinase domain that confers RON the ability to cause cell transformation, Mariana Varela, 2007     Chapter 3,82 
tumour growth and metastasis in nude mice (Santoro, Penengo et al. 1998; Williams, 
Longati et al. 1999; Peace, Hughes et al. 2001). Transgenic mice overexpressing RON 
in  the  distal  lung  epithelial  cells  develop  multiple  adenomas  and  adenocarcinomas, 
demonstrating its role in tumour formation in vivo (Chen, Zhou et al. 2002). RON has 
also been implicated in the induction of cell spreading, dissociation, migration, matrix 
invasion and tubular formation in a variety of cancerous cells as well as increasing the 
metastatic potential of tumours (Santoro, Penengo et al. 1998; Peace, Hughes  et al. 
2001) further demonstrating its role in the acquisition of malignant phenotypes. 
The oncogenic potential of RON depends on the efficiency of the kinase activity and at 
the  moment  there  are  three  mechanisms  which  can  abnormally  upregulate  it: 
overexpression, mutation and truncation. Upon activation RON can transduce a variety 
of signal transduction pathways including SOS, Grb2, Ras, PI3K, MAPK/Erk1/2, JNK, 
β-catenin, FAK, integrins, Smad 2/3 and the NF-κB complex via the formation of a 
multifunctional docking site through the phosphorylation of tyrosine residues in the 
carboxy terminal tail (Wang, Yao et al. 2006). 
It is interesting to note that beside JSRV two replication defective retroviruses exert 
their transforming activity through the expression of part of their Env glycoproteins, via 
RON activation. However, both retroviruses possess, unlike JSRV, Envs that are not 
functional.  The  S13  avian  erythroblastosis  retrovirus  is  a  replication  defective 
oncogenic retrovirus that induces small fibrosarcomas and expansion of the erythroid 
compartment resulting in severe and fatal anaemia in chickens (Beug, Hayman et al. 
1985). Interestingly, the oncogenic factor of this virus is a fusion protein composed by 
an  extracellular  and  juxtamembrane  domain  encoded  by  the  viral  env  gene  and  a 
cytosolic  region  encoded  by  c-SEA  sequences,  the  chicken  orthologue  of  RON 
(Hayman, Kitchener et al. 1985). The env encoded sequences promote dimerization and 
autophosphorylation and thus constitutive activation of the fusion protein leading to cell 
transformation (Smith, Vogt et al. 1989; Morimoto and Hayman 1994). Stk, the mouse 
counterpart of RON, is also involved in the pathogenicity of another retrovirus, the 
Friend spleen focus-forming virus (SFFV). SFFV is a replication incompetent retrovirus 
that induces erythroleukaemia in susceptible strains of mice. The major determinant of 
transformation of SFFV is the gp55 Env protein that has unique characteristics and 
associates  with  the  erythropoietin  receptor  at  the  cell  membrane  allowing  the 
proliferation  of  erythroid  cells  in  the  absence  of  erythropoietin  (Ruscetti  1999). 
Susceptibility  to SFFV is strain specific and depends on different host genes (Coffin, Mariana Varela, 2007     Chapter 3,83 
Hughes et al. 1997). One of these genes is Fv-2 which encodes the Stk tyrosine kinase. 
Susceptible mice encode a short form of Stk (sf-Stk) from an internal promoter that 
lacks  most  of  the  extracellular  domain  (Persons,  Paulson  et  al.  1999).  It  has  been 
demonstrated that sf-Stk interacts with SFFV gp55 in haematopoietic cells expressing 
the  erythropoietin  receptor  and  that  this  interaction  induces  the  activation  of  sf-Stk 
(Nishigaki, Thompson et al. 2001). Thus, it appears that SFFV induces its biological 
effects through the activation of sf-STK.  
The  role  of  the  interactions  between  RON,  HYAL-2  and  the  JSRV  Env  in  JSRV 
induced  cell  transformation  are  not  clear  and  warrant  further  investigation.  In  this 
section I will describe several experiments that demonstrate that the JSRV Env can 
transform epithelial cells independently from its cellular receptor. In addition, I will 
show that the JSRV Env associates with RON and that the cytoplasmic tail of the TM 
domain is the major determinant of the biological response of the RON-Env interaction. 
Results 
The JSRV Env transforms IEC-18 cells independently from the 
receptor binding domain 
HYAL-2  has  been  found  to  negatively  regulate  RON  in  BEAS-2B  cells.  Thus,  the 
interaction between the JSRV Env and HYAL-2 and their consequent intracytoplasmic 
degradation,  has  been  deemed  critical  for  RON  activation  and  transformation 
(Danilkovitch-Miagkova, Duh et al. 2003). If this were the case, the Env of enJSRVs 
would also induce cell transformation because they use as well HYAL-2 as a cellular 
receptor (Spencer, Mura et al. 2003). It has been shown in previous studies that the Env 
of enJS5F16 does not induce cell transformation due to differences between exogenous 
and  endogenous  Env  proteins  that  mapped  in  the  CT  (Palmarini,  Gray  et  al.  2001; 
Palmarini, Maeda et al. 2001). 
Initial experiments were performed using the BEAS-2B cells as this was the cell line 
used to demonstrate the involvement of RON in JSRV Env-induced transformation in 
the  first  place  (Danilkovitch-Miagkova,  Duh  et  al.  2003).  However,  we  could  not 
reliably induce transformation of BEAS-2B cells with the JSRV Env. Other groups, 
including the authors of the original paper also confirmed this difficulty in subsequent 
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transformation assays in another epithelial cell line, rat epithelial IEC-18 (Quaroni and 
Isselbacher 1981). Typical results obtained in transformation assays are shown in Figure 
15 and Table 3 summarizes the data obtained. Two different types of transformation 
assays were performed. In the first set of experiments IEC-18 cells were transfected 
with expression plasmids of the wild type (pCMV3JS21ΔGP-neo), endogenous (pEnv-
En2-neo), mutant (pCMV3JSΔGPY590D or F-neo) and chimeric (pMoMULVprr-JSE-
neo)  JSRV  Envs  that  also  encoded  for  the  neomycin  resistant  gene.  G418  resistant 
clones  were  selected  and  foci  of  transformed  cells  were  counted  four  weeks  after 
transfection. For the second set of experiments no G418 selection was used. 
The transformation efficiency of the JSRV Env in IEC-18 was relatively low compared 
to other cell lines such as 208F cells or NIH/3T3. However, foci of elongated refractile 
cells that lost the epithelial phenotype of the parental cells were clearly visible four 
weeks after transfection (Figure 15 panel 1). The JSRV Env mutants Y590D and Y590F 
and the Env of enJS5F16 did not induce cell transformation (Figure 15 panels 3 to 6). 
On the other hand, a chimeric Env formed by the receptor binding domain (RBD) and 
the proline rich region of MoMLV with the remaining portions of SU and TM domain 
from JSRV (pMoMMLVprr-JSE) (Chow, Alberti et al. 2003) induced transformation 
with variable efficiency between experiments. In general however, foci of transformed 
cells induced by this chimeric Env were smaller in size with respect to those induced by 
the  JSRV  Env.  We  were  unable  to  quantify  the  transfection  efficiency  of  each 
individual env expression plasmid, thus comparisons regarding the ability of different 
construct to induce cell transformation should be raised with caution.         
Foci from IEC-18 cells transformed by JSRV and the chimeric pMoMMLVprr-JSE Env 
were  picked  and  expanded.  The  resulting  lines  consisted  of  refractile  cells  with  a 
fibroblast-like phenotype that could be easily differentiated from the parental IEC-18 
cells. Both cell lines were able to form colonies in soft agar (not shown) and in both of 
them increased levels of phosphorylated Akt with respect to the parental IEC-18 cell 
line were found (not shown). We could not detect phosphorylated RON in both JSRV 
and the chimeric pMoMMLVprr-JSE Env-transformed derived cell lines although RON 
expression in these cells (and in the parental IEC-18) was at the limits of detection with 
the available reagents (not shown).   
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Figure 16. Transformation assays in rat epithelial cells (IEC-18). 
IEC-18 cells were transfected, G418 selected and foci of transformed cells were counted four 
weeks after transfection. Wild type JSRV Env and MoMLVprr-JSE (JSRV-MoMLV chimeric Env) 
induced foci of transformed cells 1) and 2) respectively.  Panels 3 to 6 show typical results 
obtained by transfecting  IEC-18 cells with  pCMV3JSΔGPY590D-neo,  pCMV3JSΔGPY590F-
neo, mock and pEnv-En2-neo (enJS5F16 Env expression plasmid) respectively. 
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Number of foci  Plasmid 
Exp. 1  Exp. 2  Exp. 3  Exp. 4 
Mock  0  0  0  0 
pCMV3ΔGP  n/a
2  n/a  18  21 
pMoMLVprr-JSE  n/a  n/a  4  10 
pCMV3ΔGP-neo  32  5  n/a  n/a 
pMoMLVprr-JSE-neo  63  13  n/a  n/a 
pCMV3ΔGPY590D-neo  0  0  n/a  n/a 
pCMV3ΔGPY590F-neo  0  0  n/a  n/a 
pEnv-En2-neo  0  0  n/a  n/a 
Table 4. Transformation assays in IEC-18 cells. 
 
JSRV,  enJS56A1,  chimeric  MoMLV-JSRV  and  MoMLV  Envs 
coimmunoprecipitate with RON 
Next, we further investigated the nature of the JSRV Env-RON association considering 
that the model of Env induced transformation of BEAS-2B cells  does not fit with the 
mechanisms of Env transformation of other epithelial cell lines (Liu and Miller 2005; 
Maeda, Fu et al. 2005). 
We  performed  co-immunoprecipitation  studies  in  human  293T  cells  by  transfecting 
them with an expression plasmid of the human RON gene and expression plasmids of  
JSRV Env (JSE-F), JSRV Env mutant Y590D (JSEY590D-F), enJS5F16 Env (JSE-
En2-F),  chimeric  MoMLV-JSRV  Env (MoMLVprrJSE-F),   MoMLV  Env  (pCEE-F) 
and human HYAL-2 (F-hHYAL2). All the Env plasmids were tagged with the FLAG 
epitope at the carboxy terminal of the CT. HYAL-2, also tagged with a FLAG epitope 
but at its amino terminal portion, was used as a positive control and normal rabbit serum 
was used as a further immunoprecipitation control. All the Env proteins used in this 
study were able to associate with RON and co-immunoprecipitation was shown both 
using  an  anti-RON  or  an  anti-FLAG  serum  (Figure  16)  and  different  transfection 
reagents (not shown). Interestingly, only the full length Env proteins were pulled down 
by  anti-RON  antibodies  suggesting  that  RON-Env  interaction  might  occur  co-
translationally  in  the  Golgi  and  this  association  interferes  with  Env  cleavage.  We 
noticed that while JSRV, enJSRV and MoMLV Env proteins used in this study are 
normally  processed  (into  the  SU  and  TM  domains),  we  were  not  able  to  detect  a 
processed TM for the MoMLV-JSRV Env chimera (bottom panel Figure 16). This is 
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not entirely surprising given the fact that this is a chimeric envelope protein formed by 
the receptor binding domain and proline rich region of MoMLV and the remaining 
portion of the SU and TM from JSRV (Chow, Alberti et al. 2003). We speculate that the 
folding of the SU and TM in this chimeric molecule hampers the access of the cleavage 
site  to  cellular  proteases  considering  that  the  SU-TM  boundary  in  this  particular 
chimera  is  identical  to  the  JSRV  Env.  The  MoMLV-JSRV  chimera  has  indeed  a 
reduced ability to transform cells (with respect to JSRV) and grossly reduced infectivity 
when used to pseudotype retroviral vectors (Chow, Alberti et al. 2003). On the other 
hand,  it  has  been  shown  that  failure  to  cleave  the  MLV  Env  does  not  necessarily 
preclude  its  ability  to  reach  the  cell  surface,  incorporation  into  virion  particles  and 
mediate infection (Zavorotinskaya and Albritton 1999). 
 
Figure  17.  Wild  type,  endogenous,  chimeric  and  mutant  of  the  JSRV  Env  co-
immunoprecipitate with RON. 
293T cells were co-transfected with an expression plasmid for human RON and one of  the 
following Env expression plasmids: wild type JSRV Env (JSE-F), chimeric JSRV-MoMLV Env 
(MoMLVprr-JSE-F),  MoMLV  Env  (pCEE-F),  enJS5F16  Env  (JSE-En2-F),  Y590D  mutant 
(JSEY590D-F) and HYAL-2 (F-hHYAL2). Forty eight hours after transfection cells were lysed, 
and lysates were immuprecipitated (IP) and analyzed by WB. Antisera used for IPs and WB are 
indicated beside each panel. Please note that the MoMLV Env (pCEE-F) is processed correctly 
but the TM domain (p15) is not visible in the figure because the gels shown are usually run for 
long periods of time in order to resolve HYAL-2 from the IgG heavy chain and better visualize 
proteins of high molecular weight such as RON.   Mariana Varela, 2007     Chapter 3,88 
It is also noticeable that two bands of similar molecular weight are present for the full 
length JSRV, enJS5F16 and JSRV Y590D Env proteins. This phenomenon is probably 
due to the immunoprecipitation of partially (newly synthesized) and fully glycosylated 
forms of the Env proteins.           
All the Env proteins described above were still able to co-immunoprecipitate with RON 
if Triton-X-100 rather than SDS was used in the lysis buffer (Figure 17).  Moreover, we 
observed co-immunoprecipitation when variable amounts of plasmid DNA were used in 
transfections as well as different amounts of proteins in the immunoprecipitates (not 
shown). 
 
 
Figure 18. Various Envs bind RON when lysed with Triton-X-100 lysis buffer. 
293T cells were co-transfected with an expression plasmid for human RON and one of  the 
following  Env  expression plasmids:  chimeric  JSRV-MoMLV  Env  (MoMLVprr-JSE-F),  MoMLV 
Env (pCEE-F) and wild type JSRV Env (JSE-F). Forty eight hours after transfection cells were 
lysed, and lysates were immuprecipitated using a Triton-X100-based lysis buffer and analyzed 
by WB. 
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The  interaction  between  RON  and  the  JSRV  is  a  bona  fide 
association 
We  performed  a  series  of  experiments  aimed  to  determine  whether  the  co-
immunoprecipitation  of  RON  with  the  various  Env  proteins  was  due  to  a  real 
association or to artefacts of the experimental conditions. First, we checked if the Env-
RON  interaction  was  preserved  when  membrane  lipids  rafts  were  disrupted  by 
cholesterol depletion prior to cell lysis. This experiment was performed in order to rule 
out the possibility that the association found by co-immunoprecipitation was merely due 
to the presence of both proteins in the same membrane microdomain. As shown in 
Figure 18, all the Env used in this study associated with RON when lipid rafts were 
disrupted by treatment with methyl-β-cyclodextrin (Niu, Mitchell et al. 2002). 
 
Figure  19.  Lipid raft  disruption does  not affect the binding between RON and  various 
JSRV Envs. 
293T cells were transfected with RON and various Env expression plasmids in triplicate. One of 
the  dishes  was  left  untreated  while  the  other  two  were  incubated  with  8  mM  of  Methyl-β-
cyclodextrin for one hour at 37°C. One of the two treated dishes was cholesterol reconstituted 
by  a  further  incubation  with  cholesterol  as  a  control.  Thereafter  all  the  dishes  were  lysed, 
immunoprecipitated and analysed by WB as indicated for each panel.  
 
Secondly, we increased the stringency of the co-immunoprecipitation of RON with the 
JSRV Env and other Env proteins by disrupting cells with SDS lysis buffer for 25 
minutes  at  37°  C  (Figure  19A)  and  by  incubating  the  immunoprecipitates  with 
increasing amounts of sodium chloride in the last washing step for 30 minutes at room 
temperature (Figure 19B). Under both experimental conditions all the tested proteins 
were still able to coimmunoprecipitate with RON. Mariana Varela, 2007     Chapter 3,90 
 
 
Figure  20.  Stringent  conditions  do  not  modify  the  association  between  RON  and  Env 
proteins. 
A) 293T cells were cotransfected as described in Materials and Methods. Forty eight hours after 
transfection cells were lysed at 37°C for 25 minutes. Cell lysates were then immunoprecipitated 
(IP) with RON or FLAG antibodies and analyzed by WB as indicated beside each panel. B) 
Immunoprecipitates  from  cells  co-transfected  with  RON  and  JSE-F  were  washed  with 
increasing amounts of sodium chloride for 30 minutes at room temperature and analyzed by WB 
as indicated. 
 
Thirdly,  we  repeated  the  co-immunoprecipitation  experiments  described  above 
replacing  RON  with  another  receptor  tyrosine  kinase,  the  epidermal  growth  factor 
receptor (EGFR). As shown in Figure 20A EGFR did not co-immunoprecipitate with 
any of the Env proteins employed above or with HYAL-2. An additional membrane 
protein, CD4, did not co-immunoprecipitate with RON (Figure 20B). 
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Figure 21. The JSRV Env does not co-immunoprecipitate with EGFR and RON does not 
co-immunoprecipitate with CD4. 
293T cells were lysed, immunoprecipitated and analyzed as described for Figure 16. 
 
We then investigated whether the RON-Env association could be specifically competed 
by the use of a JSRV Env plasmid without the FLAG epitope at the carboxy terminus 
(pCMV3JSΔGP,  named  JSE  in  the  figures  due  to  space  restrictions).  Co-
immunoprecipitations were performed from lysates of cells co-transfected with fixed 
amounts of RON and JSE-F and increasing amounts of pCMV3JS21ΔGP (JSE). As 
shown in Figure 21A, untagged JSRV Env competes with tagged JSRV Env for its 
association with RON since the interaction between RON and JSE-F diminishes when 
high amounts of JSE are present in the lysates. We found also MoMLV Env to compete 
with the JSRV Env for RON association (data not shown). A similar experiment was 
performed from lysates of cells co-transfected with fixed amounts of RON tagged with 
the HA epitope and JSE-F and increasing amounts of non tagged RON. Figure 21B 
shows that the RON-HA/JSE-F association can be competed by untagged RON. 
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Figure 22. The binding between RON and the JSRV Env can be specifically competed. 
293T  cells  were  cotransfected  with  3  µg  of  RON  (A)  or  3  µg  of  RON-HA  (B)  expression 
plasmids, 1 µg of the expression plasmid for the JSRV Env tagged with the FLAG epitope (JSE-
F) and increasing amounts of the non tagged JSRV Env (JSE) (panel A) or non tagged RON 
(panel  B).  Cells  were  lysed  48  hours  after  transfection.  RON  and  RON-HA  were 
immunoprecipitated  using  RON  or  HA  antibodies,  while  the  tagged  JSRV  Env  was 
immunoprecipitated with FLAG antibodies and analyzed by WB as indicated below each panel. 
Note that RON-Ha cross-reacts also with anti-RON antibodies.  
 
Many studies on the transforming properties of the JSRV Env have been performed in 
cell lines of mouse and rat origin. We then tested whether Stk, the mouse counterpart of 
RON, was also able to co-immunoprecipitate with the JSRV Env (and the other Envs 
employed in this study) when co-expressed in the same cells. As shown in Figure 22A, 
all the Env proteins employed in this study (and HYAL-2) co-immunoprecipitated with 
Stk. In agreement with the results with RON, the membrane protein CD4 did not co-
immunoprecipitate with Stk (not shown). It was also tested whether the short form of 
Stk (sf-Stk) that lacks most of the extracellular domain but retains the transmembrane 
and tyrosine kinase sequences (Persons, Paulson et al. 1999) was able to associate with 
the different Envs. sf-Stk was unable to co-immunoprecipitate with the JSRV Env and 
other Env proteins (Figure 22B) suggesting that the RON/Stk extracellular domain is 
necessary to associate with the JSRV Env.  Mariana Varela, 2007     Chapter 3,93 
 
Figure 23. Stk but not sf-Stk co-immunoprecipitate with the various JSRV Envs tested. 
293T cells were cotransfected as in Figure 16 with the exception that expression plasmids for 
mouse Stk (panel A) or SF-Stk (panel B) tagged with the HA epitope were used instead of RON. 
Cells were lysed, immunoprecipitated (IP) and analyzed by WB with the antibodies indicated 
beside each panel. 
 
The  surface  domain  of  the  JSRV  Env  is  not  required  to 
associate with RON 
By the use of a truncated form of the JSRV Env (ΔGPSUΔ103-352 HA) that has a large 
deletion in the SU domain (Hofacre and Fan 2004) we tested whether the SU is required 
for the interaction with RON. Co-immunoprecipitations were performed with lysates of 
293T cells transfected with RON and ΔGPSUΔ103-352 HA and analysed by WB. As 
shown in Figure 23 the SU truncated form of the JSRV Env co-immunoprecipitated 
with RON. 
 
Figure 24. The SU of the JSRV Env is not required for the interaction with RON. 
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The sole expression of RON is not sufficient to allow entry of 
JSRV into NIH 3T3 cells 
NIH 3T3 cells stably expressing the human RON protein were prepared and used in 
standard entry assays using MLV retrovirus vectors pseudotyped with the JSRV Env. 
As shown in Table 4, the expression of RON did not render these cells permissive for 
JSRV entry. Figure 24 shows RON expression in cells used to perform the entry assay. 
  Exp. 1  Exp. 2  Exp.3  Average 
NIH 3T3  10
2  6.5  0.75  3.6 10
1 
NIH 3T3- RON  4.5 10
2  2.9 10
2  5  2.2 10
2 
NIH 3T3-HYAL2  1.710
6  4.9 10
5  4.3 10
5  8.7 10
5 
Table 5. Entry assays in NIH 3T3 RON-expressing cells. 
NIH  3T3  cells  expressing  human  RON  or  HYAL-2  were  transduced  with  retroviral  vectors 
expressing alkaline phosphatase and pseudotyped with the JSRV Env. Results are expressed 
as alkaline phosphatase foci per ml. 
 
 
Figure 25. RON expression in NIH 3T3-RON cells. 
NIH  3T3,  NIH  3T3-RON  and  NIH  3T3-HYAL2  cells  were  lysed,  immunoprecipitated  and 
analysed by WB using anti-RON antibodies. 
 
All the experiments described above point to the fact that RON is a promiscuous protein 
and, besides binding to HYAL-2, also associates with the Envs of JSRV, enJSRVs, 
JSRV mutant Y590D, MoMLV and MoMLV/JSRV chimeric Env protein. However, 
JSRV cannot use RON as cellular receptor or enhance transformation in 208F cells 
(data not shown) similarly to what has been shown by other authors in dog MDCK cells 
(Liu and Miller 2005). 
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JSRV and enJSRV Envs co-localize with RON 
Since  RON  and  the  various  JSRV  Envs  were  found  to  interact  in  co-
immunoprecipiation studies, we performed confocal microscopy to determine whether 
they co-localize when co-expressed in the same cells. HeLa cells were transfected with 
an expression plasmid of the human RON protein and wild type JSRV Env tagged with 
the V5 epitope at the carboxy terminus (JSE-V5) or the Env of enJS5F16 tagged with 
the  Flag  epitope  (also  at  the  carboxy  terminus)  and  subsequently  analysed  by 
immunofluorescence (IF) and confocal microscopy. JSRV and enJS5F16 JSRV Env 
proteins  showed  membrane  and  broad  cytoplasmic  distribution,  consistent  with  a 
protein synthesized in the endoplasmic reticulum and transported to the cell membrane. 
Co-localization of RON with both, JSE-V5 and JSE-En2-F was observed at the cell 
membrane and in the cytoplasm as shown in Figure 25. 
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Figure 26. The JSRV Env co-localizes with RON. 
A) Photomicrographs showing representative examples of the major phenotypes observed in 
cells expressing JSE-V5 or JSE-En2-F and RON. Specific staining for all proteins was mainly 
observed  at  the  cell  surface  or  diffused  within  the  cytoplasm.  Co-localization  is  especially 
observed at the cell membrane. Right panels show areas of co-localization in white determined 
by  RGB  Image  J  analysis.  B)  Co-localization  parameters  as  determined  by  RGB  Image  J 
analysis. First panel shows all red and green colours. Second panel shows co-localization in 
black and white. 
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Endogenous  but  not  exogenous  JSRV  Env  inhibits  RON 
autophosphorylation 
Next  we  investigated  whether  direct  Env-RON  association  could  lead  to  RON 
activation. We performed co-transfection experiments using different amounts of RON 
expression  plasmid  that  would  either  lead  to  its autophosphorylation  (3  µg)  or  that 
would  keep  RON  expression  detectable  but  with  no  or  limited  signs  of  activation 
(100ng – 1µg) under our experimental conditions.   
We were unable to detect any increase in RON phosphorylation when 293 cells were 
co-transfected with 1µg of RON and increasing amounts of the various Env expression 
plasmids (not shown). Thus the JSRV Env (or any other Env used in this study) was not 
able by itself to induce RON activation under our experimental conditions. However, by 
co-transfecting 293 cells with 3 µg of RON expression plasmid, an amount of DNA 
sufficient to induce its autophosphorylation, and increasing amounts of Env or HYAL-2 
expression plasmids we discovered a different outcome resulting from the interaction of 
RON with the various Env proteins (Figure 26). Wild type JSRV Env and MoMLV Env 
did  not  affect  RON  autophosphorylation  (Figure  26A-B).  HYAL-2  blocked  RON 
activation as shown before by other authors (Figure 26C) (Danilkovitch-Miagkova, Duh 
et al. 2003). Surprisingly, enJS5F16-Env blocked RON autophosphorylation too. The 
degree of the block of RON phosphorylation by enJS5F16 was variable (as shown in 
Figure 26D-E) but we could not identify any technical reason behind this variability. 
JSEY590D displayed an intermediate phenotype between the JSRV and enJS5F16 Env 
(Figure 26F). As shown in Figure 27 the same results were obtained when Stk was used 
instead of RON. 
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Figure  27.  The  cytoplasmic  tail  of  various  Envs  used  in  this  study  modulates  the 
biological effects of the RON-Env interaction. 
293 cells were cotransfected with 3 µg of the RON expression plasmid and increasing amounts 
of  expression  plasmids  for  the  various  Envs  tagged  with  a  FLAG  epitope  at  the  carboxy 
terminus and HYAL-2 as a control. Forty eight hours after transfection, cells were serum starved 
overnight and lysed. Lysates were immunoprecipitated and analyzed by WB as indicated below 
each panel. D) and E) show two independent experiments where the enJS5F16 Env blocks 
RON phosphorylation at variable degrees. 
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Figure 28. The cytoplasmic tail of  various JSRV Envs modulates the biological effects of 
the Stk-Env interaction. 
293  cells  were  cotransfected  with  3  µg  of  the  Stk  expression  plasmid  tagged  with  the  HA 
epitope  and  increasing  amounts  of  expression  plasmids  for  the  various  Envs  tagged  with  a 
FLAG epitope at the carboxy terminus. HYAL-2 and CD4 were used as controls considering that 
the former but not the latter blocks Stk phosphorylation. Forty eight hours after transfection, 
cells were serum starved overnight and lysed. Lysates were immunoprecipitated and analyzed 
by WB as indicated below each panel.  
 
These experiments suggest that the CT of the TM domain of the JSRV/enJS5F16 Env 
(and Y590 in particular) influences the effects of the interaction with RON despite the 
fact that both, JSRV and enJS5F16, utilize HYAL-2 as cellular receptor (Rai, Duh et al. 
2001; Spencer, Mura et al. 2003).  Furthermore, these experiments reinforce the concept 
that RON can associate with the JSRV Env. To further support the hypothesis that the 
JSRV Env interacts with RON and that the effects on RON phosphorylation are HYAL-
2 independent, RON activation was measured in the presence of the JSRV or enJS5F16 
Env or HYAL-2. In agreement with previous studies, when increasing amounts of the 
JSRV  Env  are  co-transfected  with  fixed  amounts  of  RON  and  HYAL-2  expression 
plasmids, RON autophosphorylation increases accordingly (Figure 28A) (Danilkovitch-
Miagkova, Duh et al. 2003). The authors state that this phenomenon takes place because 
the binding of the JSRV Env to HYAL-2 liberates RON from the inhibitory effects of 
the latter (Danilkovitch-Miagkova, Duh et al. 2003). When the same experiment was 
performed with the enJS5F16 Env, a decrease in RON phosphorylation was detected Mariana Varela, 2007     Chapter 3,100 
(Figure 28B). These observations support the idea that: I) the JSRV Env can associate 
with RON directly; II) that the effects in RON phosphorylation mediated by the CT of 
the  JSRV  Env  are  HYAL-2  independent,  since  they  take  place  regardless  of  its 
presence; and III) that transformation of BEAS-2B cells mediated by the JSRV Env 
could involve the activation of RON but occurs by another mechanism than the one 
proposed  by  Danilkovitch-Miagkova  et.  al.  As  mentioned  before,  unfortunately  our 
group and others (Miller, Van Hoeven et al. 2004; Maeda, Fu et al. 2005) were unable 
to reproduce the results of transformation of BEAS-2B cells with the JSRV Env due to 
the high level of background that did not allow us to distinguish transformed from non-
transformed  cells.  Thus,  the  role  of  RON  and  HYAL-2  in  JSRV  Env-induced 
transformation of BEAS-2B cells remains elusive.  
 
Figure 29. The Env of enJS5F16 blocks RON activation even in the presence of HYAL2. 
293 cells were transfected with 5 µg of RON, 5 µg of HYAL2 (tagged with the HA epitope at the 
amino terminus) expression plasmids and increasing amounts of the JSRV or enJS5F16 Envs 
(tagged with the Flag epitope at the carboxy terminus). Forty eight hours after transfection, cells 
were serum starved and treated with a proteasome inhibitor (ALLN) overnight to preserve the 
Env-HYAL2 interaction and lysed. Cell lysates were immunoprecipitated and analyzed by WB 
as indicated beside each panel. 
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Discussion 
In this section we showed that the interaction between the JSRV Env, HYAL-2 and 
RON tyrosine kinase is more complex than previously thought. We demonstrated that 
the  JSRV  Env  can  associate  with  RON  and  the  CT  of  the  JSRV/enJS5F16  Env 
influences the biological effects of Env-RON association. Furthermore, data obtained in 
IEC-18 cells suggests that transformation of epithelial cells by the JSRV Env is likely to 
occur independently of an interaction with HYAL-2 and through a different mechanism 
that the one proposed by Danilkovitch-Miagkova, 2003. A model of JSRV Env-induced 
transformation of epithelial cells has been suggested based on the results obtained in the 
human bronchial epithelial cell line BEAS-2B by these authors. The model suggests that 
the JSRV Env induces transformation of epithelial cells by sequestering HYAL-2 and 
inducing its degradation, allowing the release of RON from the inhibitory association 
with HYAL-2 and its subsequent activation (Danilkovitch-Miagkova, Duh et al. 2003). 
Thus, transformation of epithelial cells by the JSRV Env was thought to occur through a 
receptor-dependent  mechanism  distinct  from  the  essentially  receptor-independent 
mechanism  seen  in  virus-induced  transformation  of  fibroblasts.  However,  JSRV 
induced transformation also of the canine epithelial cell line MDCK (Liu and Miller 
2005) and rat epithelial RK3E cells (Maeda, Fu et al. 2005) with mechanisms similar to 
those observed in fibroblasts and largely dependent upon the CT of the Env. In addition, 
adeno-associated vectors overexpressing the JSRV Env induced lung adenocarcinomas 
in immunocompromized mice (Wootton, Halbert et al. 2005) despite the fact that mouse 
HYAL-2 does not bind the JSRV Env (Rai, Duh et al. 2001; Liu, Duh et al. 2003). 
The rat epithelial cell line, IEC-18, was used in this study and we determined that the 
interaction of the JSRV Env with HYAL-2 is not critical to induce cell transformation 
of  epithelial  cell  lines  because:  I)  chimeric  MoMLVprr-JSE  bearing  the  receptor 
binding domain of MoMLV (and consequently not using HYAL-2 as cellular receptor) 
induced cell transformation (Chow, Alberti et al. 2003); while II) the Env of the JSRV-
related  endogenous  retrovirus  enJS5F16  (that  uses  HYAL2  as  cellular  receptor) 
(Spencer, Mura et al. 2003) did not induce cell transformation. Thus, as a whole, it 
appears from the results of this and previous studies that transformation of epithelial 
cells is mainly HYAL-2 independent (Liu and Miller 2005; Maeda, Fu et al. 2005; 
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Given the apparent differences between transformation of BEAS-2B cells and other 
epithelial cell lines including the one used in this study we decided to investigate further 
the interaction of the JSRV Env with RON tyrosine kinase.  Initially, we confirmed the 
results of previous studies showing that RON binds HYAL-2 and that this interaction 
inhibits RON autophosphorylation. However, we also found that the  JSRV Env co-
immunoprecipitates with RON. We took great care in controlling for artefacts of the 
immunoprecipitation assays since the envelope of MoMLV, another retrovirus highly 
divergent from JSRV, also co-immunoprecipitated with RON. A major concern was the 
possibility that both RON and Env are targeted to membrane lipid rafts and the results 
of the co-immunoprecipitations do not reflect a real association but merely the fact that 
the proteins tested are present in the same membrane micro domain that is not disrupted 
by our lysis procedures. Thus lysates and co-immunoprecipitations were performed with 
lysis buffers containing different detergents and under different conditions (Figures 16 
and 17 and not shown). It was also demonstrated that lipid raft disruption by cholesterol 
depletion did not alter the binding between the various Envs and RON.  In addition, we 
showed  that  the  Env-RON  association  is  maintained  if  co-immunoprecipitations  are 
performed  from  cells  lysed  at  37˚C  in  SDS-based  lysis  buffer  and  if  the 
immunoprecipitates are washed with increasing concentrations of salts. Furthermore, 
the  JSRV/enJS56A1  Env  co-localize  with  RON  at  the  cell  membrane  and  in  the 
cytoplasm  as  determined  by  confocal  microscopy.  Applying  the  same  experimental 
conditions used in the Env/RON co-immunoprecipitations,  we also determined that the 
JSRV  Env  (and  other  Env  proteins  described  in  this  study)  do  not  bind  EGFR 
(Downward, Yarden et al. 1984), another receptor tyrosine kinase, and that RON does 
not bind CD4, a membrane protein.  
Most importantly, JSRV and enJSRV Env proteins had a different biological effect on 
RON  phosphorylation.  The  non-oncogenic  enJS5F16  Env  blocked  RON 
autophosphorylation while the JSRV Env did not affect it at all. The main differences 
between the JSRV and enJS5F16 Env proteins are present in the CT of the TM domain 
(Palmarini, Hallwirth et al. 2000). Indeed, JSRV Env mutant JSEY590D that contains a 
single amino acid mutation in the CT (Palmarini, Maeda et al. 2001), also blocked RON 
autophosphorylation although to a lesser degree than the endogenous enJS5F16 Env.  
These results strongly suggest that the CT of the JSRV/enJSRVs Env modulates the 
biological effect of RON-Env interaction. It is interesting to note that RON generates 
downstream signals mainly through phosphorylation of two sites in its CT (Ponzetto, Mariana Varela, 2007     Chapter 3,103 
Bardelli et al. 1994); thus a possible interaction between the CTs of RON and Env could 
be envisaged.   
This study, however, has not been able to demonstrate that the JSRV Env interacts with 
RON in a biologically relevant system, such as in transformed cells. We failed, with the 
available reagents, to show RON activation in IEC-18 cells, similar to other studies in 
MDCK and 208F cells (Miller, Van Hoeven et al. 2004; Liu and Miller 2005). The 
same reagents were also not able to detect Ron expression, and thus Ron activation, in 
lysates of lung tumour samples from OPA affected animals by WB, which is likely due 
to  the  inability  of  the  available  antibodies  to  recognise  sheep  Ron  (not  shown). 
Overexpression of proteins in a transient transfection system can lead to artefacts that 
have to be interpreted with caution. RON has been shown to associate with a variety of 
proteins including MET, EGFR, integrins and adhesion proteins (Danilkovitch, Miller et 
al. 1999; Follenzi, Bakovic et al. 2000; Peace, Hill et al. 2003). Unfortunately RON 
activation is quite difficult to detect in vivo and in most studies RON/Stk activation is 
shown in cells that overexpress it (either transiently or stably)(Wang, Iwama et al. 1995; 
Follenzi, Bakovic et al. 2000; Rai, Duh et al. 2001; Peace, Hill et al. 2003; Angeloni, 
Danilkovitch-Miagkova et al. 2004; Miller, Van Hoeven et al. 2004; van den Akker, van 
Dijk et al. 2004; Yokoyama, Ischenko et al. 2005). Thus, it is unclear if the association 
between JSRV Env and RON has a biological significance. However, the experimental 
conditions employed in this study have also confirmed the previously described data on 
RON-HYAL-2 association  and the downregulation of RON by HYAL-2 (Danilkovitch-
Miagkova,  Duh  et  al.  2003).  However,  in  side-by-side  experiments,  we  have  also 
showed that the envelope of a JSRV-related endogenous retrovirus can inhibit RON 
autophosphorylation. Thus, it appears that as a whole, the biological relevance of RON-
HYAL-2-Env  association  in  JSRV-induced  cell  transformation  needs  still  to  be 
clarified.  
The block of RON autophosphorylation by enJSRVs Env is striking and appears to be 
determined by differences between the CTs of JSRV and enJS5F16 Env.  Possibly, the 
CT of enJS5F16 masks (directly or via other interacting proteins) RON phosphorylation 
sites. Further studies will be necessary to investigate the mechanisms of enJS5F16 Env 
induced-block of RON phosphorylation.   
The interaction between RON and the Env of enJSRVs could be relevant in conceptus 
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regulated fashion in the genital tract of the ewe, in particular in the binucleate cells of 
the  conceptus  trophoblast  (Dunlap,  Palmarini  et  al.  2005).  When  enJSRV  Env 
expression  is  blocked  in  utero  using  morpholino  antisense  oligonucleotides, 
trophoectoderm growth and differentiation is severely impaired (Dunlap, Palmarini et 
al. 2006). On the other hand, Ron 
-/
- mice embryos fail to survive after periimplantation 
(Muraoka, Sun et al. 1999) and Ron transcripts have been found within the trophoblast 
cell mass of E3.5 embryos and in the giant trophoblast cells of the placenta (Hess, Waltz 
et al. 2003), suggesting a possible role in implantation. At the moment it is not clear 
which particular enJSRV loci are transcriptionally active in the sheep placenta. It is also 
unknown whether all of the enJSRV loci express Env proteins that elicit the same block 
in RON phosphorylation as shown in this study for the Env of enJS5F16. However, the 
alternative expression of different enJSRV loci with the ability to inactivate RON at 
variable degrees in a spatial and temporal fashion could contribute to the fine tuning 
that lies behind the modulation of its activation. Moreover, it could be speculated that 
enJSRV Envs could also regulate the activation of other receptor tyrosine kinases and 
signalling  molecules  that  are  important  in  conceptus  development,  implantation  and 
placenta morphogenesis. 
The association of the JSRV Env with RON might have some effect on the overall 
pathogenesis of JSRV infection in sheep. It has been recently demonstrated that clinical 
disease is not the most common outcome of JSRV infection  during the commercial 
lifespan of sheep (Caporale, Centorame et al. 2005). Thus, the association of the JSRV 
Env with RON might not be critical for transformation but might have some influence 
on  JSRV  pathogenesis.  For  example,  JSRV  has  been  found  to  infect  adhering 
cells/macrophages (Holland, Palmarini et al. 1999) whose activation is also known to be 
mediated by RON (Correll, Morrison et al. 2004). Further studies will be necessary to 
investigate this point. 105 
Chapter 4 
Summary 
This chapter will describe the experimental work performed with the objectives of: I) 
identifying signalling pathways involved in JSRV Env-induced cell transformation; and 
II) to establish the basis for the use of OPA as a large animal model for lung cancer.  
Introduction 
The understanding of the molecular mechanisms governing pulmonary oncogenesis has 
increased tremendously throughout the last decade (Minna, Roth et al. 2002). However, 
lung cancer is still the most common cause of death of cancer patients worldwide and its 
survival  rate  after  5  years  is  extremely  poor,  highlighting  the  urgent  need  for  the 
development of better therapies and early detection strategies (Parkin, Bray et al. 2005). 
To  this  end,  appropriate  animal  models  can  be  of  great  help  in  understanding  the 
molecular  basis  of  lung  cancer,  designing  candidate  therapeutic  interventions,  new 
surgical procedures and testing novel imaging technologies for early diagnosis.  
A  variety  of  mouse  models  are  available  for  lung  cancer  (Dutt  and  Wong  2006). 
Transgenic  and  especially  “conditional”  mouse  models,  had  a  dramatic  effect  in 
understanding the contribution of oncogenes in the onset and maintenance of cancer 
(Varmus, Pao et al. 2005). In the pre-clinical settings, treatment of xenograft mouse 
models is routinely the first step used to test new anticancer drugs. However, most 
anticancer drugs fail in phase I and II clinical trials (Rothenberg, Carbone et al. 2003).      
Neoplasms of domestic animals are not extensively used as cancer models. The large 
body of knowledge in mouse genetics, the possibility to manipulate their genome and 
the availability of biological reagents make rodents the natural choice as disease model 
organisms. Large and domestic animals are more difficult and generally more expensive 
to manage compared to mice or rats. However, the completion of the sequencing of the 
genome of several domestic animal species and the development of new cloning and 
transgenic techniques open the possibility to explore other animal species as cancer 
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Among retroviruses, JSRV follows unique mechanisms to induce cell transformation, 
since its Env glycoprotein functions as a dominant oncoprotein both in vitro (Palmarini 
and Fan 2003) (Palmarini, Sharp et al. 1999; Maeda, Palmarini et al. 2001; Rai, Duh et 
al. 2001; Allen, Sherrill et al. 2002) and in vivo (Wootton, Halbert et al. 2005; Caporale, 
Cousens  et  al.  2006).  The  molecular  mechanisms  underlying  JSRV  Env-induced 
transformation have not been fully characterized but several pieces of evidence point to 
the involvement of the Ras-MEK-MAPK and PI3K-AKT pathways (Palmarini, Maeda 
et al. 2001; Maeda, Fu et al. 2005; De Las Heras, Ortin et al. 2006). 
OPA  shares  some  similarities  with  some  forms  of  human  lung  adenocarcinomas 
(Palmarini and Fan 2001; Mornex, Thivolet et al. 2003).  In addition, OPA has several 
features suggesting that it can be developed into a useful animal model for lung cancer: 
I) sheep and humans have a comparable lung size and tumour to body mass ratio; II) 
tumours in OPA can grow for a long time in the presence of a functional immune 
system;  III)  the  disease  is  experimentally  reproducible  (Sharp,  Angus  et  al.  1983; 
Palmarini  and  Fan  2003)  and  the  location/extent  of  the  induced  lesions  can  be 
modulated by the use of  replication defective viruses delivered to specific sites with an 
intrabronchial delivery (Caporale, Cousens et al. 2006).  
In this section I will describe an array of experiments aimed at identifying signalling 
pathways involved in JSRV mediated transformation and to establish the basis for the 
use  of  OPA  as  a  model  to  study  the  effects  of  small  molecule  inhibitors  in  cancer 
development. Data is provided showing that several Hsp90 inhibitors efficiently block 
transformation of rodent fibroblasts by the JSRV Env and revert the phenotype of cells 
already transformed by this oncoprotein. This phenomenon was due at least in part to 
Akt  degradation,  which  is  normally  activated  in  JSRV-mediated  transformation 
(Palmarini, Maeda et al. 2001; Caporale, Cousens et al. 2006). Importantly, Hsp90 was 
found expressed in tumour cells of sheep  with naturally occurring OPA and Hsp90 
inhibitors reduced proliferation of primary and immortalized cell lines derived from 
OPA  tumours.  Targeting  of  the  Hsp90  molecular  chaperone  has  great  potential  for 
cancer therapy (Workman 2004). Thus, OPA could be used as a large animal model for 
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Results 
Effects of signal  transduction inhibitors  in  JSRV-induced cell 
transformation of rodent fibroblasts 
The first goal of these studies was to identify inhibitors of signal transduction pathways 
that efficiently blocked JSRV Env-induced cell transformation. We assessed a total of 
22 inhibitors in two different experimental settings. In the first series of experiments, we 
used a cell line transformed by the JSRV Env (208F-tr) and determined whether the 
addition of various inhibitors reverted the phenotype of the transformed cells to the 
parental  cell  line.  In  the  second  set  of  experiments,  we  performed  standard 
transformation assays in 208F cells by transfecting an expression plasmid for the JSRV 
Env (pCMV3JS21ΔGP) and cultured them in the presence or absence of each inhibitor 
for 15 days when the number of foci of transformed cells was counted. In the first set of 
experiments, each inhibitor was used at a concentration corresponding to respectively 
10X and 1X its reported IC50. The second set of experiments was performed using the 
highest  concentration  of  each  inhibitor  that  was  found  not  to  induce  toxicity.  Each 
experiment was repeated at least twice. Results obtained are summarized in Table 5. 
Inhibitors against the Janus protein kinase (JAKs), vascular endothelial growth factor 
receptor  (VEGFR)  and  epidermal  growth  factor  receptor  (EGFR)  did  not  affect 
transformation by the JSRV Env since no or minimal reduction in the number of foci 
was observed in cultures treated with inhibitors compared to the control ones treated 
with DMSO. Inhibitors against platelet-derived growth factor receptor (PDGF) reduced 
the number of transformed foci induced by the JSRV Env from 30 to 60% as compared 
with  cells  treated  with  DMSO  alone.  However,  the  PDGF  inhibitors  used  had  a 
noticeable toxic effect in 208F cells and consequently the reduction in the number of 
transformed foci could be due simply to this phenomenon. Neither the PDGF inhibitors 
nor the inhibitors mentioned above were able to revert the phenotype of 208-tr. These 
data indicate that signalling through the JAKs,  VEGF receptor, PDGF receptor and 
EGFR  do  not  play  a  major  role  in  JSRV  induced  cell  transformation  of  rodent 
fibroblasts.  
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Table 6. Effect of inhibitors in JSRV-induced cell transformation of 208F cells. 
                                                 
3 The percentage of inhibition of transformation represents the average of at least two 
experiments and was calculated comparing the dishes treated with inhibitor versus DMSO. 
4 not analysed. 
5 Toxicity 
 
 
Pathway 
 
 
Inhibitor name 
 
Inhibitor 
concentration 
(uM) 
 
Inhibition of 
transformation
3 
(%)
 
 
Reversion of 
transformed 
phenotype 
 
Janus protein 
tyrosine kinase 
 
 
JAK inhibitor I    
0.001 
0.005 
0.01 
0.015 
0.05 
0.15 
N/A
4 
N/A 
N/A 
N/A 
N/A 
0 
No 
No 
No 
No 
No 
No 
VEGFR 
VEGF receptor 2 
kinase inhibitor III 
1 
20 
 
0 
N/A 
No 
Toxic 
 
PP2      5 
10  
41 
73.4 
No 
No 
PP1    0.0015 
0.015 
 
0 
No 
No 
Genistein  25   11.9  No 
 
Inhibitor I          
0.044 
0.088 
0.44 
0.88  
N/A 
N/A 
N/A 
0 
No 
No 
No 
No 
Inhibitor II            1.2  
12 
0 
Toxic 
No 
Toxic 
 
Emodin 
0.018 
18.5  
185 
N/A 
0 
N/A 
No 
No 
Toxic 
 
SU 6656             
0.28 
1 
2.8  
N/A 
22 
65.9
 
No 
N/A 
Yes 
Lavendustin C        2   4  No 
 
 
 
 
 
SRC (family) 
 
 
 
 
 
 
Damnacanthal  0.017 
0.17  
N/A 
0 
No 
No 
Inhibitor I                0.2 
2  
N/A 
N/A 
No 
No 
Inhibitor II             1.1 
11  
N/A 
57.5 
No 
No 
 
Inhibitor III          
0.05 
0.08 
0.5 
0.8 
N/A 
20
5 
N/A 
0 
No 
No 
No 
No 
AG 1296              1 
10  
N/A 
N/A 
No 
No 
 
 
Platelet derived 
growth factor 
receptor (PDGF) 
 
  AG 2043  
           
1 
10  
N/A 
29.2 
No 
No 
PD 153035       0.000025 
0.00025 
N/A 
0 
No 
No 
EGFR 
  AG 1478              0.003 
0.03 
N/A 
0 
No 
No 
Herbimycin A     
 
0.2  
0.4  
96 
100 
N/A 
Yes 
 
 
 
Geldanamycin 
0.0017  
0.0075 
0.0187 
0.0375 
0.075 
0.75  
0 
74 
90 
97.9 
Toxic 
Toxic 
 
N/A 
N/A 
N/A 
Yes 
Yes 
Yes 
 
Radicicol    0.27 
2.7  
N/A 
55.7 
Yes 
Yes 
 
 
 
HSP 90 
 
 
 
17-DMAG           0.5   88.8  Yes Mariana Varela, 2007     Chapter 4,109 
SRC contributes to JSRV-induced cell transformation 
As shown in Table 5, seven of nine inhibitors against the Src family of non receptor 
tyrosine kinases neither reverted the phenotype of 208F-tr cells nor reduced the number 
of foci of transformed cells in standard JSRV  Env transformation assays. However, 
SU6656  reverted  the  transformed  phenotype  of  208F-tr  cells  to  a  flatter  and  less 
translucent  morphology  and  slightly  reduced  transformation.  In  addition,  when 
transformation assays were performed in the presence of PP2 the number of foci of 
transformed cells induced by the JSRV Env was drastically reduced (~70%).  
The differences on the effects seen among the various Src inhibitors are not surprising 
since  the  specificity  and  potency  towards  each  Src  family  member  varies  (Blake, 
Broome  et  al.  2000;  Karni,  Mizrachi  et  al.  2003).  In  addition,  PP2  was  shown 
previously to have an effect on JSRV Env-induced cell transformation (Hull and Fan 
2006). To further understand the role of Src in JSRV Env mediated transformation we 
co-transfected  208F  cells  with  the  expression  plasmid  for  the  JSRV  Env 
(pCMV3JS21ΔGP)  and  increasing  amounts  of  a  dominant  negative  form  of  Src 
(SrcMF)  (Timpson,  Jones  et  al.  2001).  As  shown  in  Figure  29,  we  found  a  dose 
dependent inhibition of JSRV Env-induced transformation by SrcMF. As a whole the 
data described above suggest that Src may be involved in the mechanisms of JSRV 
Env-induced cell transformation.  
 
Figure 30. Src contributes to JSRV Env induced cell transformation. 
208F  cells  were  co-transfected  with  1  µg  of  an  expression  plasmid  for  the  JSRV  Env  and 
increasing amounts of a plasmid expressing a dominant negative form of Src (SrcMF). Results 
show  the  average  of  two  independent  experiments  and  are  expressed  as  a  percentage  of 
transformation where the number of foci resulting from transfection of 1 µg of JSRV Env alone is 
considered 100%. Bars represent standard deviation. Mariana Varela, 2007     Chapter 4,110 
Hsp90 inhibitors block transformation by the JSRV Env. 
We  next  examined  several  Hsp90  inhibitors  including  herbimycin  A  (HA), 
geldanamycin  (GA),  radicicol  and  17-DMAG.  All  the  above  mentioned  inhibitors 
suppressed  transformation  in  a  dose-dependent  manner  (Table  5)  and  reverted  the 
transformed phenotype of 208F-tr cells to a flatter and less translucent morphology 
compared to control 208-tr cells (Figure 30). Once the drugs were removed from the 
culturing  media,  cells  returned  to  display  their  original  transformed  phenotype 
demonstrating that the drugs had no effect on integration and expression of the JSRV 
Env plasmid (Figure 30 bottom panel). These results indicate that Hsp90 is involved in 
the initiation and progression of the transformation process mediated by the JSRV Env 
as well as in the maintenance of the transformed phenotype in vitro.  
Hsp90 is a molecular chaperone that participates in the folding, assembly, maturation 
and stabilization of “client” proteins including a variety of signalling molecules and 
transcription  factors  that  are  crucial  for  oncogenesis  such  as  AKT,  HER2,  c-SRC, 
NFκB,  IGFR1,  p53  and  RAF  among  others  (Zhang  and  Burrows  2004).  Hsp90 
inhibition  leads  to  proteasome-dependent  degradation  of  its  client  proteins  and  the 
consequent disruption of critical pathways involved in tumour progression and survival. 
Hsp90  suppression  could  conduce  to  the  simultaneous  disruption  of  multiple  signal 
pathways, ergo Hsp90 inhibitors are promising therapeutic reagents (Blagg and Kerr 
2006). In particular, 17-AAG has completed  Phase I (Goetz, Toft et al. 2005) and Phase 
II trials (Ronnen, Kondagunta et al. 2006). 
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Figure 31. Reversion of the transformed phenotype of 208F-tr cells. 
208-tr cells derive from a focus of cells transformed by the JSRV Env. These cells were cultured 
in the presence of Hsp90 inhibitors (or DMSO as negative control) and their morphology was 
monitored for 5 days. Illustrative examples of 208-tr cells cultured at higher or lower density in 
the presence of Hsp90 inhibitors are shown. 
 
To further understand the mechanisms underlying the effects of Hsp90 inhibitors in 
JSRV-transformed  cells,  we  examined  whether  the  JSRV  Env  was  an  Hsp90  client 
protein.  If  this  was  the  case,  the  block  in  transformation  and  the  reversion  of  the Mariana Varela, 2007     Chapter 4,112 
transformed phenotype seen with the various Hsp90 inhibitors would be due to the 
association of Hsp90 with the JSRV Env followed by proteosomal degradation. To this 
end, we assessed the expression of the JSRV Env by WB in total cell lysates extracted 
from  transformed  208F-tr  cells  or  from  208F-tr  cells  that  reverted  to  a  flatter 
morphology in the presence of Hsp90 inhibitors (Figure 31A). We could not detect 
down-regulation of the JSRV Env in 208F-tr cells when the phenotype was reverted to a 
more flat morphology in the presence of geldanamycin or herbimycin A. Moreover, we 
did not find association between the JSRV Env and Hsp90 by co-immunoprecipitation 
assays  performed  under  different  stringency  conditions  (Figure  31B)  strongly 
suggesting that the JSRV Env is not an Hsp90 client protein.  
 
Figure 32. The JSRV Env does not associate with Hsp90 and it is not degraded by Hsp90 
inhibitors. 
A)  Total  cell  extracts  were  obtained  from  208F-tr  cells  in  the  presence  of  DMSO  (negative 
control)  or  from  208-tr  that  had  reverted  their  transformed  phenotype  in  the  presence  of 
geldanamycin (GA) or herbimycin  A (HA). In addition, cell extracts were also obtained  from 
208F-tr  that reverted to  the  transformed phenotype once GA  or HA were removed from  the 
culturing media (GA reverted & removed). 200 µg of cell extracts were immunoprecipitated and 
analysed by WB as indicated below each panel. Note that the JSRV Env expressed in 208F-tr is 
tagged with a FLAG epitope at its carboxy terminus. TM indicates the transmembrane domain 
of  the  Env  glycoprotein.  B)  Lysates  of  normal  and  208F-tr  cells  (expressing  the  JSRV  Env 
tagged  with  the  flag  epitope)  were  lysed  and  immunoprecipitated  with  milder  detergents  to 
preserve weak protein-protein interactions and analysed by WB as indicated beside each panel. 
A protein of approximately 90 kDa binds non specifically to the agarose beads since it was 
detected in samples where no antibody was added (third panel). Mariana Varela, 2007     Chapter 4,113 
Hsp90 inhibitors induce Akt degradation. 
Akt is an Hsp90 client protein and the association between Hsp90 and Akt modulates 
the  kinase  activity  of  the  latter  (Sato,  Fujita  et  al.  2000).  Akt  activation  plays  an 
important role in JSRV Env-mediated transformation of 208F cells (Palmarini, Maeda 
et al. 2001; Chow, Alberti et al. 2003; Liu, Lerman et al. 2003). Considering that the 
JSRV Env itself is not  an Hsp90  client protein we tested  whether Hsp90 inhibitors 
caused changes in the expression (or phosphorylation status) of Akt in Env-transformed 
cells. To address this point, we cultured 208F-tr cells in serum free media with the 
addition of 17-DMAG (0.5 µM) (or DMSO as control) for a period of 3, 6, 12 and 24 
hours. Thereafter, total cell lysates were analysed by WB. We observed time dependent 
Akt degradation and dephosphorylation at serine 473 when cells were cultured with 17-
DMAG while no changes were seen in the expression of the JSRV Env or γ-tubulin that 
was used as loading control (Figure 32). No changes in the phosphorylation status or 
expression of Akt or the JSRV Env were observed and no changes in the transformed 
morphology of these cells were noticeable when cells were cultured with DMSO as a 
control. Akt degradation was observed when the same experiment was performed in the 
presence of radicicol, while no changes were noticeable in the level of expression of the 
JSRV  Env  or  γ-tubulin  (not  shown).  These  data  indicate  that  the  reversion  of  the 
transformed phenotype seen with the Hsp90 inhibitors could be due at least in part to 
the degradation of Akt. 
 
Figure  33.  Hsp90  inhibitors  induce  AKT  degradation  and  dephosphorylation  in  208F 
transformed by the JSRV Env. 
208F-tr cells were cultured in serum free media with the addition of 17-DMAG or DMSO as a 
negative control for 3, 6, 12 and 24 hours and cells were lysed and analysed by WB for the 
presence of Akt and pAkt. Detection of γ-tubulin was used as loading control. 
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Hsp90  inhibitors  reduce  proliferation  of  OPA-derived 
immortalized and primary cell lines. 
In order to better assess the effects of Hsp90 inhibitors on JSRV-induced transformation 
we analyzed their effects on the growth of tumour cells derived from OPA lesions. JS8 
is an immortalized cell line derived from a lung tumour of a sheep affected by OPA 
(Jassim 1988). Cells were grown for 72 hours in the presence of increasing amounts of 
radicicol and 17-DMAG and their proliferation was measured as described in materials 
and  methods.  We  found  statistically  significant  inhibition  (p=0.0002)  in  cell 
proliferation when cells were grown in the presence of 17-DMAG and radicicol at all 
the  concentrations  tested  (Figure  33).  Although  the  reduction  in  proliferation  was 
modest  it  should  be  taken  into  consideration  that  this  cell  line  has  been  passaged 
extensively  and  does  not  express  JSRV  viral  particles  in  the  supernatants  (data  not 
shown).  
Moreover, a significant reduction (p=0.04) in the growth of tumoural alveolar type II 
cells  from  naturally  occurring  OPA  cases  as  compared  to  the  normal  type  II 
pneumocytes was observed in the presence of increasing amounts of radicicol while the 
effects of 17-DMAG were more variable (not shown). The normal type II pneumocytes 
used in these proliferation assays were found to express markers such as SP-A, SP-C 
and presented lamellar bodies by electron microscopy (Archer, Jacquier et al. 2007). 
Tumour cells were confirmed to express JSRV by the detection of reverse transcriptase 
activity in the culture supernatants and the detection of the viral major capsid protein by 
WB (Archer, Jacquier et al. 2007).  
 
Figure 34. Hsp90 inhibitors reduce proliferation of OPA derived cells. 
17-DMAG and radicicol significantly reduce (p 0.0002) proliferation of JS8 cells. Bars in both 
panels represent standard deviation. Mariana Varela, 2007     Chapter 4,115 
Discussion 
The aim of this study was to identify signalling pathways involved in JSRV induced cell 
transformation by the use of drugs that could efficiently block transformation by the 
JSRV Env in vitro and to establish the functional basis for the development of OPA as a 
large  animal  model  for  lung  cancer.  JSRV  is  unique  among  oncogenic  retroviruses 
because  its  envelope  glycoprotein  functions  as  a  dominant  oncoprotein  (Palmarini, 
Sharp et al. 1999; Maeda, Palmarini et al. 2001; Rai, Duh et al. 2001; Allen, Sherrill et 
al.  2002;  Palmarini  and  Fan  2003).  Transfection  of  a  variety  of  cell  lines  with 
expression  plasmids  for  the  JSRV  Env  readily  results  in  the  induction  of  foci  of 
transformed cells. In addition, adeno-associated viral vectors expressing the JSRV Env 
induce  lung  cancer  in  immunosuppressed  mice  (Wootton,  Halbert  et  al.  2005). 
Furthermore, replication defective JSRV vectors expressing only the viral Env induce 
lung  cancer  in  sheep,  the  natural  host  of  JSRV  infection  (Caporale,  Cousens  et  al. 
2006). Thus, the JSRV/OPA model is an excellent system where the significance of 
findings obtained in vitro can be immediately translated in vivo.  
We found that the Src pathway and the molecular chaperon Hsp90 are involved in the 
mechanisms of cell transformation induced by the JSRV Env and that OPA could be 
used as an alternative large animal model for the development of Hsp90 inhibitors and 
the study of the molecular mechanisms underlying their effects in cancer development. 
These  conclusions  are  based  on  the  fact  that  various  Hsp90  inhibitors  efficiently 
blocked transformation by the JSRV Env and reverted the morphology of cells already 
transformed by it and we could in part understand the mechanism behind these effects. 
We found that the JSRV Env is not an Hsp90 client protein considering that I) Hsp90 
and the JSRV Env do not co-immunoprecipitate and II) Hsp90 inhibitors do not affect 
the levels of expression of the JSRV Env in 208-tr cells with a phenotype reverted to a 
flatter untransformed morphology. We also demonstrated that Hsp90 inhibitors reduced 
the levels of Akt expression in 208F cells transformed by the JSRV Env. Activation of 
the PI3K/ Akt pathway is one of the features displayed by cells transformed by the 
JSRV Env and the inhibitory effects of the Hsp90 inhibitors in this system could be due, 
at least in part, to Akt degradation. Akt is activated in a variety of cell lines transformed 
by the JSRV Env (Palmarini, Maeda et al. 2001; Liu, Lerman et al. 2003; Zavala, Pretto 
et al. 2003; Varela, Chow et al. 2006) and in cell lines derived from lung tissues of 
sheep affected by OPA (Suau, Cottin et al. 2006) thus, the results obtained here are in 
agreement with the important role played by Akt in JSRV induced cell transformation. Mariana Varela, 2007     Chapter 4,116 
The Akt kinases (Akt1, Akt2 and Akt3) are critical intermediate molecules in signalling 
pathways  that  are  involved  in  the  regulation  of  cell  proliferation  and  survival  by 
inactivating  proapoptotic  factors  like  BAD,  procaspase-9  and  Forkhead  (Hennessy, 
Smith et al. 2005). Several human cancers including breast, gastric and renal cancer, 
among  others,  display  Akt  activation  that  has  been  correlated  with  poor  prognosis 
and/or  advance  disease  (Altomare  and  Testa  2005).  Importantly,  several  studies 
demonstrate the involvement of Akt in human lung carcinogenesis, in particular 67 % of 
samples  of  non-small  cell  lung  cancer  (NSLC)  showed  immuno-reactivity  for 
phosphorylated AKT (Lee, Kim et al. 2002). Moreover, cell lines derived from NSLC 
showed activated AKT  that promoted cell survival and resistance to chemotherapy 
(Brognard, Clark et al. 2001). Thus, therapies targeting Akt could be effective in the 
treatment of lung cancer. However, since Akt is involved in the regulation of many 
physiological processes its inhibition could lead to serious side effects and a consequent 
low therapeutic index. OPA could provide a useful system to study the efficacy as well 
as the short and long term effects of these therapies. 
Finally, we demonstrated proliferation of OPA-derived tumour cells in vitro is inhibited 
by radicicol and 17-DMAG and that Hsp90 is expressed in OPA tumour cells by IHC 
[experiments performed by Fabienne Archer and Marcelo de las Heras, (Varela, Golder 
et al. 2007)].  
Lung  cancer  is  a  multi-step  process  that  involves  the  accumulation  of  genetic  and 
epigenetic  alterations  that  cause  the  activation  of  several  signal  pathways 
simultaneously  (Girard,  Zochbauer-Muller  et  al.  2000;  Digel  and  Lubbert  2005). 
Ideally, therapeutic interventions for cancer should be able to interfere with a variety of 
signal  transduction  pathways  that  are  involved  in  cell  transformation.  Heat  shock 
proteins  have  been  found  to  be  overexpressed  in  several  haematological  and  solid 
human cancers, including lung cancer (Yufu, Nishimura et al. 1992; Chant, Rose et al. 
1995; Santarosa, Favaro et al. 1997; Senju, Sueoka et al. 2006). For reasons that yet 
remain to be fully clarified, Hsp90 extracted from tumour cells has a higher binding 
affinity  for  17-AAG  than  Hsp90  extracted  from  normal  tissue,  allowing  the 
accumulation  of  the  drug  in  tumours  (Kamal,  Thao  et  al.  2003).  Moreover,  Hsp90 
inhibitors have been shown to reduce proliferation of several human lung cancer cell 
lines  and  induce  further  growth  inhibition  when  combined  with  irradiation  (Senju, 
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pathways that are involved in the development of cancer makes them ideal therapeutic 
agents for the treatment of lung cancer.  
The mechanisms of cell transformation by the JSRV Env are not completely clarified 
but involve the PI3K-Akt, the Ras-MEK-MAPK pathways and possibly, as shown in 
this study, also Src considering that two Src inhibitors and a dominant negative Src 
(SrcMF) reduced JSRV Env transformation. All these pathways have been implicated in 
the  development  of  human  lung  cancer  (Brognard,  Clark  et  al.  2001;  Kolch  2002; 
Vivanco and Sawyers 2002; Zhang, Kalyankrishna et al. 2007). Thus, JSRV-mediated 
transformation can be a useful model to study the molecular mechanisms underpinning 
the effects of Hsp90 inhibitors on particular cell signalling molecules in tumours where 
several pathways are activated simultaneously, both in vitro and in vivo. 
There is an increasing need of animal models for studying the safety and efficacy of the 
numerous  anticancer  drugs  that  are  under  development  (Collis  2006).  OPA  can  be 
experimentally reproduced with a short incubation period (~4-12 weeks) when lambs 
are  inoculated  intratracheally  with  concentrated  virus  preparations.  Under  these 
circumstances, the primary target cells of infection produce new infectious virus that is 
able to infect and hence transform new cells leading to the appearance of lesions of 
different sizes that tend to coalesce (Figure 34). It could be argued that the use of this 
model  could  be  “overpowering”  even  for  effective  drugs,  given that  new  infectious 
virus expressing a dominant oncoprotein is continuously produced. However, a JSRV-
replication-defective  virus  (JS-RD)    has  been  recently  developed  that  proved  to  be 
oncogenic in a high percentage of inoculated lambs (Caporale, Cousens et al. 2006). In 
addition, JS-RD can be inoculated by bronchoscopy in well defined anatomical regions 
of the lungs, increasing the opportunity to develop intravitam imaging techniques where 
lesion development is continuously monitored. Mariana Varela, 2007     Chapter 4,118 
 
Figure  35.  Extension  of  the  OPA  lesions  can  be  modulated  by  the  use  of  replication 
competent or incompetent viruses. 
Cartoon representing two experimental models of OPA. (A) Young lambs have many available 
target cells (pneumocytes type II or possibly pulmonary stem cells) that can be infected and 
transformed by JSRV. Tumour cells produce infectious virus that can then infect and transform 
other  target  cells  resulting  in  many  satellite  and  coalescing  lesions.  On  the  other  hand, 
experimental inoculation of young lambs with replication incompetent JS-RD (B) will result in 
infection  and  transformation  of  target  cells  that  do  not  produce  infectious  virus, resulting  in 
tumour  nodules  derived  from  a  single  transformed  cell.  The  cartoon  is  only  a  schematic 
representation of the histopathological lesions in OPA. Tumour cells in OPA grow usually in a 
well organized manner along the alveolar walls. Image kindly provided by Marco Caporale. 
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The finding that the effects of inhibitors of Hsp90 in cell transformation can be studied 
in this system demonstrates that OPA could be used as tool for the development and 
improvement of other Hsp90 inhibitors. Although animals affected by OPA have not 
been used to test the therapeutic potential of any drugs so far, inhibitors of Hsp90 offer 
an interesting opportunity to challenge OPA in this regard considering the promising in 
vitro findings shown in this study. In conclusion, OPA offers a system that allows: a) 
the study of the molecular mechanisms leading to the development of lung cancer both 
in vivo and in vitro; b) the study and improvement of early detection techniques like 
imaging  tools  and  serum  biomarkers  that  so  far  have  been  unsuccessful  in  the 
prevention of human lung cancer  (Shaw, Kirsch et al. 2005) and III) the evaluation of  
new therapeutic agents before they reach the clinic as well as the experimentation and 
development of radiotherapy and surgery. In this respect, OPA (and in general large 
animal cancer models) can be a valid alternative to rodent models.  120 
Chapter 5 
Summary 
This chapter describes a series of experiments performed to characterize the enJSRV 
Envs present in the sheep genome and their role in placental morphogenesis of sheep. A 
set of results described in this chapter formed part of a larger study published in 2006 
(Dunlap,  Palmarini  et  al.  2006)  and  provided  the  framework  for  the  design  of  the 
majority of the experiments reported here.  
Introduction 
ERVs are present in the genome of all vertebrates as stable inherited Mendelian genes 
(Boeke and Stoye 1997). They are thought to arise from ancient germ line infections by 
exogenous retroviruses and their copy number increase via retrotransposition or germ 
line reinfection (Boeke and Stoye 1997). As a result of the accumulation of different 
types of mutations (i.e. insertions, deletions, substitutions) the great majority of ERVs 
are  non  infectious  and  non  pathogenic  (Gifford  and  Tristem  2003).  The  biological 
relevance of the presence of ERVs in the mammalian genome is controversial. They 
have been characterized as junk DNA as well as critical for mammalian development 
(Bock and Stoye 2000). However, the fact that ERVs comprise approximately 8% of the 
human genome (Lander, Linton et al. 2001) and that various animal species possess 
transcriptionaly active proviruses with intact open reading frames millions years after 
integration support the idea that they might provide benefits to their hosts. A possible 
beneficial  role  for  the  expression  of  ERVs  is  protection  from  exogenous  retrovirus 
infection. As demonstrated in mice, chickens and cats ERVs can confer resistance to 
superinfection by exogenous retrovirus by receptor blockage (Boeke and Stoye 1997). 
Another example is provided by Fv1 locus that encodes an endogenous Gag-like protein 
and blocks infection by the Friend strain of murine leukaemia virus (Best, Le Tissier et 
al. 1996; Boeke and Stoye 1997). Physiological functions have been also attributed to 
ERV,  for  example  the  tissue  specific  expression  of  salivary  amylase.  Amylase-
associated proviruses are thought to contain transcriptional control elements that are 
specifically  active  in  the  parathyroid  gland,  thus  suggesting  that  specific  salivary 
expression is due to proviral insertion (Ting, Rosenberg et al. 1992; Samuelson, Phillips 
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the presence of intact env genes in the syncytiotrophoblasts which have been preserved 
over thousands of years together with the observation that they elicit fusion of cells in 
vitro, has led to the speculation that they are important for placental morphogenesis and 
evolution and that they have been positively selected (Mi, Lee et al. 2000; Voisset, 
Bouton et al. 2000; Dupressoir, Marceau et al. 2005). 
HERV-W, HERV-FRD and ERV-3 are three human ERVs (HERV) whose  env coding 
genes display a high level of expression in the human placenta (Venables, Brookes et al. 
1995; Blond, Lavillette et al. 2000; de Parseval, Lazar et al. 2003). HERV-W is not 
present in the human genome as a complete provirus, however its Env protein, also 
referred to as syncytin-1, is preferentially expressed in the syncytiotrophoblast which is 
a  multinuclear  tissue  forming  the  outer  surface  of  the  foetal  part  of  the  placenta 
providing a barrier with the maternal blood. The syncytiotrophoblast is produced by 
intercellular fusion of trophoblast cells and is responsible for the transport of oxygen, 
nutrients and waste products, hormone production and immune tolerance (Benirschke 
and  Kaufmann  2000).  Syncytin  is  a  80  kDa  glycosylated  protein  and  possesses 
characteristic features of other retroviral Env proteins such as the presence of a leader 
peptide,  a  potential  proteolytic  site,  a  fusion  peptide-like  sequence  and  a  putative 
immunosuppressive region. It also contains a hydrophobic membrane-spanning domain 
that suggests its insertion into the plasma membrane (de Parseval, Lazar et al. 2003). 
There is considerable information suggesting that syncytin is involved in the fusion of 
the cytotrophoblasts to form the syncytiotrophoblast. Transfection of a variety of cell 
lines with HERV-W env results in increased cellular fusion and this phenomenon is 
reduced when the cell cultures are treated with an antibody against the HERV-W Env 
protein (Blond, Lavillette et al. 2000; Mi, Lee et al. 2000). In addition, induction of 
fusion of BeWo cells, (a human trophoblastic choriocarcinoma cell line) (Pattillo, Gey 
et  al.  1968),  by  forskolin    increased  expression  of  syncytin  (Mi,  Lee  et  al.  2000). 
Moreover,  anti-sense  inhibition  of  syncytin  expression  in  primary  trophoblast  cells 
reduced the number and size of syncytia formed during culture (Frendo, Olivier et al. 
2003).  
The Env glycoprotein of HERV-FRD, referred to as syncytin-2, is structurally similar to 
syncytin-1, however it entered the primate genome before the split of the New World 
and the Old World Monkeys, more than 40 million years ago while syncytin-1 entered 
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World  Monkeys  (de  Parseval  and  Heidmann  2005).  It  also  elicits  cell  fusion  when 
transiently transfected in several cell lines (Blaise, de Parseval et al. 2003). 
The Env protein of ERV-3 is also expressed in the syncytiotrophoblast and was the first 
endogenous retroviral Env to which a physiological function  was attributed (Boyd, Bax 
et al. 1993). It has a long ORF although is prematurely terminated by the presence of a 
stop codon in the TM region which truncates the hydrophobic domain that is required 
for anchoring to the cell membrane (Cohen, Powers et al. 1985). It also lacks a leader 
and  a  fusion  peptide  and  although  it  harbours  a  region  with  homology  to  an 
immunosuppressive domain its function is likely diminished by the lack of membrane 
anchorage  (Rote,  Chakrabarti  et  al.  2004).    ERV-3  Env  does  not  elicit  cell  fusion, 
however its mRNA levels increase in BeWo cells treated with forskolin. When ERV3 
Env is stably expressed in undifferentiated BeWo cells it induces changes characteristic 
of trophoblast differentiation such as increased levels of  β-hCG, growth inhibition and 
altered morphology (Lin, Xu et al. 1999). Considering that ERV-3 Env is expressed in a 
variety of normal tissues and in particular hormone producing organs, including adrenal 
and sebaceous glands and testis, it could be speculated to play a general role in hormone 
production  (Rote,  Chakrabarti  et  al.  2004).  However,  1%  of  150  healthy  Caucasian 
individuals were found to be homozygous for a premature stop codon that potentially  
could result in a severely truncated non-functional protein (de Parseval and Heidmann 
1998). Thus, it is debatable whether ERV-3 Env could really play any critical biological 
function. 
Interestingly, two murine ERV env genes have been identified which are specifically 
expressed in the placenta at the level of the syncytiotrophoblast-containing labyrinthine 
zona. They are highly fusogenic in ex vivo transfection assays and are present in all 
Muridae tested which suggests positive selection (Dupressoir, Marceau et al. 2005). 
Sheep possess at least 27 copies of betaretroviruses in their genomes highly related to 
the exogenous and pathogenic JSRV (York, Vigne et al. 1992; Arnaud, Caporale et al. 
2007).  Both  endogenous  and  exogenous  JSRVs  use  hyaluronidase  2  (Hyal2)  as  a 
cellular  receptor  and  enJSRVs  can  block  JSRV  replication  at  early  stages  of  the 
retroviral  cycle  probably  by  receptor  interference  (Spencer,  Mura  et  al.  2003). 
Moreover, two enJSRV loci can block JSRV replication at a late stage in the retroviral 
replication cycle, a block referred to as JSRV late restriction (JLR) (Mura, Murcia et al. 
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to  interact  with  the  trafficking  cellular  machinery  and  accumulate  in  the  cytoplasm 
where  they  are  degraded  by  the  proteasome  (Arnaud,  Murcia  et  al.  2007;  Murcia, 
Arnaud et al. 2007). These observations support the hypothesis that enJSRV protect the 
host against pathogenic retroviruses. 
enJSRVs are highly expressed in the female reproductive tract (Palmarini, Hallwirth et 
al. 2000; Dunlap, Palmarini et al. 2005). In particular, in the uterus enJSRVs RNA and 
protein are observed in the endometrial luminal epithelium (LE) and in the glandular 
epithelium (GE) (Spencer, Stagg et al. 1999; Palmarini, Hallwirth et al. 2000; Palmarini, 
Gray et al. 2001). In addition, enJSRV RNA is detected in the trophoectoderm in a 
temporal fashion that is coincident with key events in the development of the sheep 
conceptus (Dunlap, Palmarini et al. 2005). In particular enJSRV expression is most 
abundant in the trophoblast giant binucleate cells (BNC) and multinucleated syncytial 
plaques of the placentomes. 
The  ruminant  placenta  is  classified  as  cotyledonary  on  the  basis  of  its  anatomical 
features. It is characterized by discrete areas of attachment, the placentomes, which are 
formed by the interaction of areas of the chorioallontois and the endometrium. The 
foetal part of the placentome is the cotyledon and the maternal parts are the caruncles 
(Igwebuike 2006). In sheep, morula-stage embryos enter the uterus by day 4-5 after 
mating and by day 6 the blastocysts contain a blastocoele surrounded by a monolayer of 
trophoectoderm (Guillomot 1995; Spencer, Johnson et al. 2004). By day 11 they have 
hatched from the zona pellucida and develop into a tubular form and by day 12 they 
begin to elongate, reaching 25 cm or more by day 17. The elongation of the blastocysts 
is critical for the production of interferon (IFN-τ), which is the pregnancy recognition 
signal, and for proper implantation (Spencer, Johnson et al. 2007). Apposition of the 
trophoectoderm and the LE takes place between days 14 and 19 and is then followed by 
the attachment and interdigitation of cytoplasmic projections of the trophoectoderm and 
the microvilli of LE. Trophoblast giant BNC start to appear on day 14 (Wooding 1984) 
and  it  is  believed  that  they  are  the  result  of  consecutive  nuclear  divisions  without 
cytokinesis of trophoblast mononuclear cells (MTC), a process referred to as mitotic 
polyploid (Wooding 1992). The BNCs then migrate to the microvilliar junction and fuse 
with individual LE cells  to form trinucleate fetomaternal hybrid cells (Wooding 1984). 
BNCs  continue to migrate and fuse with trinucleate cells  while cells of the LE get 
displaced to ultimately form the syncytial plaques by day 24 (limited to 20-25 nuclei in 
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of the placentomes. The placentomes are formed by interdigitation of foetal placental 
cotyledons  and  endometrial  caruncles  and  are  the  functional  units  that  will  provide 
hematrophic  nutrition  to  the  conceptus.  The  functions  of  BNCs  are  mainly:  I)  the 
formation  of  the  hybrid  fetomaternal  syncytia  for  successful  implantation  and  the 
cotyledonary growth of the placentome; and II) the production and synthesis of proteins 
and hormones like placental lactogen, pregnancy associated glycoproteins (PAGs) and 
progesterone (Wooding 1992). Trophoblast BNCs of the sheep placenta are analogous 
to  the  giant  cells  of  the  syncytiotrophoblast  of  the  human  placenta  (Hoffman  and 
Wooding 1993). 
The RNA of enJSRVs is first detected by RT-PCR in the conceptus on day 12 which is 
coincident with their elongation and the production of IFN-τ. Hyal2 mRNA is detected 
in the conceptus, exclusively in the BNC and the syncytial plaques of the cotyledons, 
starting from day 16 when trophoblast giant BNC differentiation takes place (Dunlap, 
Palmarini et al. 2005). These results led to the hypothesis that expression of enJSRVs 
and Hyal2 are important for peri-implantation trophoectoderm differentiation in sheep 
(Spencer, Johnson et al. 2007). The authors propose that the expression of enJSRVs in 
trophoblast  cells  starting  on  day  12  increase  their  proliferation  by  undefined 
mechanisms. It is possible that BNCs derive from division of MTCs without cytokinesis 
or by fusion of MTCs. In the latter scenario some MTCs would begin to express Hyal2 
and  fusion  would  take  place  by  the  interaction of  Hyal2  with  the  Env  of  enJSRVs 
expressed in another MTC. By day 16 the newly formed BNCs start to migrate and fuse 
with the LE to form trinucleate cells. During this period both BNCs and the LE express 
enJSRV Env while only BNCs express Hyal2, therefore the formation of trinucleate 
cells could also be the result of cell fusion elicited by the interaction between enJSRV 
Env  and  Hyal2.  Fusion  would  continue  throughout  most  of  gestation  and  the  co-
expression of enJSRVs and Hyal2 in the same cells supports the idea that Hyal2 binds 
the  enJSRV  Env  in  the  surface  of  BNCs  inducing  fusion  and  the  formation  of 
multinucleated syncytia (Spencer, Johnson et al. 2007). 
All  of  the  evidence  reported  so  far  for  primates,  rodents  and  sheep  points  to  the 
suggestion that ERVs have influenced mammalian evolution and have been positively 
selected  for  a  physiological  role  in  placenta  morphogenesis.  In  this  section  I  will 
describe an array of experiments aimed to help understand the role of enJSRV Envs in 
the  morphogenesis  of  the  sheep  placenta  in  vitro  as  well  as  the  characterization  of 
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Results 
The  expression  of  enJSRV  Envs  can  be  blocked  with 
morpholino antisense oligonucletides 
A morpholino antisense oligonucleotide (MAO) was designed to specifically inhibit the 
expression of enJSRV env mRNAs (MAO-env). The ultimate goal of the experiment 
was to use these MAOs to block enJSRV Env expression in utero to test the hypothesis 
that  enJSRVs  are  essential  in  periimplantation  ovine  conceptus  development  and 
placenta morphogenesis. MAOs are short chains of morpholino subunits comprised of a 
nucleic  acid,  a  morpholino  ring  and  a  non-ionic  phosphorodiamidate  intersubunit 
linkage. Morpholinos act via a steric block mechanism that is RNAse-H independent, 
inhibiting  splicing  and/or  translation      (Summerton  1999).  They  are  effective  when 
designed to complement the nucleotide region around the start codon and/or possibly 
splicing sites of a given gene mRNA. Since the nucleotide sequence around the splice 
acceptor and start codon of the exogenous JSRV and the enJSRVs loci known at the 
time are highly conserved, one common MAO should be able to inhibit splicing and 
translation  of  most  enJSRV  proviral  loci  expressing  intact  env  genes  (Palmarini, 
Hallwirth  et  al.  2000).  A  series  of  in  vitro  experiments  were  conducted  to  test  the 
morpholino  effectiveness  in  human  293T  cells  transiently  transfected  with  an 
expression plasmid of the env of enJS5F16 (pSV-En2-EnvFlag) driven by the simian 
virus 40 promoter and tagged with the FLAG epitope at the carboxy terminus (Figure 
35). MAO-env very effectively blocked the expression of enJS5F16 Env (Figure 35B) 
in a dose dependent manner (Figure 35C), while a five-mismatch (MAO-5mis) and a 
standard  control  MAO  (MAO-std)  had  no  effect  (Figure  35B-C).  MAO-env  and 
controls had no effect in the expression of enJSRV Gag (Figure 35D) since Gag is 
synthesized from a full length genomic mRNA, whereas Env is produced only from 
correctly spliced mRNA (Figure 35A) (Vogt 1997). 
These results prompted the use of MAO-env in utero to test the effects of  loss of 
function (Dunlap, Palmarini et al. 2006). Dunlap and colleagues at Texas A&M injected 
MAO-env into the lumen of the ovine uterus on day 8 after mating and the effects were 
determined on day 16 or 20. Two control groups were used where ewes were injected 
with MAO-std and MAO-5mis. The conceptuses removed from ewes injected with the 
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MAO-env treated ewes that were fragile and smaller. Histological examination revealed 
the presence of fewer trophoblast cells in the MAO-env conceptuses with an abnormal 
vacuolated  cytoplasm,  which  correlated  with  a  reduction  in  the  amount  of  IFN-τ 
collected from uterine flushes. Most importantly, the amount of trophoblast BNCs was 
severely reduced to almost complete absence in MAO-env treated conceptuses. When 
the same experiment was repeated and the results evaluated at day 20 most of the MAO-
env treated ewes exhibited oestrous at day 17-18 after mating which is indicative of 
early  pregnancy  loss  due  to  inadequate  production  of  IFN-τ.  When  normal  day  15 
trophoblast cells were isolated and cultured in vitro they were shown to express enJSRV 
env and gag and their proliferation was reduced by 33% in the presence of MAO-env. 
The results of this study are reported in Dunlap et al. 2006. The data strongly supports 
the hypothesis that enJSRVs play a critical role in mononuclear cell outgrowth and 
differentiation of trophoblast giant BNCs during periimplantation (Dunlap, Palmarini et 
al. 2006). 
 
Figure 36. Design and effect of morpholinos on enJSRV Env expression in vitro. 
A) MAO-env were designed to inhibit splicing and translation of enJSRV env mRNA but not 
expression  of  full  length  genomic  RNA.  B)  293T  cells  were  mock  transfected  (lane1)  or 
transfected with an expression plasmid of the enJS5F16 Env tagged with the FLAG epitope at 
the carboxy terminus (lanes 2-4). Cells were then treated with MAO-env (lane 2), MAO-5mis 
(lane  3)  or  MAO-std  (lane  4)  as  controls  and  lysed  after  48  hours,  immunoprecipitated  and 
analyzed  by  WB.  C)  Cells  were  mock  transfected  (lane1)  or  transfected  with  an  expression 
plasmid for the enJS5F16 Env (lanes 2-9) and then treated with Endo-Porter alone (the delivery 
reagent) (lane 2), MAO-std as a control (lane 3), increasing amounts of MAO-5mis (lanes 4-6; 
20, 40 and 80 µM respectively) and MAO-env (lanes 7-9; 20, 40, 80 µM respectively). After 48 
hours cells were  lysed, immunoprecipitated  and analyzed by WB. D) 293T cells were  mock 
transfected (lane 1) or cotransfected with an expression plasmid of the env of enJS5F16 and 
pCMV2enJS5F16  expressing  the  full  length  enJS5F16  clone  (lanes  2-4).  Cells  were  then 
treated with Endo-Porter alone (lanes 1 and 2), MAO-5mis (lane 3) or MAO-env (lane 4) and 
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enJSRV Env characterization 
First we wanted to determine if the various Env glycoproteins expressed by different 
enJSRV  loci  possessed  the  same  biological  characteristics.  Frederic  Arnaud  in  our 
laboratory  screened  a  sheep  genomic  BAC  library  (CHORI-243)  and  isolated  26 
individual enJSRV proviruses, including the previously cloned enJS56A1 and enJS5F16 
(Arnaud, Caporale et al. 2007). 
Sixteen  enJSRV  loci  were  identified  that  contained  an  intact env  ORF.  The  newly-
cloned enJSRV envs maintain the characteristic nucleotide sequence and domains of the 
previously identified enJS5F16 and enJS56A1 env glycoproteins. Sequence alignment 
revealed 92.2 to 99.7% identity among the enJSRV Envs and 87.7 and 92.4 between 
exogenous  and  enJSRVs  Envs  at  the  amino  acid  level.  The  predicted  hydrophobic 
profiles of the JSRV Env and the Env of enJS5F1613, as prototype of an enJSRV Env, 
are  shown  in  Figure  36.  The  sequence  alignment  shown  in  Figure  37  allows  the 
identification of characteristic Env domains: I) a signal peptide is present at the amino 
terminus portion of  Env [SU starts at amino acid 81(Murcia, Arnaud et al. 2007)]; II) a 
furin consensus cleavage site (R-X-[R/K]-R) (Nakayama 1997) is present between the 
SU and TM domains; III) a hydrophobic segment is present at the amino terminus of 
TM which in other retroviral Envs maps to the location of the fusion peptide (Hunter 
1997); IV) a hydrophobic transmembrane anchor domain; and V) a cytoplasmic tail at 
the carboxyterminal of TM lacking the characteristic transformation domains present in 
the JSRV Env.  
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Figure 37. Hydrophobic profiles and characteristics of betaretroviral Envs of sheep. 
The  hydrophobic  profile  of  enJSRV  Envs  and  JSRV  Env  was  calculated  by  the  Kyte  and 
Doolittle  method.  Only  the  hydrophobic  profile  of  enJS5F16  is  shown  as  an  example.  The 
orange  box  indicates  the  signal  peptide;  the  red  line  indicates  the  consensus  proteolytic 
cleavage site separating SU from TM; the green and yellow boxes correspond to hydrophobic 
regions associated with the fusion peptide and the membrane spanning domain respectively. 
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Figure 38. Amino acid sequence alignment of betaretroviral envs of sheep. 
Sequence alignment was performed using the Clustal W method. The boundaries between the 
signal peptide (SP), SU and TM are indicated. The VR3 region is highlighted and the amino 
acids in the red box indicate the YXXM motif present in the JSRV Env. The env of enJSRV6 
lacks a start codon in the position found for the other env genes, however this env could be 
translated by the use of a downstream methionine. Mariana Varela, 2007     Chapter 5,130 
We next sub-cloned twelve of the sixteen envs, into expression plasmids and assessed 
the  cellular  distribution  of  the  Env  proteins  by  immunofluorescence  and  confocal 
microscopy.  Some of the enJSRVs env were not further used. For example the env of 
enJS5F16 was already cloned (Palmarini, Maeda et al. 2001). envs of enJSRV16 and 
enJSRV18 are identical therefore only the env of enJSRV16 was cloned and  enJSRV4, 
enJSRV23 and enJSRV24 lack the 5’LTRs. The use of an antibody raised against the 
TM of the exogenous JSRV Env revealed that enJSRV Envs have a broad cytoplasmic 
distribution, as expected for proteins synthesized in the ER, and possibly membrane 
expression  as  shown  in  Figure  38.  We  could  not  detect  Env  expression  in  cells 
transfected  with  expression  plasmids  for  enJSRV-7,  enJSRV-11,  enJSRV-15  and 
enJSRV19 Env glycoproteins. The possible explanations for this observation are that: I) 
the env carried by these loci are somehow defective and readily degraded; or II) that 
these constructs do not express sufficient levels of Env. 
 
Figure 39. Cellular distribution of enJSRV Envs as determined by immunofluorescence 
and confocal microscopy. 
Photomicrographs showing representative examples of the major phenotypes observed in COS 
cells transiently expressing enJSRV Envs. Specific staining was mainly observed diffused within 
the cytoplasm (second and third panels) and possibly at the cell surface (fourth panel). Bars 
represent 10 µm. 
 
We  then  used  standard  retroviral  vectors  pseudotyped  by  various  enJSRV  Envs  to 
determine their ability to utilize Hyal2 of different species as a cellular receptor. We 
engineered NIH 3T3 stably expressing the sheep, goat or bovine Hyal2 and performed 
standard viral entry assays. As shown in Figure 39 the Envs of enJSRV-4, enJSRV-
16/18  and  enJSRV-26  showed  titers  similar  to  the  vectors  pseudotyped  with  the 
exogenous JSRV Env in both NIH 3T3 cells stably expressing the sheep and the goat 
Hyal2 genes. The Envs of enJSRV-6, enJSRV-7, enJSRV-11, enJSRV-15, enJSRV-16, 
enJSRV-19 and enJSRV-20 mediated entry less efficiently, while the Envs of enJSRV-
9, enJSRV-13 and enJS56A1 did not mediate entry at all in the same cells lines. The 
inability of the last three Envs to mediate cell entry could not be explained by lack of Mariana Varela, 2007     Chapter 5,131 
expression of the constructs since, as shown above, they were found expressed when 
analyzed by immunofluorescence and confocal microscopy, although it is possible that 
they  are  not  functional.  Interestingly,  these  Envs  posses  two  to  eight  amino  acid 
differences within the receptor binding domain that could explain their inability to use 
Hyal2 as a cellular receptor.   As described above, we were not able to detect expression 
of  the  Envs  of  enJSRV-7,  enJSRV-11,  enJSRV-15  and  enJSRV-19  by  confocal 
microscopy. However, their ability to mediate cell entry, albeit at a lower efficiency, 
indicates that these constructs are being expressed at some level. Entry assays were also 
performed in the ovine uterine stromal oST cell line, with virus pseudotyped with those 
enJSRV Envs that did not mediate entry efficiently, to rule out the possibility that these 
Envs do not interact with Hyal2 but with other receptors. As shown in Figure 40 none of 
the enJSRV Envs tested were able to mediate entry in this cell line in contrast to the 
exogenous JSRV that was used as a positive control.  
None of the enJSRV Envs utilized bovine Hyal2 as a cellular receptor as efficiently as 
sheep or goat Hyal2 as previously reported by the exogenous JSRV Env (Dirks, Duh et 
al. 2002). This could explain the lack of enJSRV colonization of Bos taurus (Arnaud, 
Caporale et al. 2007). It should be taken into consideration that the reduced ability of 
the Envs of enJSRV-7, enJSRV-9, enJSRV-11, enJSRV-13 enJSRV-15, enJSRV-20, 
enJS56A1 and enJSRV-19 to mediate viral entry could be due to the inability of these 
Envs to be efficiently packaged. 
 
Figure 40. Receptor usage of exogenous and endogenous Betaretroviruses of sheep. 
Viral entry assays were performed in NIH 3T3 cells stably expressing the ovine, goat or bovine 
Hyal2 gene. Cells were transduced with MLV-based retroviral vectors expressing the alkaline 
phosphatase  gene  and  pseudotyped  with  various  enJSRV  Envs.  Results  are  expressed  as 
alkaline phosphatase foci per ml (APF/ml) and are indicated as <20 when the titer was less than 
20 APF/ml. Mariana Varela, 2007     Chapter 5,132 
 
Figure 41. Entry assays in oST cells. 
Ost  cells  were  transduced  as  described  for  the  previous  figure.  Results  are  expressed  as 
alkaline phosphatase foci per ml (APF/ml). 
As shown in Figure 37, none of the identified enJSRV envs encoded for a VR3 region 
similar to the exogenous JSRV env, in particular all of them lacked a YXXM motif in 
the  cytoplasmic  tail  of  the  TM  domain  which  is  critical  for  transformation  by  the 
exogenous JSRV Env (Liu, Wang et al. 2001; Maeda, Palmarini et al. 2001; Palmarini, 
Maeda et al. 2001; Zavala, Pretto et al. 2003; Liu and Miller 2005; Cousens, Maeda et 
al.  2007).  Standard  transformation  assays  were  performed  in  208F  cells  to  test  the 
transforming potential of these enJSRV Envs. As expected, none of the enJSRV Envs 
induced transformation two weeks after transfection (Table 6). 
enJSRV Env 
construct 
Number of 
foci
6 
JSRV-Env  289.5 
enJS56A1-Env  0 
enJS5F16-Env  0 
enJSRV4-Env  0 
enJSRV6-Env  0 
enJSRV7-Env  0 
enJSRV9-Env  0 
enJSRV11-Env  0 
enJSRV13-Env  0 
enJSRV15-Env  0 
enJSRV16/18-Env  0 
enJSRV10-Env  0 
enJSRV20-Env  0 
enJSRV26-Env  0 
 Table 7. enJSRV Env transformation assays. 
                                                 
6 The numbers of foci represent the average of at least two experiments. 
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enJSRV  Envs  do  not  interfere  with  JSRV-Env  induced  cell 
transformation 
The  mechanisms  used  by  the  JSRV  Env  to  induce  cell  transformation  are  not 
completely understood, however several pieces of evidence point to the involvement of 
the  PI3K-AKT  and  the  Ras-MEK-MAPK  pathways  (Palmarini,  Maeda  et  al.  2001; 
Maeda, Fu et al. 2005; De Las Heras, Ortin et al. 2006). Recent work performed in our 
laboratory using mass spectrometry analysis identified the association of the JSRV Env 
with  the  signal  transducer  B-Raf  (Murgia  and  Palmarini,  unpublished  results).  The 
mass-spec  data  was  validated  by  co-immunoprecipitations  assays  performed  in 
transformed 208F cells as well as transiently transfected 293T cells. Interestingly, B-Raf 
is directly and indirectly involved in the modulation of the Ras-Raf-Mek-Erk and the 
PI3K/Akt pathways (Stork 2003; O'Neill and Kolch 2004; Kolch 2005; Stork and Dillon 
2005) which are activated in JSRV transformed cells. We were interested in testing 
whether the non transforming enJSRV Envs and the Y590 mutant were also able to 
interact with B-RAF to gain insight into the domains involved in this association. As 
shown  in  Figure  41  we  found  interaction  between  enJSRV  Envs  and  B-RAF  by 
immunoprecipitation studies performed in transiently transfected 293T cells as well as 
with the Y590 mutant.  
Next, we tested whether the enJSRV Envs could function as dominant negative proteins 
and prevent transformation by the exogenous JSRV Env. Indeed, enJSRVs Envs may 
interact with some of the same proteins that are possibly used by the JSRV Env to 
mediate transformation, To this end standard transformation assays were performed in 
208F  cells  with  pCMV3JS21ΔGP,  an  expression  plasmid  of  the  JSRV  Env,  and 
increasing amounts of various enJSRV Env expression plasmids. None of the enJSRV 
Envs tested were able to reduce significantly the number of foci induced by the JSRV 
Env (Figure 42). 
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Figure 42. EnJSRV Envs co-immunoprecipitate with B-RAF. 
293T  cells  were  cotransfected  with  5  µg  of  B-RAF  expression  plasmid  tagged  with  the  HA 
epitope  and  5  µg  of  expression  plasmids  of  the  JSRV  Env,  various  enJSRV  Envs  and  the 
Y590F mutant of the JSRV Env tagged with the FLAG epitope at the amino terminus (F-JSE, F-
enJSRV6-13-6 or F-JSE-Y590F) or the JSRV Env (JSE-F) and the Env of enJS5F16 tagged 
with the FLAG epitope at the carboxy terminus (JSE-En2-F). 48 hours after transfection cell 
were lysed, immunoprecipitated and analyzed by WB as indicated in each panel. 
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Figure 43. enJSRv Env do not prevent transformation by the JSRV Env. 
Transformation assays in  208F cells were performed by transfecting 1 µg of the expression 
plasmid  of  the  JSRV  Env  (exJSRV)  and  3,  6  and  9  µg  of  expression  plasmids  of  various 
enJSRV Envs and the Env of MLV as a control, as indicated in the top of each chart. Results 
represent the average of four experiments and are expressed as a percentage of transformation 
where the number of foci obtained with the JSRV Env alone is considered a hundred percent. 
Bars represent standard deviation. 
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To rule out the possibility that the efficiency of the cotransfection was low (a significant 
percentage of cells taking up and expressing the JSRV Env plasmid did not take up the 
enJSRV Env plasmid), cell lines stably expressing enJSRV Envs were produced by 
infecting 208F cells with retrovirus vectors encoding the various enJSRV Envs and the 
neomycin resistance gene. Colonies of neomycin resistant clones were pooled and used 
in standard transformation assays by transfecting the JSRV Env plasmid. Stable cell 
lines were  shown to express enJSRV Envs by  RT-PCR (see below, Figure 47). As 
shown in Figure 43 no changes in the number of foci were detected between the assays 
performed in cell lines expressing an empty vector and cells lines expressing enJSRV 
Envs.  Altogether, these results indicate that enJSRV Env cannot prevent transformation 
by the exogenous JSRV Env in vitro. 
 
Figure 44. Transformation assays in cell lines stably expressing enJSRV Envs. 
208F  cells  stably  expressing  an  empty  vector  (pLNCX2)  or  various  enJSRV  Envs  were 
prepared as described in Materials and Methods and used in standard transformation assays 
transfecting two different amounts of DNA of the JSRV Env (0.1 µg and 1 µg of DNA, panel A 
and  B  respectively).  Foci  were  counted  two  weeks  after  transfection.  Results  represent  the 
average of two experiments and are expressed as a percentage of transformation where the 
number of foci obtained in the cell line expressing the empty vector is considered a hundred 
percent. Bars represent standard deviation. 
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enJSRV Envs are not fusogenic in vitro 
The  cellular  mechanisms  underlying  mononuclear  trophoectoderm  proliferation  and 
differentiation into trophoblast giant BNCs in ruminants are poorly understood. The 
temporal  and  spatial  expression  of  enJSRV  Envs  and  Hyal2  in  the  sheep  placenta 
together with retarded blastocyst elongation and failure in the differentiation of BNCs 
after  enJSRV  Env  inhibition  in  utero  suggest  their  involvement  in  trophoblast 
proliferation and differentiation (Dunlap, Palmarini et al. 2005; Dunlap, Palmarini et al. 
2006).  We  hypothesized  that  the  formation  of  giant  BNCs,  trinucleate  fetomaternal 
hybrid cells and ultimately the establishment of the multinucleated syncytia could be the 
result of cell fusion elicited by the expression of enJSRV Envs and Hyal2. This idea is 
supported by the fact that Env proteins of ERVs present in the primate and mouse 
genomes, and highly expressed in the placenta, induce cell fusion in vitro (Mi, Lee et al. 
2000; Blaise, de Parseval et al. 2003; Dupressoir, Marceau et al. 2005). Therefore we 
investigated the fusogenic potential of enJSRV Envs in vitro. To this end 293, COS, 
HeLa  and  NIH-3T3  cells  stably  expressing  the  sheep  hyal2  gene  were  transiently 
transfected  with  expression  plasmids  of  the  various  enJSRV  Envs  and  cells  were 
monitored for 48 hours. As shown in Figure 44 none of the enJSRV Envs elicited cell 
fusion in the analyzed cell lines in contrast to the Envs of HERV-W or HTLV that were 
used as positive controls. 
It  is  possible  that  the  lack  of  fusogenic  activity  of  enJSRV  Envs  observed  in  the 
previous experiments was due to the absence of other molecules required for fusion 
besides from Hyal2 in the tested cell lines. To test this possibility, the same assays were 
performed in ovine trophoblast cells (oTr) from day 15 conceptuses (kindly provided by 
Dr.  Thomas  Spencer)  (Dunlap,  Palmarini  et  al. 2006).  This  cell  line  was  indirectly 
shown to express Hyal2 since it allowed entry of retroviral vectors pseudotyped with the 
JSRV Env (not shown). As shown in Figure 45 we could not detect cell fusion of oTr 
cells expressing enJSRV Envs.  
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Figure 45. Fusion assays. 
From top to bottom fusion assays performed in COS, 293, NIH 3T3-ovine Hyal2 and HeLa cells. 
Left  panels  show  representative  micrographs  of  the  results  obtained  when  cells  express 
enJSRV Envs. Right panels show fusion induced by the Env of HERV-W that was used as a 
positive control. Mariana Varela, 2007     Chapter 5,139 
 
 
 
 
 
Figure 46. EnJSRV Envs do not induce fusion of oTr cells. 
OTr  cells  were  transiently  transfected  with  various  enJSRV  Env  expression  plasmids  and 
monitored for seven days for the presence of cell fusion. Cells were stained with basic fucsin 
two and seven days after transfection and photographed. 
  
We also tested whether oTr expressing enJSRV Envs could fuse with cells of the ovine 
luminal epithelium (oLE) (Johnson, Burghardt et al. 1999) to mimic the formation of 
fetomaternal  hybrid  cells.  As  shown  in  Figure  46  we  could  not  detect  cell  fusion 
between oTr cells expressing enJSRV Envs and oLE cells expressing ovine Hyal2. 
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Figure 47. EnJSRV Env do not induce fusion of oTr with LE cells. 
oTr cells were transiently transfected with expression plasmids of enJSRV Envs and plated in 6 
well plates. Two hours later they were overlaid with oLE cells transiently expressing the ovine 
hyal2 gene and the presence of cell fusion was monitored for 72 hours when cells were stained 
with basic fucsin and photographed. Expression of HERV-W Env induced fusion of oTr cells. 
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enJSRV Envs do not enhance proliferation of 208F cells 
Since oTr cells were not available to us at the time, we used rat 208F cells (that have 
been extensively utilized in the study of the transforming properties of the JSRV Env) 
as  a  first  approach  into  the  elucidation  of  the  molecular  mechanisms  inducing  cell 
proliferation and differentiation of trophoblast cells by enJSRV Envs (Chow, Alberti et 
al. 2003; Liu, Lerman et al. 2003).  
Since the proliferation of oTr cells isolated from day 15 conceptuses  is reduced by  
33% when enJSRV Env expression is blocked by MAO-env (Dunlap, Palmarini et al. 
2006)  we  wanted  to  test  whether  208F  cells  expressing  enJSRV  Envs  displayed  an 
increased proliferation rate compared to cells expressing empty vector. If so, we would 
investigate further the molecular mechanisms underpinning this effect. To this end 208F 
cells stably expressing various enJSRV Envs were prepared as described in Materials 
and Methods and cell proliferation was measured using the WST assay. enJSRV Env 
expression was determined by RT-PCR as shown in Figure 47. Two different cells lines 
were  prepared  and  each  cell  line  was  assessed  in  triplicate  in  two  independent 
experiments. Experiments were also performed by culturing cells in the presence of 2 or 
5% FBS in order to be able to detect subtle changes in cell proliferation that otherwise 
would not be recognized if high concentrations of serum were used. As shown in Figure 
48  no  changes  in  cell  proliferation  were  detected  under  any  of  the  experimental 
conditions  tested  when  208F  cells  express  enJSRV  Envs.  The  same  results  were 
obtained when individual cell clones were analyzed (not shown). 
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Figure 48. enJSRV Env expression in 208F stable cell lines as demonstrated by RT-PCR. 
EnJSRV Env expression was determined by RT-PCR from RNA extracted from the indicated 
stable cell lines. Primers were designed in conserved regions so that one pair would amplify all 
the envelopes and the full length product. Amplification of rat β-actin was used as a positive 
control (middle panel) and no PCR product was obtained when the cDNA was prepared without 
the  addition  of  reverse  transcriptase,  indicating  the  absence  of  DNA  contamination  (bottom 
panel). Numbers on the left indicate base pairs. 
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Figure 49. EnJSRV Envs do not enhance proliferation of 208F cells. 
A) Cell proliferation of 208F cells stably expressing the indicated enJSRV Envs or empty vector 
(pLNCX2)  after  120  hours  of  culture  in  media  supplemented  with  5%  FBS.  Each  column 
represents the combined data of four experiments done in triplicate each time. Bars indicate 
standard deviation. B) Growth curve of one representative experiment of 208F cells stabling 
expressing the indicated enJSRV Envs or empty vector and cultured in media supplemented 
with 5% FBS to demonstrate that no differences in the cell proliferation rate were observed at 
any of the time points analyzed. 
 
enJSRV Envs do not promote invasion of 208F cells 
Trophoblast  giant  BNCs  have  differentiated  from  the  MTC  by  day  16  and  migrate 
through the apical tight junctions of the chorion to fuse apically with the cells of the 
endometrial LE of the uterus forming trinucleate hybrid fetomaternal cells throughout  
the  whole  gestational  period  (Wooding  1992). Giant  and  BNC  typically  exhibit  the 
capacity of migration and invasion, albeit the degree of migratory activity varies within 
species.    The  synepitheliochorial  placentation  of  sheep  could  be  characterized  by  a 
“restricted” invasion since trophoblast BNCs migrate towards the endometrial LE but 
do not go beyond it in contrast to the haemochorial human placenta where these cells 
cross several layers of the uterine wall (Wooding 1992; Spencer, Johnson et al. 2004). 
We wanted to test whether enJSRV Env expression could promote cell invasion. To this 
end  a  tridimensional  inverse  invasion  assay  with  a  matrigel  reconstituted  basement Mariana Varela, 2007     Chapter 5,144 
membrane matrix was performed using 208F cells stably expressing enJSRV Envs. As 
shown in Figure 49 we could not detect differences in the invasive phenotype in cells 
expressing  enJSRV  Envs  compared  to  the  control  cells.  Of  great  concern  was  the 
observation that control cells, expressing the empty retroviral vector, displayed a highly 
invasive phenotype and that we obtained variable results within experiments. To rule 
out the possibility that the selection of cells with neomycin was playing a role in this 
phenomenon,  we  prepared  new  set  of  cell  lines  that  were  not  subject  to  neomycin 
selection. Under the same experimental conditions we still observed a highly invasive 
phenotype in control cells and big variations within experiments (not shown). 
 
Figure 50. Invasion assays of 208F cells expressing enJSRV Envs. 
Invasion assays were performed in duplicates and three independent fields per sample were 
analyzed and quantified. Invasion was visualized by staining cells directly with calcein followed 
by confocal microscopy analysis and quantification using the Image J software. Only cells in the 
75µm section or above were considered invasive for quantification purposes. A composition of 
these sections was quantified and results are expressed as a percentage of invasion where the 
100% value is taken by cells expressing the empty vector alone. The chart shows the average 
of three experiments and bars represent standard deviation. 
 
enJSRV  Env  expression  does  not  increase  proliferation,  the 
appearance of binucleate cells or migration of oTr cells 
We next analyzed the effect of enJSRV Env expression in oTr cells. We wanted to 
address  whether  enJSRV  Env  over-expression  increases  oTr  cell  proliferation 
considering that a 33% reduction in their growth was observed when cultured in the 
presence  of  MAO-env  (Dunlap,  Palmarini  et  al.  2006).  To  this  end  oTr  cells  were Mariana Varela, 2007     Chapter 5,145 
transiently  transfected  with  expression  plasmids  of  various  enJSRV  Envs  and  cell 
proliferation was measured using the WST assay after 72 hours of culture. As shown in 
Figure  50,  no  difference  in  the  proliferation  rate  was  detected  in  oTr  cells 
overexpressing enJSRV Envs. 
 
Figure 51. EnJSRV Env overexpression does not increase proliferation of oTr cells. 
Data are shown as a % of proliferation where growth of mock transfected cells is considered as 
100%.  Each  column  represents  the  average  of  four  independent  experiments  with  eight 
replicates for each experiment. Bars represent standard deviation.  
Based on the fact that enJSRV Env inhibition of expression in vivo was associated with 
an  undeveloped  conceptus  and  an  almost  complete  lack  of  trophoblast  giant  BNCs 
(Dunlap, Palmarini et al. 2006), we were interested in  testing if enJSRV Env expression 
induced the appearance of BNCs. OTr cells transfected with the respective enJSRV Env 
plasmids were plated in 6 well dishes 2 hours after transfection. After 72 hours cells 
were fixed, stained with May Grunwald Giemsa and the number of BNCs counted. As 
shown in Figure 51 no changes in the number of BNCs were observed after enJSRV 
Env over-expression. 
We next investigated if enJSRV Env over-expression would induce cell migration of 
oTR cells. Standard migration assays were performed in transwell chambers with oTr 
cells transiently expressing enJSRV Envs. As shown in Figure 52 we could not detect 
differences in the migratory properties of any of the cells analyzed. Mariana Varela, 2007     Chapter 5,146 
 
 Figure 52. Percentage of BNCs after enJSRV Env expression. 
Between 400 and 700 cells were counted for each well and scored as mononuclear or binuclear 
and then the percentage was calculated. The experiment was repeated six independent times. 
Bars represent standard deviation. 
 
 
Figure 53. OTr cells migration when over-expressing enJSRV Envs. 
Migration assays were performed in transwell chambers as described in Materials and Methods. 
Cell migration was quantified after 1 day (not shown) or 3 days of culture. Cells were stained 
with  calcein  and  five  random  fields  were  photographed  using  a  confocal  microscope  and 
quantified using the Image J software. Each column represents the average of two experiments. 
Bars represent standard deviation. 
 
Finally, we performed migration assays with oTr cells that were treated with only Endo-
Porter  (the  delivery  agent),  MAO-5mis  or  MAO-env.  Figure  53  shows  that  no 
statistically significant differences were observed in the migration of oTr cells in which 
enJSRV Env expression is inhibited. 
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Figure 54. Migration assay in oTr treated with MAO. 
OTr cells were plated in transwell chambers with media containing Endo-Porter alone or Endo-
Porter plus MAO-5mis or MAO-env and incubated for 48 hours. Cells were then stained and ten 
pictures per wells were taken and quantified as described above. Experiments were repeated 
twice independently. Bars represent standard deviation. 
 
Discussion 
In this section, a series of experiments were performed with the intention to elucidate 
the mechanisms behind the regulation of ovine trophoblast growth and differentiation 
by  enJSRV  Envs.  We  hypothesized  that  enJSRV  Envs  and  Hyal2  regulate  placenta 
morphogenesis in sheep by modulating cell-cell fusion and/or intracellular signalling 
pathways. Our hypothesis was based on the observation that the block of enJSRV Env 
expression in utero resulted in retarded conceptus growth and BNC differentiation in 
sheep (Dunlap, Palmarini et al. 2006). Moreover, HERV-W Env (syncytin) has been 
found to regulate trophoblast growth an differentiation in vitro (Lin, Xu et al. 1999) and 
human and mouse syncytins elicit cell fusion in vitro (Mi, Lee et al. 2000; Dupressoir, 
Marceau et al. 2005). 
To experimentally address our hypothesis, we first characterized the currently known 
enJSRV Envs that possess an intact ORF (Arnaud, Caporale et al. 2007). By standard 
viral entry assays we demonstrated that most of the Envs analyzed were able to mediate 
viral entry using goat and ovine Hyal2. None of the enJSRV Envs utilise the bovine Mariana Varela, 2007     Chapter 5,148 
Hyal2 protein probably justifying the reason why enJSRVs have not been found in Bos 
taurus (Arnaud, Caporale et al. 2007).  
We showed that these enJSRV Envs do not induce cell transformation in vitro and 
cannot interfere with transformation induced by the exogenous JSRV although they are 
able  to  interact  with  B-Raf,  one  of  the  cellular  molecules  known  to  mediate 
transformation by the JSRV Env (Murgia and Palmarini, unpublished results).  
It is interesting to note that enJSRV Envs have a high degree of similarity with the 
oncogenic JSRV Env. It is tempting to speculate that both endogenous and exogenous 
JSRV Envs share similar mechanisms to induce trophoblast proliferation/differentiation 
and cell transformation respectively, since placenta morphogenesis has been regarded as 
a  “pseudo-tumour”  or  a  “physiological  metastasis”  (Soundararajan  and  Rao  2004; 
Ferretti, Bruni et al. 2007). Although many of these parallels come from comparisons 
made with the human placenta, trophoblast cells in general are characterized by a high 
proliferative  rate,  migratory  and  invasive  properties  and  the  capacity  to  evade  the 
immune  system,  which  are  also  characteristics  of  cancer  cells.  Interestingly,  human 
cytotrophoblast  cells  express  functional  tumour-associated  genes  and  are  capable  of 
engaging in autocrine stimulatory loops, rendering them less dependent on survival and 
growth factors from the surrounding tissue (Ferretti, Bruni et al. 2007). Moreover, the 
growth stimulatory effects can be amplified by signals provided by the neighbouring 
cells through paracrine loops (Ferretti, Bruni et al. 2007). However, the ultimate fate of 
trophoblast cells is terminal differentiation, which regulates their tumour-like attributes 
and the progression to senescence and apoptosis. The difference between malignant cell 
transformation and normal trophoblast development is that in the latter, the cellular and 
molecular  events  leading  to  cell  proliferation/migration/invasion  are  spatially  and 
temporally regulated, following a highly controlled plan. Thus, trophoblast cells are an 
ideal  model  for  the  study  of  the  regulation  of  cell  growth,  differentiation, 
migration/invasion and carcinogenesis. enJSRV  and JSRV Envs could mediate their 
effects  through  the  activation  of  similar  pathways  considering  that  both  are  able  to 
interact with B-Raf that is implicated in JSRV  mediated  transformation and in the 
growth and migration of human trophoblast cells (Pollheimer and Knofler 2005). 
We  tested  the  possibility  that  enJSRV  Envs  are  important  for  BNC  and 
syncytiotrophoblast  formation  by  eliciting  cell  fusion  as  proposed  for  syncytins  in 
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detect cell-cell fusion in several cell lines transiently transfected with enJSRV Envs or 
in oTr cells. The lack of fusogenic activity of enJSRV Envs could be due to several 
reasons. Firstly, the limitations of the in vitro systems used should be considered. It is 
possible  that  other  molecules  beside  enJSRV  Envs  and  Hyal2  are  required  for  the 
induction of cell fusion and these are absent in the cell lines used. We have used oTR 
cells to safeguard us from this problem; however there is no guarantee that oTR cells in 
vitro faithfully represent trophoblast cells in vivo. 
The in vivo loss of function experiments using MAO-env indicated that enJSRV Env 
influences  mononuclear  trophoectoderm  cell  growth  and  differentiation  during 
conceptus elongation. This process precedes the formation of multinucleated syncytia 
(Dunlap, Palmarini et al. 2006). Thus, we initially tested whether enJSRV Env over-
expression could increase the proliferation rate and the migratory/invasive properties of 
208F cells (as a first approach) and oTr cells. We detected no changes in proliferation 
and migration/invasion in either cell type. enJSRV Env over-expression did not induce 
the appearance of BNCs either. Failure to detect a different phenotype, measured by 
changes in cell proliferation/migration/invasion, after enJSRV Env expression in 208F 
is not surprising since these are immortalized rodent fibroblasts whose characteristics 
are far from similar to the attributes of conceptus trophoblast cells. The inability to 
induce changes in oTr cells after enJSRV Env over-expression could be attributed to the 
fact that the day 15 oTr cells used in these experiments already express enJSRV Envs 
and therefore their over-expression by transient transfection does not induce profound 
effects. However, we did not induce a reduction in cell migration after blocking enJSRV 
expression with MAO-env. 
It  is  also  possible  that  multiple  enJSRV  Envs  are  necessary  to  induce  cell 
proliferation/migration/invasion since that several Envs appear to be co-expressed in the 
placenta (Rote, Chakrabarti et al. 2004; Seifarth, Frank et al. 2005). In conclusion, we 
were unable to experimentally reproduce in vitro the effects of enJSRV Env in vivo. 
However, as mentioned before it should be highlighted that oTr cells used in these 
studies were primary cultures that had been frozen twice and passaged at least eight 
times and thus any conclusions arising from these studies should be considered with 
caution. 
An  obligatory  step  in  the  understanding  of  the  role  of  enJSRVs  in  placenta 
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the identification of the enJSRV loci expressed in the placenta. In particular it would be 
interesting  to  know  the  specific  loci  that  are  expressed  during  the  periimplantation 
period. The knowledge of which enJSRV loci are expressed in the placenta could have 
facilitated the design of the in vitro studies presented here and the evaluation of Envs 
that are unable to encode full length products because of the presence of stop codons, as 
is the case of enJSRV1. As previously mentioned, the Env protein of ERV3 contains a 
premature stop codon that prevents the expression of the membrane spanning domain, it 
also  lacks  signal  and  fusion  peptides (Rote,  Chakrabarti  et  al.  2004).  Despite  these 
unusual characteristics, it seems to be involved in trophoblast differentiation and thus 
the role of prematurely terminated enJSRV Envs in BNC differentiation, which were 
not included in this study, should be taken into consideration. Moreover, it would be 
interesting to learn if enJSRV insertions could regulate neighbouring genes in a tissue 
and temporal specific fashion by the creation of alternative promoters, enhancers or 
polyadenylation signals as it is the case for the HERV-K element, which is inserted in 
proximity of the insulin-like growth factor gene and seems to mediate its expression 
during human syncytiotrophoblast formation (Bieche, Laurent et al. 2003). 
In conclusion, all of data reported to date in sheep, primates and mice suggests that 
ERVs have been positively selected for a physiological role in placenta morphogenesis 
and possibly, the diversity of placenta structures found among species could reflect the 
differential use of ERV Env glycoproteins among mammals (Villarreal 1997). 151 
Chapter 6 
Discussion 
Retroviruses have the ability to integrate their genetic information into the host genome, 
the capacity to transduce cellular genes and the opportunity to colonize the germ line of 
the host. ERVs are present in the genomes of all vertebrates (Gifford and Tristem 2003) 
and can be used as DNA fossils to unravel virus-host coevolution over millions of years 
(Coffin 2004). ERVs have protected the host against exogenous retroviruses (Gardner, 
Rasheed  et  al.  1980;  O'Brien,  Berman  et  al.  1983;  Arnaud,  Caporale  et  al.  2007) 
maintained genomic plasticity (Hughes and  Coffin 2001) and play  a critical role in 
placental morphogenesis (Mi, Lee et al. 2000; Dunlap, Palmarini et al. 2006).  
Sheep betaretroviruses constitute a perfect model to study retrovirus biology. JSRV is 
the causative agent of OPA, a naturally occurring lung cancer of sheep. The expression 
of one of its structural proteins (Env) is sufficient to induce cell transformation both in 
vitro  and  in  vivo,  which  is  a  unique  feature  among  oncogenic  retroviruses (Maeda, 
Palmarini et al. 2001; Rai, Duh et al. 2001; Allen, Sherrill et al. 2002; Danilkovitch-
Miagkova, Duh et al. 2003; Zavala, Pretto et al. 2003; Liu and Miller 2005; Caporale, 
Cousens  et  al.  2006).  OPA,  besides  being  a  disease  that  has  important  economic 
consequences  for  the  farming  industry  represents  a  large  animal  model  to  study 
pulmonary carcinogenesis and to develop novel therapeutic and diagnostic interventions 
(Palmarini and Fan 2001) (this thesis). The sheep genome harbours at least 27 copies of 
ERVs highly related to the exogenous and pathogenic JSRV (enJSRVs). Two of the 
enJSRV  loci  are  transdominant  towards  related  exogenous  viruses  using  a  unique 
mechanism of viral interference acting at the late stages of the retroviral cycle [JSRV 
late restriction (JLR)] (Mura, Murcia et al. 2004; Arnaud, Caporale et al. 2007; Arnaud, 
Murcia et al. 2007; Murcia, Arnaud et al. 2007). A recent study from our laboratory 
strongly  supports  the  hypothesis  that  selection  of  transdominant  enJSRV  loci  has 
protected  sheep  against  infection  with  related  exogenous  retroviruses.  Thus, 
endogenization  and  selection  of  ERVs  that  may  act  as  restriction factors  is  another 
mechanism used by the host against retroviral infections (Arnaud, Caporale et al. 2007). 
enJSRVs  have  also  evolved  to  play  a  critical  role  in  placental  morphogenesis  by 
regulating conceptus development (Dunlap, Palmarini et al. 2006). Thus the interaction 152 
between JSRV, enJSRVs and their host provides a unique model to study many aspects 
of retrovirus biology 
The  aim  of  the  first  part  of  this  thesis  was  to  gain  insights  into  the  molecular 
mechanisms  underpinning  JSRV  Env  induced  cell  transformation.  In  addition, 
experiments  were  performed  to  determine  whether  the  knowledge  gained  into  the 
JSRV/OPA system could be used for the development of OPA as a large animal model 
for lung carcinogenesis. The objective of the second part of this study was to unravel 
how  enJSRV  Envs  regulate  trophoblast  growth  and  differentiation.  The  two  major 
points studied in this thesis might seem unrelated at first. However, some of the major 
biological  consequences  of  JSRV  and  enJSRVs  interaction  with  the  host,  such  as 
oncogenesis  and  placental  development,  are  both  mediated  by  the  viral  envelope 
glycoprotein.  In  addition,  placental  morphogenesis  has  been  regarded  as  “pseudo-
tumourigenesis”  and  similar  molecular  pathways  seem  to  be  shared  by  cancer  and 
trophoblast  cells  to  turn  on  their  highly  proliferative  and  invasive  phenotypes 
(Soundararajan and Rao 2004). Thus, we used our knowledge of the mechanisms of cell 
transformation induced by the JSRV Env to understand the role of enJSRV Envs in 
placental morphogenesis.  
We first investigated the role of the receptor tyrosine kinase RON and Hyal2 in JSRV 
Env induced transformation. We showed that: I) RON interacts with both the exogenous 
and endogenous JSRV Envs and the cytoplasmic tail of the Env appears to be the major 
determinant of the biological effects of the RON-Env interaction; and II) Hyal2 is not 
involved  in  the  transformation  of  epithelial  cells.  We  then  investigated  the  signal 
pathways  involved  in  JSRV  mediated  transformation  by  using  a  variety  of  signal 
transduction  inhibitors.  As  a  result  of  these  studies  we  found  that  the  molecular 
chaperone  Hsp90  regulates  JSRV  induced  cell  transformation  at  least  in  part  by 
downregulating Akt expression. Thus, we could use in the future the JSRV/OPA model 
as a tool for the evaluation of the mechanisms of action and efficacy of new therapeutic 
agents.  
We  wanted  then  to  elucidate  the  mechanisms  by  which  enJSRV  Envs  regulate 
trophoblast  growth  and  differentiation.  Our  original  goal  was  to  set-up  an  in  vitro 
system  where  we  could  study  the  role  of  enJSRV  Envs  in  cell  proliferation, 
migration/invasion.  Unfortunately  we  were  unable  to  set-up  this  in  vitro  approach. 153 
Thus,  it  still  remains  to  be  determined  how  enJSRV  Envs  contribute  to  conceptus 
development and placenta morphogenesis. 
What is the relevance of studying the mechanisms of transformation of an oncogenic 
retrovirus of sheep? OPA, aside from being one of the most important viral diseases of 
sheep, also has striking similarities with some forms of human lung adenocarcinomas 
(Palmarini  and  Fan  2001).  Thus  the  understanding  of  the  molecular  mechanisms 
governing  JSRV  induced  cell  transformation  could  provide  insights  into  the 
development of human lung cancer (Palmarini and Fan 2003). Lung cancer is the most 
common cause of death among human cancer patients worldwide and the survival rate 
is  very  poor,  which  stresses  the  lack  of  effective  therapies  and  early  detection 
techniques (Parkin, Bray et al. 2005). Thus, the use of animal models other than the 
mouse could provide new insights especially for the development of new therapeutic 
and diagnostic strategies. It is clear that better animal models are required to facilitate 
drug development considering that most of the currently available models are based on 
conditional  transgene  expression  or  conditional  gene  knockouts  that  usually  do  not 
reflect  the  tumour  spectrum  observed  in  humans.    In  this  scenario,  OPA  offers  an 
alternative animal model where cancer development can be studied in a natural setting. 
As previously mentioned the JSRV Env is a dominant oncoprotein both in vitro and in 
vivo.  The  JSRV  Env  has  been  shown  to  activate  the  PI3K/Akt  and  the  Ras-MEK-
MAPK pathways (Palmarini, Maeda et al. 2001; Maeda, Fu et al. 2005; De Las Heras, 
Ortin et al. 2006). These pathways are involved in cellular responses to a variety of 
stimuli  that  activate  membrane,  cytoplasmic  and  nuclear  signalling  networks 
(Dhanasekaran and Johnson 2007). It is now apparent that they can transduce a diverse 
array  of  signals  into  specific  cellular  functions  through  their  spatial  and  temporal 
regulation within the cell. Although at the moment it is not clear how the JSRV Env 
engages the cell signalling network to activate these pathways, the elucidation of the 
multi-protein complexes that might be assembled upon JSRV Env expression could 
provide insight into the understanding of the regulation of the cell signalling network. 
OPA can be experimentally reproduced in lambs with a short incubation period and in 
the presence of a functional immune system. Thus, the JSRV/OPA system allows us to 
immediately  address  in  vivo  in  the  sheep,  observations  gained  from  experiments  in 
tissue culture.  
In the work presented here we demonstrated that several Hsp90 inhibitors suppressed 
JSRV Env-induced transformation in vitro. The JSRV-OPA model could be used for the 154 
development of new Hsp90 inhibitors for the treatment of lung adenocarcinoma. Hsp90 
inhibitors are believed to be good candidates for cancer therapy considering that: I) lung 
cancer  is  the  result  of  genetic  and  epigenetic  alterations  that  lead  the  activation  of 
several signal transduction pathways simultaneously (Girard, Zochbauer-Muller et al. 
2000; Digel and Lubbert 2005) and II) Hsp90 inhibitors are able to disrupt various 
signal transduction pathways simultaneously (Blagg and Kerr 2006). 
Our  laboratory  is  interested  in  investigating  whether  bronchioalveolar  stem  cells 
(BASCs) are the actual target of JSRV transformation, rather than type II pneumocytes 
and Clara cells. JSRV expression is found by IHC in tumour cells but not in the normal 
type II pneumocytes and Clara cells surrounding the lesions (Palmarini and Fan 2003; 
Caporale, Centorame et al. 2005). It is currently believed that some types of cancers 
develop and are maintained by a minority of cells, cancer stem cells, that have the 
capacity of self renewal and give rise to more progenitor-like and differentiated cells in 
a disorganized fashion (Burkert, Wright et al. 2006). The fact that BASCs have been 
proposed  to  maintain  type  II  pneumocytes  and  Clara  cells  and  give  rise  to 
adenocarcinomas in mice (Kim, Jackson et al. 2005) supports the idea that JSRV targets 
BASCs.  
ERVs have been described as either junk DNA or as essential for mammalian evolution 
(Bock  and  Stoye  2000).  They  have  also  been  linked  with  both  detrimental  and 
beneficial roles for the host. One of the most fascinating aspects of the biology of ERVs 
is their possible role/s in placental morphogenesis. ERVs have been speculated to play a 
physiological role in placenta morphogenesis for almost three decades considering that 
retroviral particles have been detected frequently in the reproductive tract of several 
animal  species  (Kalter,  Helmke  et  al.  1973;  Vernon,  McMahon  et  al.  1974;  Kalter, 
Heberling et al. 1975; Smith and Moore 1988; Harris 1991; DeHaven, Schwartz et al. 
1998). A few years ago, the identification of HERVs expressing intact env ORFs in the 
human placenta and the ability of these Envs to elicit cell fusion in vitro provided some 
evidence for the involvement of ERVs in placental development (Mi, Lee et al. 2000). 
Moreover, a systematic in silico analysis identified two fusogenic retroviral murine env 
genes  with  similar  characteristics  to  the  human  genes  supporting  the  idea  that 
independently  acquired  ERVs  were  positively  selected  and  contributed  to  the 
development of the placenta in different species (Dupressoir, Marceau et al. 2005). The 
study of enJSRVs has provided the first piece of evidence of a physiological role played 
by  ERVs  in  conceptus  and  placental  development in  vivo  (Dunlap,  Palmarini  et  al. 155 
2006). By blocking enJSRV Env expression in utero by MAO we demonstrated that 
they  are  essential  for  sheep  trophoblast  outgrowth  and  BNC  differentiation.  Early 
pregnancy loss was observed in MAO-env-treated ewes probably due to the reduced 
production  of  INF-τ  by  the  growth  retarded  conceptus.  The  understanding  of  the 
molecular  mechanisms  governing  sheep  trophoblast  differentiation  and  the  role  of 
ERVs in this process would provide invaluable information for comparative physiology 
and  pathology,  considering  that  for  ethical  reasons  similar  experiments  can  not  be 
performed in humans.  
One of the objectives of this thesis was to study how enJSRVs regulate trophoblast cell 
growth and differentiation. Despite the fact that we were unable to identify phenotypic 
changes in cells upon enJSRV Env expression,  it is interesting to mention how the 
knowledge of the mechanisms of cell transformation induced by the JSRV Env could be 
translated in the cellular machinery engaged by enJSRV Envs to promote trophoblast 
differentiation.  Interestingly,  Ron 
-/
-  mouse  embryos  fail  to  survive  after  the 
periimplantation period (Muraoka, Sun et al. 1999). This, together with the fact that Ron 
transcripts have been detected  within the trophoectoderm surrounding the inner cell 
mass of E3.5 embryos, in particular in the giant trophoblast cells of later stage embryos, 
and that Ron overexpression promotes an invasive phenotype, suggests that Ron might 
be  required  for  embryo  implantation  and  trophoblast  viability (Muraoka,  Sun  et  al. 
1999; Hess, Waltz et al. 2003).  MSP (the Ron ligand) deficient mice are phenotypically 
normal and do not display reproductive problems (Bezerra, Carrick et al. 1998), thus it 
may be possible that in sheep Ron could be activated by other means including enJSRV 
Envs.  In  this  study  we  have  demonstrated  that  the  Env  of  enJS5F16  inhibits  Ron 
activation. Since constitutive Ron activation has been found to promote cell spreading, 
dissociation, migration and invasion (Wang, Yao et al. 2006), which are some of the 
attributes  of  trophoblast  BNCs,  it  is  feasible  that  enJSRV  Envs,  by  inhibiting  Ron 
activation, contribute to the less invasive phenotype of the ruminant placenta. We have 
no information at this time of which enJSRV loci are expressed in the placenta and if 
they all display the same level of inhibition towards Ron. However, it is possible that 
the  spatial  and  temporal  expression  of  different  enJSRV  loci  with  diverse  activities 
towards Ron and with different affinity for Hyal2 (that can also inhibit Ron activation 
(Danilkovitch-Miagkova,  Duh  et  al.  2003)),  mediate  the  highly  regulated  series  of 
events that culminate with the appearance of BNCs and their migration towards the LE. 
Ron  splice  variants  have  been  found  in  association  with  altered  Ron  expression  in 
cancer cells (Wang, Yao et al. 2006). enJSRV Envs could also have different biological 156 
effects on these splice variants that might be expressed and/or required in a “tumour 
like” tissue like the placenta. Considering that Ron forms a multichaperone complex 
with  Hsp90  (Germano,  Barberis  et  al.  2006),  the  latter  could  be  involved  in  the 
stabilization  of  these  splice  variants  or  activated  Ron  itself.  Even  though  all  these 
scenarios could possibly be taking place in trophoblast cells, the signals that ultimately 
dictate  the  activation  of  particular  enJSRV  loci  during  the  periimplantation  period 
remain to be determined. The development of an appropriate in vitro system will be 
required to dissect these mechanisms.  
It could be speculated that enJSRVs could contribute to placental morphogenesis not 
only by the expression of Env proteins but also by transcriptional regulatory control of 
their  LTRs  by  the  creation  of  alternative  promoters,  enhancers  and  polyadenylation 
signals.  The  insertion  of  HERV-E  in  the  5’  UTR  of  the  growth  factor  pleitropin 
provides an example of a trophoblast specific promoter created upon retroviral insertion 
which seems to contribute to the invasive phenotype of the trophoblast (Schulte, Lai et 
al. 1996). Another example is provided by the expression of the insulin growth factor 4 
(INSL4) in the placenta which seems to be driven by a HERV-K insertion (Bieche, 
Laurent et al. 2003). 
Another  aspect  to  discuss  is  the  possible  role  of  ERV  Envs  in  maternal  immune 
tolerance to the foetus. Many retroviral Envs seem to mediate immunosuppression by 
means of the expression of a stretch of conserved amino acids present in the TM domain 
(Cianciolo, Copeland et al. 1985). Syncytin 1 and 2 harbour this immunosuppressive 
region and it has been speculated that they contribute to the creation of an immune 
tolerant environment for the foetus although the mechanism by which this region is 
immunesuppressive remains unclear (Villarreal 1997; Mi, Lee et al. 2000).  On the 
other hand it is unlikely that full immune suppression is due to the expression of a 
single retroviral gene. None of the currently known enJSRV Envs harbour a known 
immunosuppression domain, although this does not exclude the possibility that they do 
play a role in maternal tolerance to the foetus. 
In conclusion, although a role of ERVs in the reproductive biology of several animal 
species has been speculated for quite some time, the study of enJSRVs has provided the 
first  in  vivo  evidence  for  their  involvement  in  placental  morphogenesis  (Dunlap, 
Palmarini et al. 2006).  However, the lack of knowledge of the cellular and molecular 
mechanisms governing trophoblast outgrowth and differentiation during early stages of 157 
pregnancy  in  ruminants  (Cammas,  Reinaud  et  al.  2005)  has  made  it  difficult  to 
understand how enJSRV Envs exert their biological effects. Our early speculation, that 
enJSRV Env are essential for BNCs and syncytia formation by eliciting cell to cell 
fusion through a mechanism similar to viral-cell fusion, as proposed for syncytins in 
humans  and  mice,  now  seems  unlikely  given  that  none  of  the  enJSRV  Envs  tested 
induced fusion when overexpressed in a variety of cell lines (although technical issues 
could account for this observation). Given the complexity and the temporal and spatial 
regulation  of  the  signalling  pathways  that  command  pregnancy  recognition  and 
conceptus  implantation  in  sheep  (Spencer,  Johnson  et  al.  2007)  it  is  feasible  that 
enJSRV Envs are just one of the components that contribute to the chain of events that 
ultimately  result  in  a  successful  pregnancy.  It  still  remains  to  be  determined  which 
enJSRV  loci  are  expressed  in  the  ovine  placenta.  It  seems  likely  that  cooperation 
between several env genes would be required since both humans and mice present two 
related syncytins genes with possibly redundant properties. On the other hand, there is 
evidence  to  support  the  hypothesis  that  ERV  have  been  positively  selected  for  a 
beneficial  role  in  placental  morphogenesis  and  possibly  have  contributed  to  the 
evolution of placental mammals (Harris 1991). 
Overall, ERVs provide an excellent model to study the evolutionary interplay between 
exogenous  retroviruses,  endogenous  retroviruses  and  their  host.  Despite  all  the 
discoveries made in these last years on this fascinating group of viruses, there are still 
many critical aspects on the pathogenesis of OPA, on the mechanisms leading to JLR 
and the role of enJSRVs in reproductive biology that remain to be elucidated that would 
provide  the  background  required  for  the  development  of  preventive/therapeutic 
strategies. Unravelling of these unknown aspects of JSRV and OPA biology provides an 
exciting challenge for the next generation of PhD students! 
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